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Narrowly dispersed amino-functionalised polystyrene microspheres, with a range of 
diameters, were successfully synthesised via emulsion and dispersion 
polymerisation. Fluorescent labelling allowed cellular translocation to be assessed in 
a variety of cell lines and was found to be very high, but controllable, whilst 
exhibiting no detrimental effect on cellular viability. In order to fully determine the 
mode of microsphere uptake, “beadfected” melanoma (B16F10) cells were studied 
using both chemical and microscopic methods. Uptake was found to be wholly 
unreliant upon energetic processes, with microspheres located cytoplasmically and 
not encapsulated within endosomes, an important characteristic for delivery devices. 
In order to demonstrate the effective delivery of exogenous cargo mediated by 
microspheres, short interfering (si)-RNAs were conjugated to beads and investigated 
for the gene silencing of enhanced green fluorescent protein (EGFP) in cervical 
cancer (HeLa) and embryonic (E14) stem cells. EGFP knockdown was found to be 
highly efficient after 48 – 72 hours. Dual-functionalised microspheres displaying a 
fluorophore (Cy5) and siRNA allowed only those cells beadfected with the delivery 
vehicle (and thus containing siRNA) to be assessed for EGFP expression, yielding an 
accurate assessment of microsphere-mediated gene silencing. In addition, by 
manipulation of the microsphere preparation conditions, micro-doughnuts and 
paramagnetic microspheres were produced and their cellular uptake assessed. 
Paramagnetic microspheres were found to enter cells efficiently and were 
subsequently used to bias the movement of beadfected cells in response to an 
externally applied magnet, while micro-doughnuts were found to exhibit cell 
selective properties and were noted to traffic specifically to the liver in vivo. 
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Chapter 1: Introduction 
 
1.1. The Importance of the Cellular Membrane 
 
The cellular membrane poses a formidable barrier to the intracellular flux of 
compounds circulating extracellularly and creates an additional complexity in the 
world of drug design or cellular investigation. The reason for this is due to the 
selective permeability of the membrane towards compounds, based mainly on ionic 
charge and hydrophobicity.1 A typical eukaryotic cell membrane is composed of a 
lipid bilayer made up of phospholipids, which spontaneously arrange themselves 
with the polar (phospho) head-group directed towards the exterior and interior 
aqueous regions of the cell, sandwiching the hydrophobic carbon chains in between.2 
However, the cellular membrane is much more complicated than just a simple 
bilayer. Dispersed throughout the membrane are various proteins, channels, lipids 
and carbohydrates (Figure 1.1), allowing numerous cellular functions to occur, 




Figure 1.1. The Lipid Bilayer. Pictorial representation of the lipid bilayer, comprising phospho-






1.2. Cellular Uptake Pathways 
 
1.2.1. Passive Diffusion 
For compounds to freely diffuse across the lipid bilayer they should be non-polar or 
uncharged so as not to interact with the phospho head-groups and to facilitate 
translocation across the hydrophobic fatty region.3 A passive diffusive mechanism is 
not reliant on an energy source and may still occur at low temperatures (Figure 1.2). 
However, due to the strict selective permeability of the membrane many entities are 
not able to cross passively and require alternative mechanisms. Amino acids, ions, 
proteins and other bulky materials are examples of compounds which are unable to 
cross the bilayer in a diffusive manner and rely on ion transport channels or active 
pathways, such as endocytosis. 
 
 
Figure 1.2. Cellular Uptake. Some of the main cellular uptake pathways, including passive diffusion, 
ion transport channels and endocytosis (not drawn to scale). 
 
1.2.2. Ion Channels 
Ion channels are typically voltage or ligand-gated pores in the membrane that allow 
solutes to travel across their electrochemical gradient (Figure 1.2).4 The ‘gate’ may 
be operated by chemical or electrical signals from the cell or by the 
binding/dissociation of a specific ligand.5,6 Although this mechanism of cellular 
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transport is important to ion flux, it is not applicable to many larger macromolecules 
(e.g. proteins) and these constructs require an alternative uptake pathway. 
 
1.2.3. Endocytosis 
Endocytosis is a process by which the material to be internalised is captured within a 
portion of the cellular membrane that encapsulates the cargo to form a vesicle. Once 
internalised, the vesicle pinches off internally from the intracellular membrane 
(Figure 1.2). The term ‘endocytosis’ is a general concept that encompasses several 
biologically distinct pathways. In fact, it can be broken down into three sub-
mechanisms: phagocytosis,7 pinocytosis8 and receptor mediated endocytosis.9 
Phagocytosis is an operation usually seen only in specialist cells known, 
broadly, as phagocytes. This process involves non-specific endosome formation, 
where the cell effectively ‘eats’ the particulate. Pinocytosis is similar to phagocytosis 
in as much as it is non-specific vesicular formation and is typically observed in 
professional cells. However, the vesicles formed are very small and are typically 
filled with extracellular fluid and, hence, it is sometimes referred to as ‘cell 
drinking’. Receptor mediated endocytosis applies to the endocytic pathways which 
rely on the formation of specialist vesicles, for example those coated with a specific 
protein, and tends to be much faster than either phago- or pinocytosis. These include 
clathrin-mediated endocytosis10 and caveolae-mediated endocytosis.11 Clathrin 
mediated endocytosis relies on coating of the pits with the protein, clathrin, which is 
recruited by adapter proteins (e.g. AP2) to the membrane. Clathrin stabilizes 
deformation of the membrane to allow vesicle budding. As the endosome 
invaginates, dynamin (a GTPase) polymerises across the top to pinch off the 
endosome from the membrane allowing it to become internalised (Figure 1.3).12 An 
example of a construct internalised by this mechanism is the blood plasma protein, 
transferrin.13 In the case of caveolae mediated endocytosis, small flask shaped 
intrusions into the cell membrane form rich in caveolin, which is thought to aid local 
membrane deformation (Figure 1.3), eventually resulting in the formation of a 
vesicle, which becomes internalised.14 Lactosylceramide, an important constituent of 




Figure 1.3. Receptor-Mediated Endocytosis. Left: Caveolae vesicles rich in caveolin; Right: 
Clathrin mediated vesicle formation (internalised vesicle is not drawn to scale). 
 
Common to most forms of endocytosis is energy expenditure and a consequent 
reliance on an energy source, such as adenosine triphosphate (ATP), which releases 
energy when it is hydrolysed to adenosine diphosphate (ADP) and adenosine 
monophosphate (AMP). 
It should be noted that particulates internalised by endocytosis still remain 
‘separated’ from the cell’s internal environment due to the barrier presented by the 
endosomal membrane. In addition, endosomes and latterly formed lysosomes have 
aggressive degradation machinery (in particular, acid hydrolases),16 which can 
damage biological cargo and hence endosomal escape is desired when delivering 
material intracellularly if cytoplasmic localisation is required for function. 
 
1.3. Delivery Methods 
 
Since some exogenous material is unable to enter cells by any of the aforementioned 
pathways, several methods have been developed for delivering these materials 
intracellularly. Largely, these methods can be separated into three groups; physical 
(or mechanical) methods, chemical methods and carrier systems.  
 
1.3.1. Physical and Mechanical Methods 
Physical and mechanical methods include electroporation,17 photoporation18 and 
micro-injection19 and have been used to deliver anything from small drug molecules 
to DNA.20, 21 In general, these methods involve making a transient hole in the 
membrane to facilitate the delivery of compounds which will not cross the membrane 
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alone. Following permeation, the cell membrane can repair itself; however, physical 
processes for cellular delivery can be laborious and have a low success rate, meaning 
it is difficult to translate to high-throughput approaches.22  
 
1.3.2. Chemical Methods 
Chemical methods work on a similar concept using chemical agents, for example 
solvents or streptolysin-O,23 to transiently permeate the membrane. Such methods 
have been used to deliver proteins intracellularly, but can suffer from cytotoxicity 
issues.24 As such, less aggressive techniques have been developed in the form of 
carrier devices. 
 
1.3.3. Carrier Systems 
A diverse range of delivery vessels upon which a cargo can be attached or 
encapsulated, have been developed and studied immensely. For example, Cell 
Penetrating Peptides (CPPs)25 such as HIV TAT-derived peptides, have been used to 
deliver an assorted range of cargo from small molecules to bulky proteins.26 CPPs 
based on TAT typically have a cationic cluster of 6 arginine residues and 2 lysines in 
a sequence of 9-10 amino acids, a notable example being GRKKRRQRRR.27 
However, concerns have been raised over the toxicity and metabolic stability of some 
cell penetrating peptides, which may result in some limitation in their use.28, 29 
Cationic lipids30 have been used mostly in the delivery of RNA and DNA31, 32 and 
have been commercialised under various trade names including HiPerFect® and 
Lipofectamine®. They are typically composed of long carbon chain ‘tails’ with 
cationic head-groups which, in an aqueous environment, spontaneously organise 
themselves into DNA containing micelles or lipoplexes in a system that mimics the 
cell membrane itself. They have been used to efficiently transfect several cell lines, 
including primary cells.33 However, they can be toxic and special care must be taken 
during use to limit undesired effects.34 
Since the populisation of carbon nanotubes in 1991,35 much work has 
focused on their intracellular use.36 Thus, they have been used to deliver cell 
impermeable dyes and siRNA to several cell lines, including primary cells.37, 38 
Although effective, there are several drawbacks associated with their use. 
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Foremostly, there have been serious concerns over their in vivo toxicity, especially so 
in the case of the larger nanotubes and much confusion has surrounded their 
biocompatibility.39 In addition, careful consideration must be made of the 
functionalisation expressed on the nanotube to facilitate a device which is aqueously 
soluble with enhanced biocompatibility.40 
Thus, there is a great need for a delivery vehicle that is stable, non-toxic and 
easily prepared and functionalised as well as being able to enter a broad range of 




Microspheres have been utilised in research for many years and have wide ranging 
applications in the biomedical and chemical fields as well as in industry. Their 
synthesis has been well studied to produce a range of sizes and compositions. For 
example, in 1986 Tseng et al. reported the synthesis of highly uniform polymer 
particles by a technique known as dispersion polymerisation.41 Here, they dispersed 
styrene in ethanol with azo-type initiators and a polymeric stabiliser 
(polyvinylpyrrolidone, PVP) to produce mono-dispersed spherical latex products in 
the size range of 1 – 10 µm in diameter. Using a co-polymerisation approach, they 
were additionally able to easily incorporate a range of functionalisations, including 
amines, carboxyls and silanes. Following from this, in 1994, Delair et al. obtained 
200 – 1000 nm latex particles with a highly uniform spherical morphology using 
emulsion polymerisation.42 Here styrene was co-polymerised with divinylbenzene, a 
cross-linking agent which grafts growing polystyrene chains together yielding a final 
product that was robust and stable (Figure 1.4).43  
 
Figure 1.4. DVB Cross-Linking. Co-polymerisation of styrene with divinylbenzene, yielding highly 
cross-linked stable particles. 
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Due to the spherical nature of the latex products, they have been termed 
microspheres and have since been routinely generated using a range of methods. The 
more common amongst these are suspension, dispersion and emulsion 
polymerisation. Suspension polymerisation typically produces larger sized 
microspheres approximately 50 to 500 µm in diameter.44 This technique involves 
dispersion of the monomer with a stabiliser in an aqueous solution (for example, 
water) and the size of the product may be altered by changing the stirring speed. 
Dispersion polymerisation45 is a simplistic one-pot method designed to produce 0.5 
to 10 µm microspheres and relies on a homogeneous mixture of the monomer, 
initiator and stabiliser in an organic phase from which the insoluble polymer product 
can precipitate. Emulsion polymerisation42 is used to form smaller sized products, 
approximately 10 – 104 nm in diameter. Here, polymerisation of the monomer occurs 
within micelles dispersed in an aqueous medium. 
Microspheres have previously been used in a diverse range of applications 
including flow cytometry, markers of phagocytosis and DNA arrays.46, 47, 48 
However, their use as delivery vehicles of therapeutic or investigative cargo in non-




It was the aim of this thesis to further develop the construction of 
microspheres and investigate the methods of their formation by polymerisation. 
Accordingly, attempts were made to manipulate the microspheres, forming 
‘magnetic’ constructs, which could in-turn be developed as tools for intracellular 
delivery allowing the biased movement of cells by an externally applied magnetic 
field.  
In turn, it was of interest to explore polystyrene microspheres as vehicles for 
intracellular delivery to a selection of cell lines and to establish whether 
microspheres exerted any detrimental cytotoxicity on cells, which could have 
negative implications on their use as delivery agents. Of particular importance was 
investigation of the mechanism by which microspheres enter non-phagocytic cells 
and, in particular, if their internalisation renders them captive within acidic 
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organelles (e.g. endosomes) or if they are localised cytoplasmically. Non-endosomal 
capture means that the translation of the delivery device from in vitro to in vivo use 
can be simplified as they do not require the application of endosomal disrupting 
agents and is additionally important to the delivery of many constructs (e.g. enzymes 
and proteins).36 
Furthermore, following analysis of microsphere-cell interactions, it was an 
essential aim to investigate microspheres as delivery agents of a biologically relevant 
cargo. To this affect, the delivery of siRNA was investigated since it is presently a 
“hot” area of research and requires cytoplasmic localisation for function and thus 




























The appeal of microspheres lies largely in the diverse range of applications these 
particles have. They are not only used as vehicles for intracellular delivery but also 
for applications ex vitro, for example in investigation of DNA hybridisation (where 
DNA is coupled to microspheres and anchored to surfaces exhibiting a 
complementary sequence)48 or as fluorescent probes in flow cytometry.47 
Furthermore, they are cheap, easy to produce and functionalise, have a long shelf-life 
and they can be produced from a diverse range of materials and in a multitude of 
sizes. Their applications in industry range from paints49 and adhesives50 to water 
treatment51 and, more recently, cosmetics.52 They are also widely used in many areas 
of research, for example in catalysis53 and immunodiagnostics.54 In terms of 
intracellular delivery, biodegradable microspheres have been studied more 
extensively than their bio-stable counterparts,55 largely due to the applications of 
biodegradable microspheres in drug delivery, where the delivery device can degrade 
resulting in a release of an encapsulated drug.56 
 
2.1.1. Biodegradable Microspheres 
Microspheres can be tailored to biodegrade by the introduction of monomers that 
will break down under physiological conditions. Examples are lactic acid (giving 




Biodegradable microspheres can be prepared via the polymerisation of monomers 
using suspension, dispersion or emulsion polymerisation to achieve particles of the 
desired size.57, 58, 59 However, due to the availability of linear biodegradable 
polymers, it is some what more common for biodegradable microspheres to be 
prepared directly from these and there are several methods by which they may be 
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made. Amongst these are solvent evaporation methods (sometimes called the double 
emulsion technique) and spray-drying. Solvent evaporation forms microspheres via 
the evaporation of an organic solvent from the linear polymer (oil) droplets and is 
one of the more extensively studied and used procedures.60 Firstly, the polymer is 
added to an organic phase (typically dichloromethane) or melted at high 
temperatures. Water is added to produce the primary emulsion and the mixture is 
stirred to produce polymer droplets. This is then added to a larger volume of aqueous 
medium which contains a stabiliser (for example, polyvinylpyrrolidone) and the 
mixture is stirred vigorously in order to produce a multiple emulsion. The organic 
solvent is then evaporated allowing the polymer to harden and precipitate producing 
microspheres. The microsphere size and porosity can be controlled by alteration of 
various factors including polymer concentration, temperature and stirring rate with 
particles from 1 to 100 µm being produced.61 The attraction of this method is that 
drug molecules can be added into water during formation of the primary emulsion 
and become encapsulated within the polymer construct as it hardens, where it may 
consequently be released as the polymer degrades.62  
The spray drying technique takes a polymer solution and sprays it through a 
nozzle producing a fine mist, which as it dries forms microspheres.63 Plasticisers 
(e.g. citric acid) are often added to the polymer solution to promote the formation of 
smooth-surfaced microspheres. Several factors can affect the microsphere diameter, 
which lies typically in the range of 1 to 10 µm, including the rate of spraying, nozzle 
size and the drying temperature. 
Regardless of method, it is important to choose the appropriate conditions for 
preparing biodegradable microspheres since the polymer molecular weight, diameter 
and morphology are all important factors for biodegradability.  
 
2.1.2. Bio-Stable Microspheres 
The sensitivity of bio-degradable polymers to aggressive solvents can limit the 
chemistry that can be performed on the beads and, in addition, they are not 
particularly suitable as investigative tools where it would be undesirable for the 
microsphere to degrade, for example as biological sensors. Thus, microspheres 
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prepared with stable monomers and with cross-linking may be more desirable for 
some applications. 
 
2.1.2.1. Applications of Bio-Stable Microspheres 
A major established application of bio-stable microspheres is the investigation of 
phagocytic cells by flow cytometry. Bio-stable microspheres can be easily labelled 
with a fluorophore, yielding a stable fluorescent construct that can allow analysis of 
phagocytosis by quantitative flow cytometric methods. As such, microspheres have 
been used to investigate the phagocytic activity of pulmonary alveolar macrophages 
(PAMs),64 pinocytosis and phagocytosis in rat peritoneal macrophages65 and 
activation of alveolar macrophages.66 In addition, they have been used as sensors for 
measuring intracellular calcium levels using Indo-1, a calcium sensitive construct67 
and they have also been applied in the successful measure of intracellular pH 
utilising the pH sensitive nature of carboxyfluorescein.68 Using this approach, 
intracellular pH can be measured accurately over long time periods, which is not 




Several approaches may be adopted to produce bio-stable microspheres and a wide 
range of monomers are available. Typically, suspension, dispersion and emulsion 
polymerisation are employed as described previously42, 70, 71 due to the simple set-up 
and controllability of the microsphere size and quality by simple measures. 
 
Suspension Polymerisation 
Suspension polymerisation typically results in the production of comparatively large 
microspheres, in excess of approximately 50 µm in diameter, similar to the solvent 
evaporation method for preparing biodegradable microspheres. In this process, a 
monomer is dispersed in an aqueous media resulting in the production of monomer 
droplets. An initiator (which is soluble in the monomer) is added and polymerisation 
occurs within the monomer droplets resulting in the generation of large polymer 
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microspheres.72 The microsphere size can be controlled by varying, for example, the 
stirring rate. 
Suspension polymerisation has been used in the synthesis of sodium 
polyacrylate microspheres, which is a popular super-absorbent polymer used in 
nappies.73 However, the use of suspension polymerisation to prepare microspheres 
for the bio-medical field and intracellular delivery is limited74 due to the large 
diameters of the polymer products and their poly-dispersity. For microspheres 
relevant to these areas of research, alternative polymerisation methods, including 
dispersion and emulsion polymerisation, are generally applied. 
 
2.2. Dispersion Polymerisation 
 
Dispersion polymerisation is of particular appeal as it is a simple method where the 
reagents are mixed in one organic phase and the polymer product is allowed to 
precipitate from the homogeneous solution over a period of several hours. It gives 
high conversions and the microspheres are typically narrowly dispersed in size and 
easily manipulated to give a range of diameters between 0.5 and 10 µm – ideal for 
biological analysis.75, 76 
Although the mechanical set-up of a dispersion polymerisation reaction is 
easy, the mechanism is complex and not well understood. The required monomers 
and initiator are dispersed in an organic phase containing a stabiliser, for example 
polyvinylpyrrolidone (PVP). Upon heating, a radical initiator disassociates forming 
radicals which react with the monomer and polymerisation begins. Initially, there is a 
rapid nucleation phase forming mono-dispersed nuclei swollen with monomer, short 
oligomers and initiator radicals.77 Polymerisation takes place within the swelled 
monomer droplets since this is where the initiator is soluble. The stabiliser is thought 
to adsorb to the surface of the nuclei allowing precipitation as mono-dispersed 
primary particles, which grow by swelling with more monomer or short oligomers to 
produce microspheres (Figure 2.1).78, 79 Many factors are capable of affecting the 
size and quality of the polymer product produced, such as the stabiliser molecular 
weight, temperature, stirring rate and monomer concentration to name but a few 
(Figure 2.2).80, 81, 82, 83 
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Figure 2.1. Mechanism of Dispersion Polymerisation. Nuclei result in the formation of primary 
particles which, when appropriately stabilised, precipitate as microspheres. 
 
 
Figure 2.2. Altering the Particle Size. A selection of the many factors which can alter the size, 




This adaptability makes it all-the-more attractive as it allows the production of a 
wide range of products with varying diameters using the same simple approach. 
Dispersion polymerisation was thus investigated in-depth for the production of a 
range of robust microspheres, for analysis of cellular delivery. 
 
2.2.1. Stabiliser Molecular Weight  
An uncomplicated method of altering microsphere size reliably is by consideration of 
the steric stabiliser used to aid precipitation of the polymer product from solution. 
Polyvinylpyrrolidone (PVP) is a widely used stabiliser and is available in a range of 
molecular weights from 1,300,000 to 10,000 Da. During nuclei and primary particle 
formation hydrophilic PVP chains may graft or adsorb onto the surface of the 
precipitating particles and offer stabilisation via steric interactions with other PVP 
chains (Figure 2.3). 
 
Figure 2.3. Polyvinylpyrrolidone Mw. Microsphere stabilisation by PVP with low molecular weight 
(e.g. 10,000 Da) and high molecular weight (e.g. 360,000 Da) chains. 
 
Lower molecular weight chains of PVP grafted to the surface of microspheres permit 
the growth of larger beads as they have a lower degree of steric repulsion than larger 
molecular weight chains (and thus allow the microsphere to swell with monomer and 
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oligomer, which polymerise to form a larger sized particle).86 However, a 
disadvantage of using low molecular weight chains of PVP is that the stabilisation is 
less efficient and agglomeration of the microspheres can be a problem. 
PVP with molecular weights of 10,000, 29,000, 40,000 and 360,000 Da were 
used in dispersion polymerisation reactions to investigate the effect of the stabiliser 
molecular weight. Styrene (2.4) was chosen as the main monomer as it is widely 
available and can be readily polymerised in a free radical manner. To allow 
production of robust particles a cross-linking agent, p-divinylbenzene (DVB) (2.5), 
was used, which effectively ties the polystyrene chains together making the 
microspheres more stable. Functionalisation was introduced by use of 
vinylbenzylamine as a hydrochloride salt (VBAH) (2.3.2), which was prepared from 
vinylbenzylchloride (2.1) via the phthalimide protected analogue (2.2) (Scheme 2.1) 
and acidified from the free amine (2.3.1).42 The monomers (styrene, DVB and 
VBAH) were heated in the presence of a radical initiator, azobisisobutyronitrile 
(AIBN), to initiate radical formation and the product was precipitated over 18 hours 
(Scheme 2.2). 
 
Scheme 2.1. VBAH. Preparation of p-vinylbenzylamine.HCl (VBAH) (2.3.2) from p-
vinylbenzylchloride (2.1). Free amine, p-vinylbenzylamine, is (2.3.1). 
(i). 1 eq. potassium phthalimide, DMF, 50 ºC, 15 hours; (ii). 2 eq. hydrazine hydrate, ethanol, reflux, 3 
hours; (iii). 6N acidic isopropanol (HCl), 0 ºC. 
 
 
Scheme 2.2. Amino-Microspheres. Preparation of polystyrene latex microspheres (2.6.1), (2.6.2), 
(2.6.3) and (2.6.4) with DVB cross-linking expressing amino functionality prepared via dispersion 
polymerisation with PVP 10,000 – 360,000 Da. 
(2.1) (2.2)
 16
(i). 0.01 eq. AIBN, N2; (ii). 0.04 eq. PVP (Mw: 10,000 – 360,000 Da), ethanol, 70 ºC, 18 hours. 
 
After precipitation, the microsphere suspension was cooled and washed sequentially 
(methanol and water) to remove excess reagents.87 The microsphere diameter was 
assessed using a technique known as laser diffractometry, which also goes by the 
names static laser light scattering, Fraunhofer diffraction or Mie scattering. 
 
 2.2.1.1. Laser Diffractometry 
In laser diffractometry, when light hits a particle a number of events can occur 
including diffraction, refraction, reflection or absorption. How the light is scattered 
gives information about the size of the particle that the light interacted with and 
allows determination of a particle size distribution. If the particle size is larger than 
the wavelength of the incident of light, then the light will preferentially scatter by 
diffraction and a laser diffractometer can collect information on the size distribution 
by detecting light scattered mainly in the forward direction of the sample (Figure 
2.4). However, if the particle is smaller in diameter than the wavelength of the 
incident of light then refraction and absorption are the predominant interactions and 
information on the size of the particle is gathered from light scattered mainly to the 
sides and backwards of the particle (Figure 2.4). A mathematical algorithm allows 
deduction of a size distribution for the cloud of particles analysed. 
 
 
Figure 2.4. Laser Diffractometry. A light source is focused using a Fourier lens and is diffracted, 
refracted, reflected or absorbed by particles and the information collected from this gives rise to a size 
distribution profile. 
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 2.2.1.2. Altering PVP Molecular Weight 
Polymerisations using PVP with a molecular weight of 10,000 Da often yielded a 
low viscous suspension (meaning a limited conversion of the reagents) and 
agglomeration was evident. The mean particle size by laser diffractometry was found 
to be 3.3 µm (2.6.1) (Figure 2.5b) but the distribution was poly-dispersed with a 
coefficient of variation of 79%.  
 
 
Figure 2.5. Microsphere Diameter with PVP Mw. Laser diffractometry analysis of microspheres a. 
variation of microsphere diameter with PVP molecular weight; b. 3.3 µm beads (PVP 10,000 Da, 
(2.6.1), S.D. 2.6 μm, C.V. 79%); c. 1.4 µm beads (PVP 29,000 Da, (2.6.2), S.D. 0.6 µm, C.V. 44%); 
d. 0.7 µm beads (PVP 40,000 Da, (2.6.3), S.D. 0.41 µm, C.V. 59%); e. 0.4 µm beads (PVP 360,000 
Da, (2.6.4), S.D. 0.2 µm, C.V. 39%). 
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PVP 29,000 Da, as expected with its increased molecular weight, yielded smaller 
microspheres (1.4 µm) (2.6.2) and the suspension appeared more viscous with a good 
conversion of reagents (Figure 2.5c). PVP with a molecular weight of 40,000 Da 
continued the trend yielding smaller microspheres (2.6.3) with a mean diameter of 
0.7 µm (Figure 2.5d). In the case of PVP 360,000 Da, the mean diameter was found 
to decrease further to 0.4 µm and, on account of the efficient stabilisation offered by 
the high molecular weight chains of PVP, little aggregation of the particles was seen 
and the coefficient of variation decreased to 39% (2.6.4) (Figure 2.5e). The 
relationship between PVP molecular weight and the mean diameter of microspheres 
can be represented in a graphical manner (Figure 2.5a), showing not only that larger 
molecular weights of PVP yield smaller microsphere diameters, but also indicated 
the narrowing of the size distribution with larger molecular weight PVP (from the 
error of the distribution). 
The quality of the polymer product was additionally assessed by scanning 
electron microscopy (SEM) (Figure 2.6), a microscopic method that scans the 
surface of a material using a high energy beam of electrons.  
 
 
Figure 2.6. Scanning Electron Microscopy. Microspheres prepared from PVP 10,000 Da (2.6.1) 
(Scale bar is 10 µm), 29,000 Da (2.6.2) (Scale bar is 10 µm), 40,000 Da (2.6.3) (Scale bar is 5 µm) 
and 360,000 Da (2.6.4) (Scale bar is 2 µm). 
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Microspheres prepared with PVP 10,000 Da were heavily agglomerated, while 
microspheres prepared with larger molecular weight chains of PVP (≥ 29,000 Da) 
showed smooth surfaced, evenly sized beads, confirming the results obtained by laser 
diffractometry. 
Many avenues can be approached to increase the efficiency of stabilisation in 
dispersion polymerisations to produce mono-dispersed microspheres, for example, 
by alteration of the solubility of PVP. This may be achieved simply and in a subtle 
manner by alteration of the polymerisation solvent system to increase or decrease the 
solubility of PVP and thus, increase or decrease effective PVP available for 
stabilisation. 
 
2.2.2. Stabiliser Solubility 
Polyvinylpyrrolidone (Figure 2.7) is a hydrophilic stabiliser and polar solvents will 
result in excellent solubility in solution. 
 
Figure 2.7. Structure of Polyvinylpyrrolidone. The value of n is dependent on the molecular weight 
of the stabiliser. 
 
 2.2.2.1. Addition of Water 
The obvious choice to increase the polarity of the solvent system is by the addition of 
water. Thus, deionised water was added at concentrations of 0.5 – 9% to the 
polymerisation liquor (ethanol) using PVP with a molecular weight of 40,000 Da and 
the effect on the polymerisation and the product yielded was investigated. Reactions 
were performed on a Radley carousel to allow 12 reactions to be carried out in 
parallel with temperature, nitrogen flow rate and stirring speed kept uniform (Figure 
2.8). At water contents of 0.5 – 5% little change was observed in the size distribution 
of the population, which was found to be broad with a coefficient of variation of 
approximately 70% and a mean diameter of 0.7 µm (Table 2.1). However, at water 
contents of between 6 and 8% in ethanol an interesting effect was observed. The 
diameter of the microspheres, (2.7.1), (2.7.2) and (2.7.3), decreased to 0.4 µm and 
the size distribution narrowed remarkably giving a coefficient of variation of 
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approximately 16%, indicating the microspheres were essentially mono-dispersed 
(Table 2.1).  
 
Figure 2.8. Radley Carousel. Stirring rate, temperature and gas flow are kept constant. 
 
 
Table 2.1. Addition of Water. Variation of microsphere diameter and amine loading with water 
content (0.5 – 9%) in ethanol. Amine loading was determined by quantitative ninhydrin analysis on 3 
mg of dried microspheres. 6, 7 and 8% water generated (2.7.1), (2.7.2) and (2.7.3) respectively. 
 
Using 7% water in ethanol, a mean diameter of 0.5 µm was achieved and the 
coefficient of variation was only 14% (2.7.2). Importantly, incorporation of the 
amino functionalised monomer was not detrimentally affected and 29 µmolg-1 of 
amine was recorded by a quantitative ninhydrin test.88 Furthermore, (2.7.2) appeared 
 21
stable in aggressive solvents, such as DMF and had a smooth even surface and 




Figure 2.9. Scanning Electron Microscopy. a. 0.5 µm microspheres formed from 7% water in 
ethanol (2.7.2) (Scale bar is 2 µm); b. 0.5 µm microspheres formed from 7% water in ethanol and 
treated for 18 hours with dimethylformamide (DMF) (Scale bar is 2 µm). 
 
Using the optimum content of 7% water (which resulted in the most narrowly 
dispersed product), the effect of water addition on other molecular weights of PVP 
(10,000 – 360,000 Da) was investigated and is summarised in Table 2.2, where a 
decrease in microsphere size was generally noted. 
 
 
Table 2.2. Water Addition with PVP Mw. The effect of the addition of 7% water to polymerisations 
performed in ethanol using PVP with molecular weights of 10,000, 29,000 and 360,000 Da. 
 
This trend suggests that water aids the solubility of PVP making available a greater 
effective concentration of PVP and thus resulting in a greater stabilisation effect, 
yielding smaller sized microspheres with a more narrow distribution. However, it 
was noted that for low molecular weights of PVP (Mw 10,000 Da), the addition of 





 2.2.2.2. Addition of n-Butanol 
The success of influencing microsphere diameter and dispersity by the addition of 
water encouraged the investigation of alternative solvents. Thus, the effect of adding 
small contributions (0.5 – 10%) of n-butanol to ethanol was investigated and the 
results are summarised by Table 2.3. Incorporations of 2, 4 and 9% n-butanol to 
ethanol (shown in red) resulted in a narrowing of the size distribution of the 
microsphere product (from a coefficient of variation of 59% (for 2.6.3) to 13 - 14%). 
However, it did not significantly result in an increase or decrease in the microsphere 
diameter, which remained at 0.7 – 0.8 µm. The quality of the polymer product 
yielded from a reaction containing 2% n-butanol was assessed by SEM (Figure 
2.10). The microspheres (2.8) appeared spherical and evenly sized with a narrow size 
distribution, confirming the results obtained by laser diffractometry. 
 
 
Table 2.3. Addition of n-Butanol. Variation of microsphere diameter and amine loading with n-
butanol content (0.5 – 10%) in ethanol. 2% n-butanol generated (2.8). 
 
 
Figure 2.10. Effect of n-Butanol. a. Laser diffractometry analysis of microspheres (2.8), giving a  
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size of 0.7 µm (S.D. 0.09 µm, C.V. 13.2%); b. Scanning Electron Microscopy of microspheres 
prepared by dispersion polymerisation in ethanol with 2% n-butanol (Scale bar is 1 µm). 
 
 
 2.2.2.3. Addition of 1,2-Dimethoxyethane 
To alter the microsphere diameter more dramatically the addition of 1,2-
dimethoxyethane (1,2-DME), which is much less polar than ethanol and is not a good 
solvent for PVP solubility, was investigated (Table 2.4). In general, addition of 1,2-
DME resulted in agglomeration and large particle size distributions as evidenced by 
laser diffractometry (Figure 2.11a). However, addition of 2% 1,2-DME resulted in 
an increase in the microsphere diameter to 1.4 µm, without a significant broadening 
of the size distribution (Figure 2.11b). SEM confirmed microspheres (2.9) were 
evenly sized and had smooth surfaces (Figure 2.12). 
 
 
Table 2.4. Addition of DME. Variation of microsphere diameter and amine loading with 1,2-
dimethoxyethane content (0.5 – 10%) in ethanol. 2% 1,2-DME generated (2.9). 
 
 
Figure 2.11. Laser diffractometry. Histograms of a. 3 µm microspheres prepared with 6% 1,2-DME  
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in ethanol showing coagulation (S.D. 3.9 µm, C.V. 129%); b. 1.4 µm microspheres prepared with 2% 
1,2-DME in ethanol (2.9) (S.D. 0.4 µm, C.V. 31%).  
 
 
Figure 2.12. Scanning Electron Microscopy. 1.4 µm microspheres (2.9) prepared from 2% 1,2-
DME in ethanol (Scale bar is 10 µm). 
 
Presumably, the coagulation noted with the addition of 1,2-DME was directly related 
to a decrease in the polarity of the solvent and a subsequent decrease in PVP 
solubility affording less efficient stabilisation of the microspheres. 
 
 2.2.2.4. Addition of Toluene 
To facilitate further increases in microsphere diameter, investigation was made into 
the addition of toluene, a non-polar solvent. As with 1,2-DME, addition of toluene 
largely resulted in the agglomeration of the polymer product (Table 2.5). However, 
addition of 4% toluene gave narrowly dispersed 1.8 µm microspheres (2.10) as 
shown by laser diffractometry and confirmed by SEM (Figure 2.13). 
 
 
Table 2.5. Addition of Toluene. Variation of microsphere diameter and amine loading with toluene  
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content (0.5 – 10%) in ethanol. 4% toluene generated (2.10). 
 
 
Figure 2.13. Effect of Toluene. a. Laser diffractometry of microspheres (2.10), giving a size of 1.8 
µm (S.D. 0.3 µm, C.V. 16.1%); b. Scanning Electron Microscopy of microspheres (2.10) prepared by 
dispersion polymerisation from 4% toluene in ethanol (Scale bar is 5 µm). 
 
2.2.2.5. Conclusions on Stabiliser Solubility 
Addition of small percentages of co-solvents to the ethanol base solvent in the 
dispersion polymerisation of styrene, DVB and VBAH in the presence of PVP has 
successfully resulted in the production of microspheres from 0.4 – 1.8 µm in 
diameter. All the microspheres exhibited the incorporation of the amine functionality 
and had even spherical morphologies. Although the mechanism of dispersion 
polymerisation is not well understood, this demonstrates that small, simple changes 
to the reaction media content can have a reliable yet dramatic effect and may easily 
achieve a multitude of microsphere diameters. 
 
2.3. Emulsion Polymerisation 
 
Emulsion polymerisation typically results in the preparation of particles less than 0.5 
µm in diameter. As such, small sized particles for cellular investigations were 
prepared by an emulsifier-free emulsion polymerisation procedure as has been 
previously reported.42 
Emulsion polymerisation is a reasonably well studied and widely applied 
procedure for the production of a range of polymers, including synthetic rubbers and 
latex paints.89, 90, 91 The mechanism by which emulsion polymerisation results in the 
production of a polymer precipitate was first established in the 1940s92, 93 and has 
recently been re-evaluated by the help of computer simulations.94 Simplistically, the 
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process of emulsion polymerisation can be divided into 3 main stages; firstly, an 
emulsion is formed with the monomer in an aqueous solution containing a surfactant, 
resulting in the production of large micelles into which the monomer can diffuse. A 
water-soluble initiator is added and is able to react with monomer in the micelles 
(Figure 2.14, Interval 1). During heating, the monomer polymerises producing a 
polymer particle, resulting in a system that contains both monomer droplets 
(monomer not contained within micelles) and early polymer particles (Figure 2.14, 
Interval 2). In the last stage of the emulsion polymerisation, monomer from the 
excess monomer droplets diffuses into the polymer particles, where it may react with 
initiator resulting in further oligomeric chains (Figure 2.14, Interval 3) and a final 
microsphere product.  
 
 
Figure 2.14. Emulsion polymerisation. Summary of the 3 stages: micelle formation, polymerisation 
and precipitation. 
 
In the production of nanometer sized microspheres, the main monomer 
(styrene), the cross-linking agent (DVB) and the functionalised co-monomer 
(VBAH) were added to boiled nitrogen-bubbled water with magnesium sulphate, as a 
form of stabiliser. After 30 minutes at 80 ºC, water-soluble radical initiator, 2,2’-
Azobis-2-methyl propionamide (V-50), was added and the resulting emulsion was 
stirred for 1 hour producing 0.1 µm microspheres (2.11) or 2 hours producing 0.2 µm 
 27
microspheres (2.12) (Scheme 2.3). Microspheres were sized by laser diffractometry 
(Figure 2.15) and 0.2 µm microspheres were additionally evaluated by SEM (Figure 
2.16). 
 
Scheme 2.3. Microspheres. Production of microspheres, (2.11) and (2.12), by emulsion 
polymerisation. 
(i). 0.004 eq. MgSO4, water, 80 ºC, 30 min; (ii). 0.005 eq. V-50, water, 80 ºC, 1 – 2 h. 
 
 
Figure 2.15. Laser Diffractometry. Histograms of microspheres prepared by emulsion 
polymerisation, giving a. 0.2 µm microspheres (2.12) (S.D. 60 nm, C.V. 25%); b. 0.1 µm 
microspheres (2.11) (S.D. 15 nm, C.V. 14%). 
 
 
Figure 2.16. Scanning Electron Microscopy. 0.2 µm microspheres (2.12) prepared by dispersion 
polymerisation (Scale bar is 1 µm). 
 
As Figure 2.15 shows, the microspheres (2.11) and (2.12) were narrowly dispersed 
and Figure 2.16 indicates that 0.2 µm microspheres had smooth, spherical 
morphologies.  
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Thus, using dispersion and emulsion polymerisation a selection of 
microspheres have been prepared from 0.1 µm up to 2 µm, which all exhibit a 
narrow size distribution and have smooth spherical morphologies. Microspheres in 
this size range will have particular applications for intracellular studies, for example 
in delivery and cellular investigations. 
 
2.4. Cellular Uptake 
 
The use of polymer microspheres for intracellular studies is not a novel technique. In 
fact, they are well established tools.47 However, their intracellular use in non-
phagocytic cells is not well documented. As such, it was of interest to study the 
uptake of a selection of polystyrene microspheres (0.2, 0.5 and 2 µm), prepared as 
above, in a range of cell lines (Table 2.6) at varying incubation times. Cells which 
grow in adhesion and suspension as well as mouse, human and embryonic stem cells 
were studied. 
 
Table 2.6. Cell Lines. Established cell lines investigated for microsphere uptake, including 
mouse/human adherent and suspension cells and mouse stem cells. 
 
2.4.1. Preparation of Fluorescent Microspheres 
In order to study the uptake of microspheres in cells it was necessary to couple a 
fluorophore to the beads so they can be seen intracellularly by standard microscopy 
or cytometry methods. To this affect, a selection of amino-functionalised polystyrene 
microspheres (0.2, 0.5 and 2 µm, (2.12), (2.7.2) and (2.10) respectively) were linked 




Scheme 2.4. FAM-Microspheres. Preparation of 0.2, 0.5 and 2 µm 5(6)-carboxyfluorescein 
microspheres (2.16), (2.17) and (2.18) via aminohexanoic microspheres (2.13), (2.14) and (2.15).  
(i). 1 N NaOH; (ii). 10 eq. Fmoc-Ahx-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (iii). 20% 
piperidine/DMF; (iv). 10 eq. 5(6)-carboxyfluorescein, 10 eq. PyBOP, 10 eq. HOBt, 10 eq. DIPEA, 18 
h, 25 ºC. 
 
The use of the hexanoic spacer unit was for two reasons. Firstly, incorporation of a 
spacer lessens steric repulsions between the bulky dye molecules and amino residues 
embedded within the entangled polymeric chains. Secondly, use of some spacer units 
can result in enhanced biocompatibility and can aid the interactions between 
microspheres and cell surfaces.95 Carboxyfluorescein was successfully coupled to all 
sizes of microspheres and they were confirmed to be fluorescent by fluorescence-
based flow cytometry (Figure 2.17), compared to uncoupled microspheres. 
 
 
Figure 2.17. Flow Cytometry. a. uncoupled non-fluorescent microspheres; b. 2 µm (2.18); c. 0.5 µm 
(2.17); and d. 0.2 µm (2.16) fluorescein microspheres (excitation: 488 nm, emission 515 – 545 nm). 
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Adaptation of the microspheres making them fluorescent allows not only for 
microspheres which have been internalised by cells to be examined by microscopy, 
but also allows for quantitative techniques, such as flow cytometry to measure the 
percentage of cells which have been “beadfected” by fluorescent microspheres. 
 
2.4.2. Flow Cytometry 
Fluorescence-based flow cytometric techniques allow for the high-throughput 
quantification of cellular fluorescence and can analyse several thousand cells per 
second. The technique works by passing the cells in a stream of droplets (where one 
droplet contains, approximately, one cell) through a series of lasers, which excite the 
fluorophore present. Emission from the fluorescent compound is collected by a 
detector and relayed to a computer. 
More specifically, techniques like Fluorescence Activated Cell Sorting 
(FACS) allow for cell populations to be sorted based on their fluorescent output 
(Figure 2.18).  
 
 
Figure 2.18. Fluorescence Activated Cell Sorting (FACS). Cells are passed in a stream of droplets 
through a series of lasers. They can be charged positive or negative dependent on their fluorescent 
output and sorted via charged deflection plates. Instrument shown is a BD Bioscience FACAria and 
the inset image shows the deflection plates and sorting chamber. 
 
Here, the droplets are charged positive or negative dependent on their fluorescence 
(or lack of fluorescence) and they may then be deflected into a collection chamber 
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via charged deflection plates. This allows pure populations to be isolated and 
analysed.  
0.2, 0.5 and 2 µm fluorescein microspheres, (2.16), (2.17) and (2.18), were 
incubated with human erythroleukemic (K562) cells, mouse (E14) stem cells, mouse 
fibroblast (L929) cells, human cervical cancer (HeLa) cells, human embryonic 
kidney (HEK293T) cells, mouse melanoma (B16F10) cells, human Jurkat T-cells 
and mouse macrophage (RAW264) cells to study cellular uptake. Incubations were 
run over 6 – 24 hours at a constant microsphere concentration of 86 µg/mL (Graph 
2.2), to establish cell line dependence on uptake and how microsphere diameter 
affects internalisation. Uptake was found to be high across all cell lines analysed and 
was dependent on incubation time with, expectedly, longer incubation times resulting 
in higher uptakes. In addition, smaller sized microspheres (0.2 µm (2.16) and 0.5 µm 
(2.17)) were found, in general, to enter cells more rapidly than the larger 2 µm 
microspheres (2.18). However, this result may be expected for steric reasons, as a 2 
µm bead has a volume up to 100 times that of a 0.2 µm microsphere. In addition, 
microspheres showed good uptake in both suspension (K562 and Jurkat) and 
adherent cells, showing microspheres are able to enter a range of cell lines cultured 
in diverse ways. Unsurprisingly, RAW264 cells were seen to ingest a high number of 
microspheres as they are a professional phagocyte cell type (Figure 2.19). In this cell 
line, over-loading was noted to be a problem and incubations had to be strictly 
controlled (via microsphere concentration and incubation time). Additionally, 
HEK293T cells also showed impressive uptake, as has been previously reported,95 
with beadfection more than 90% after 24 hours using smaller sized microspheres, 
(2.16) and (2.17). In addition, cancer cells (B16F10, HeLa and K562), which can 
traditionally be more difficult to deliver external cargo to, efficiently took up 
microspheres with uptake approaching 95% after 24 hours using, in particular, 0.2 
µm microspheres.  
In addition, the beadfected cells were assessed for their fluorescence intensity 
after 24 hours and compared to one another to evaluate which cells took up the 





Graph 2.2. Uptake of fluorescein microspheres. 0.2 (2.16), 0.5 (2.17) and 2 µm (2.18) uptake by a) 
K562; b) E14; c) L929; d) HeLa; e) HEK293T; f) B16F10; g) Jurkat and h) RAW264 cells after 6, 12 
and 24 h incubations. % uptake was measured as the % of cells with a fluorescent emission exceeding 
untreated control cells, which were taken as 0% uptake. Microsphere concentration was 86 µg/mL. 
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Figure 2.19. Cellular Over-Loading. Microscopy of 0.5 µm fluorescein microspheres (2.17) (86 
µg/mL) by RAW264 cells after 24 hours. a. Phase contrast image; b. Fluorescence image 
(microspheres in green). Scale bar is 50 µm. 
 
 
Graph 2.3. Fluorescence Intensity. Intensity of cells (arbitrary units) beadfected with 2, 0.5 or 0.2 
µm fluorescein microspheres (86 µg/mL) after 24 hours. 
 
As expected, RAW264 mouse macrophage cells took up the highest number of all 
microsphere sizes and thus were the most fluorescent. However, most other cell 
types showed comparable fluorescence suggesting they ingested similar numbers of 
microspheres. 
Uptake of the microspheres was confirmed by pseudo-confocal microscopy 
(Figure 2.20), showing B16F10 cells as a representative example stained with an 




Figure 2.20. Microscopy of Uptake. B16F10 cells labelled with AlexaFluor-568 phalloidin (actin 
filaments) and Hoechst 33342 (nuclei) with a. Fluorescein labelled 2 µm microspheres, (2.18); b. 
Fluorescein labelled 0.5 µm microspheres, (2.17); c. Fluorescein labelled 0.2 µm microspheres, (2.16). 
Scale bar is 25 µm. Images collected after 12 hours (microsphere concentration of 86 µg/mL). 
 
2.4.3. Microscopy 
Confocal microscopy works by imaging cells in slices whereby, at any one time, only 
one slice (or ‘Z-slice’) of the cell can be seen, as all light that is not in focus is 
eliminated using a pin-hole system (Figure 2.21). The slices can then be stacked and 
reconstructed to generate a 3-D model.  
 
 
Figure 2.21. Confocal and Pseudo-Confocal Microscopy. These techniques work by eliminating 
out-of-focus light from an image. 
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Pseudo-confocal microscopy works in a similar manner, whereby 3 images are taken 
of closely associated Z-slices within a cell. The 3 images are then combined and out-
of-focus light is eliminated using a computer-based algorithm, generating one image 
of a single section of a cell (Figure 2.21, inset). Similar to confocal microscopy, 
pseudo-confocal microscopy can be used to generate a 3-D model of the imaged 
material. As such, it allows microspheres inside and outside the cell to be 
distinguished. 
 
2.4.4. Embryonic Stem Cells 
Embryonic stem cells are an undifferentiated cell line, which can be indefinitely 
maintained in in vitro cultures.96, 97 Their importance in research is related to their 
ability to differentiate into all cell types (Figure 2.22).98 However, in general, 
delivery of cargo intracellularly to stem cells has been hindered by poor uptake and, 
in some cases, extensive cytotoxicity.99, 100 
 
 
Figure 2.22. ES Cells. Embryonic stem cells can differentiate into all lineages of both the foetus and 
the adult. 
 
In contrast, embryonic stem cells (E14TG2a or E14) showed good uptake of 0.2 µm 
and 0.5 µm microspheres (90 and 70% respectively after 24 hours) (Figure 2.23). 
Although, it should be noted that uptake was relatively poor at short incubation times 
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suggesting microspheres require longer times to efficiently enter stem cells. In 
addition, E14 cells did not efficiently take up the larger 2 µm microspheres (35% 
after 24 hours). However, given the typically smaller size of stem cells in comparison 
to some transformed cell lines (which can be up to 70 µm in diameter), it may not be 
surprising that E14 cells were less capable of taking up these larger particles. 
 
 
Figure 2.23. Microscopy of ES Cells. E14 incubated with a. 2 µm fluorescein microspheres (2.18); 
b. 0.5 µm fluorescein microspheres, (2.17), and c. 0.2 µm fluorescein microspheres, (2.16). Actin 
filaments stained with AlexaFluor-568 phalloidin and nuclei with Hoechst 33342. Images collected 
after 12 hours (microsphere concentration 86 µg/mL). Scale bar is 50 µm. 
 
2.4.5. Concentration Dependence 
Analysis was additionally made of the concentration dependence of uptake by adding 
varying concentrations (30 – 60 µg/mL) of 0.2, 0.5 and 2 µm microspheres to 
B16F10, HeLa and HEK293T cells. Uptake analysis was performed after 24 hours 
and the results are summarised by Graph 2.4. As may be expected, lower 
concentrations of microspheres (of all sizes) yielded lower uptake than higher 
concentrations. However, it must be noted that microspheres, even at low 
concentrations, are in great excess over cells (up to nearly 3 million times) (Table 
2.7). Such an excess means that varied concentrations may have a lesser effect on 
cellular uptake than perhaps might be expected, due to saturation. 
 
 
Table 2.7. Microspheres per Cell. Number of microspheres per mL and per cell under typical culture 
conditions, based on a concentration of 86,000 cells/mL. 
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Graph 2.4. Concentration Dependence. Uptake of 0.2 (2.16), 0.5 (2.17) and 2 µm (2.18) 
microspheres after 24 hours in B16F10, HeLa and HEK293T cells at concentrations of 30 and 60 
µg/mL. 
 
2.4.6. Extracellular Quenching 
In order to distinguish between internalised microspheres and those on the 
extracellular membrane of cells, flow cytometry was performed in a solution 
designed to quench any extracellular fluorescence associated with the fluorescein 
microspheres (0.2% trypan blue/Hank’s Balanced Saline Solution (HBSS)). Trypan 
blue is an intercalating dye (excitation ~ 520 nm and emission ~ 650 nm), which is 
unable to translocate the membrane of healthy cells (Figure 2.24). 
 
Figure 2.24. Trypan Blue. Structure of intercalating dye, trypan blue. 
 
Instead it coats the extracellular membrane of the cell and any fluorescein-like 
fluorophores on the exterior cellular membrane can be quenched in a Fluorescence 
Resonance Energy Transfer (FRET)-like system (Figure 2.25).101 
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Figure 2.25. Extracellular Quenching. Fluorescein-like fluorophores can be quenched by trypan 
blue in a FRET system. 
 
In order to assess the extracellular quenching ability of trypan blue, B16F10 mouse 
melanoma cells were incubated with fluorescein microspheres (0.2, 0.5 and 2 µm) 
for periods between 10 minutes and 24 hours. Cellular uptake was assessed by flow 
cytometry in 0.2% trypan blue/HBSS (pH 7.4) and in a control solution of 2% foetal 
calf serum (FCS) in Phosphate Buffered Saline (PBS, pH 7.4), which will not offer 
any quenching of extracellular fluorescence. The results are summarised by Graph 
2.5a-c and Figure 2.26.  
 
Graph 2.5. Extracellular Quenching. Flow cytometric analysis of cellular uptake in B16F10 after 10 
minutes – 24 hours, analysed in 2% FBS/PBS or 0.2% trypan blue/HBSS with a. 2 µm fluorescein 
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microspheres (2.18); b. 0.5 µm fluorescein microspheres (2.17); c. 0.2 µm fluorescein microspheres 
(2.16). Microsphere concentration was 86 µg/mL.  
 
 
Figure 2.26. Extracellular Quenching. Left: Flow cytometry histograms in 2% FBS/PBS or 0.2% 
TB/HBSS after 6 hours of a. un-beadfected control cells; b. cells beadfected by 2 µm fluorescein 
microspheres (2.18); c. cells beadfected by 0.5 µm fluorescein microspheres (2.17); d. cells 
beadfected by 0.2 µm fluorescein microspheres (2.16). Right: Microscopy of B16F10 cells beadfected 
with 0.5 µm fluorescein microspheres (2.17) after 24 hours and 30 minutes in 2% FBS/PBS and 0.2% 
TB/HBSS. 
 
At short incubation times (ca 10 minutes to 1 hour), microspheres in suspension have 
not yet settled on the cells (which grow in adhesion) and as such, there is little 
difference between the cellular uptake of the microspheres in the quenching and non-
quenching solutions. However, after 3 hours significant differences are observed in 
the uptake of microspheres 0.2 and 0.5 µm in diameter indicating efficient quenching 
with the trypan blue solution. After 3 hours, the uptake differed by as much as 35% 
using 0.5 µm microspheres and further differences were seen after 6 hours. After 
prolonged incubation times (12 – 24 hours), cellular uptake in the quenching and 
non-quenching solution began to equalise again, indicating that the majority of the 
microspheres on the surface of the cells have been ingested. This was confirmed by 
microscopy (Figure 2.26, right), where images were collected in the control solution 
(2% FBS/PBS) and in trypan blue/HBSS. After 30 minutes, vast differences were 
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seen between quenched and unquenched cells (Figure 2.26, right bottom), indicating 
that the majority of the microspheres were extracellular. However, after 24 hours less 
difference was noted (Figure 2.26, right top), indicating that microspheres had been 
internalised and corroborating the results achieved by flow cytometry. 
However, 2 µm microspheres showed similar uptakes in the control solution 
and in the trypan blue quenching solution, even at short incubation times. The reason 
for this may be two-fold. Either the 2 µm microspheres rapidly enter cells upon 
contact, meaning they are all intracellular and cannot be quenched by trypan blue or 
it may be indicative of the larger size of the 2 µm microsphere not being efficiently 
quenched. Given the previous findings indicating that 2 µm microspheres enter cells 
slower than the smaller beads, the latter explanation may be more appropriate. 
 
2.4.7. Definable Loadings 
An additional advantage that microspheres exhibit over alternative delivery methods 
is that defined cellular loadings could be achieved with, in particular, the 2 µm 
microspheres (2.18). Definite cell populations containing 1 bead, 2 beads and 3 beads 
could be distinguished by flow cytometry (Figure 2.27) and the cell populations 
could be easily sorted obtaining pure populations of specific loadings. The benefit of 
this is that by alteration of the microsphere concentration and incubation time, a 
definable and known loading can be achieved. This means that the concentration of 
cargo per cell can be controlled in an efficient and simple manner. 
 
2.4.8. Culture Requirements 
Some cellular delivery devices (e.g. cationic lipids) require special culture conditions 
for their efficient intracellular translocation, such as serum-free conditions or 
antibiotic-free media.102 Not only does this add a complexity to experiments, but it 
can also have a detrimental effect on the cell cultures. In contrast, microspheres were 
seen to enter cells under normal (serum-supplemented) culture conditions making 
their use uncomplicated and also demonstrating possible translation in vivo, where 
tolerance of serum is essential.103 To demonstrate that the uptake of microspheres 
was not affected by serum, a selection of cells were studied for their uptake under 
serum-supplemented and serum-free conditions (Table 2.8). 
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Figure 2.27. Definable Cellular Loadings. B16F10 cells incubated with 2 µm fluorescein 
microspheres, a. Flow cytometric histogram after 6 hours; b – d. Microscopy following sorting, where 
b. shows one bead/cell; c. shows two beads/cell; d. shows three beads/cell. 
 
The uptake of microspheres was not seen to dramatically increase or decrease when 
cultured in complete or serum-free media, demonstrating microsphere indifference to 
varied culture conditions. 
 
 
Table 2.8. Serum-Free vs Serum-Supplemented. Uptake of 0.2 µm (2.16), 0.5 µm (2.17) and 2 µm 
(2.18) fluorescein microspheres in B16F10, K562 and L929 cells in complete media and serum-free 





The uptake of 0.2, 0.5 and 2 µm microspheres has been seen in a variety of cell lines 
and was found to be high but controllable. However, it is vital that microspheres do 
not exhibit cytotoxicity in these cells if they are to be applied as delivery devices. In 
order to examine this, MTT assays104 were used to assess cellular viability in the 
presence and absence of 0.2 µm (2.16), 0.5 µm (2.17) and 2 µm (2.18) fluorescein 
microspheres. MTT assays use 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, a tetrazole which is converted by healthy cells to purple formazan crystals. 
Once dissolved, the absorbance of the formazan produced can be measured (λ = 570 
nm) and related to the cellular viability (taking untreated control cells as 100 % 
viable). Graph 2.6 summarises the cellular viability of E14, HeLa, HEK293T, 
B16F10, K562, L929 and Jurkat cells treated with 0.2, 0.5 and 2 µm microspheres at 
concentrations of 75 and 150 µg/mL. No substantial cytotoxicity was noted in any 
cell line using any size of microsphere at the concentrations tested (viability was over 
70% in all cases and was generally more than 90%). However, HEK293T cells were 
noted to be more sensitive to microspheres than the other cell lines. This is likely due 
to over-loading of the cells by microspheres rather than toxicity inherent of the 
particles themselves, as uptake of the beads was noted to be rapid and high 
(approaching 90% after 6 hours) in this cell line. A separate control was established 
where microspheres alone were incubated in the presence of MTT to show that 
microspheres are unable to convert yellow MTT to the purple formazan crystals.39 
 
2.6. In Vivo 
 
As has been previously seen with some forms of nanotube, even when cytotoxicity is 
not evident in vitro, toxicity can still occur in vivo as the biological system is much 
more complex. As such, it was of interest to examine the affect of microspheres in 
the animal model and, in particular, to evaluate toxicity. Consequently, a 6 week old 
mouse was given an intravenous tail vein injection of 0.5 µm Cy7 coupled 
microspheres and the subject was then imaged after 6 hours (Figure 2.28). 
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Graph 2.6. Cellular Viability. a) E14; b) HeLa; c) HEK293T; d) B16F10; e) K562; f) L929 and g) 
Jurkat cells in the presence of 75 and 150 µg/mL 0.2, 0.5 and 2 µm fluorescein labelled microspheres, 
(2.16), (2.17) and (2.18) respectively, assessed for viability by MTT assay. ‘Control’ (black) indicates 
untreated cells, assumed to be 100% viable. Analysis was performed after 24 hours. 
 
 
Microspheres were found in the lung, liver and spleen but no adverse effects were 
noted in the animal, even after prolonged time periods. These results demonstrate 




Figure 2.28. In Vivo. Right: A 6 week old mouse following intravenous tail vein injection of Cy7-
coupled 0.5 µm microspheres (imaged after 6 hours, shown on the left – control animal, with no 




0.2, 0.5 and 2 µm microspheres have been prepared by emulsion and dispersion 
polymerisation and characterised by laser diffractometry and SEM. In particular, 
alteration of the conditions employed in the dispersion polymerisation of styrene, 
divinylbenzene and vinylbenzylamine in an alcoholic media generated microspheres 
with a wide range of controllable diameters from 0.4 µm up to 2 µm. 
In addition, the polymer products were shown to be evenly sized with 
smooth, spherical morphologies and subsequently, the uptake of the microspheres 
was demonstrated in a wide range of cell lines, including mouse stem cells, 
suspension and adherent cell lines of both murine and human species. Uptake was 
found to be good over all lineages investigated and was additionally found to be not 
only cell line dependent, but also dependent on the microsphere diameter, 
concentration and the incubation time. MTT assays confirmed that the microspheres 
did not detrimentally affect cell viability at the concentrations analysed, 









As described in Chapter 1, permeability of the cellular membrane is strictly 
regulated and vital for cell survival.105 In order for a molecule to passively diffuse 
across the lipid bilayer it must fulfil stringent criteria in terms of its molecular weight 
and solubility.1 As such, many compounds are unable to enter cells under passive 
conditions and instead rely on energetic uptake mechanisms. Endocytosis is a general 
term for a number of cellular uptake pathways that include phagocytosis,8 
pinocytosis7 and receptor mediated endocytosis.9 These pathways are reliant upon an 
energy source106 and result in vesicular formation around the cargo, which is 
subsequently internalised. As a consequence of endocytosis, the cargo is trapped 
within an acidic organelle (~ pH 5 - 6) known as an endosome, receptosome, 
phagosome or coated vesicle, dependent on the nature of the endocytosis and its 
cellular location (Figure 3.1).  
 
 
Figure 3.1. Endocytosis. Active uptake pathways can result in the cargo being trapped in phagosomes 
(left), endosomes (middle) or coated vesicles (right).7, 8, 9 
 
The acidity of the vesicle is required for function of the degradative enzymes present 
within it and is maintained via proton pumps on the vesicular membrane. If a cargo is 
unable to escape the endosomal compartment then it will be trafficked from early 
endosomes to late endosomes and eventually to lysosomes, which have aggressive 
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degradation machinery, for example acid hydrolases (including nucleases and 
proteases) specifically capable of degrading a range of foreign materials.16 For a 
cellular delivery device to be considered successful, its cargo must escape from the 
endosomal environment and be released cytoplasmically. Often, endosomal 
disrupting agents, such as chloroquine (a mild base, which accumulates in the acidic 
endosomes causing swelling and destabilisation), are required to force early release 
of the cargo from the endosome.36 In the case of some delivery agents, such as some 
cationic lipids, they contain a component that facilitates release from the endosome. 
For example, dioleoylphosphatidylethanolamine (DOPE)107 is thought to act via 
fusion of the lipid with the endosomal wall to facilitate release of the cargo 
cytoplasmically and is thus described to be “fusogenic”.108 Clearly, if a delivery 
vehicle requires the application of endosomal disrupting agents in order for the cargo 
to be delivered cytoplasmically, its use in vivo may be limited. As such, it was 
important to fully understand the mechanism of entry by which microspheres enter 
cells so as to fully appreciate the possible spectrum of their applications. 
 
3.2. Microsphere Uptake 
 
Despite the reasonably widespread intracellular use of microspheres, their 
mechanism of uptake by non-phagocytic cells is not well understood and detailed 
studies regarding their cellular uptake are limited.109 In general, two main uptake 
mechanisms may be considered; active endocytic processes110 and/or passive 
diffusive mechanisms.111 Insertion into the lipid bilayer and diffusion to the 
intracellular environment has previously been suggested for carbon nanotubes112, 113 
after finding sodium azide (which interferes with the mitochondrial production of 
ATP, the main energy source for endocytosis) had a limited effect on uptake. 
Endocytosis as a mechanism for microsphere uptake has been supported by findings 
using commercially available microspheres.109, 110, 114 However, this form of uptake 
does not explain how microspheres can be successfully used as pH and calcium 
sensors,67, 68 which require cytoplasmic localisation for function. Furthermore, the 
results obtained from studies on microsphere uptake are highly variant due to 
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differences in experimental set-up, cell type, bead composition and functionality 
amongst other things, which often lead to contradictory results. 
Following on from observations that microspheres with sizes between 0.2 and 
2 µm are highly efficiently taken up by a diverse range of cell types it became 
increasingly important to understand how they entered cells. Consequently, it was the 
ambition of this chapter, to deduce the mechanism of intracellular uptake of 0.2, 0.5 
and 2 µm amino functionalised polystyrene microspheres into cells using a number 
of techniques, both chemical and microscopy-based. 
 
3.3. Chemical Inhibition of Uptake 
 
The use of chemical inhibitors to selectively block endocytic pathways has been 
widely applied in uptake studies and successfully used to realise the mechanism of 
cellular entry for cationic lipids and carbon nanotubes.35, 110 Chemical modulators of 
cellular uptake are simple to apply to cells and affordable (in comparison to more 
expensive antibodies for receptor staining). However, many of the inhibitors are 
organic compounds insoluble in water and often require solvation in aggressive and 
cytotoxic solvents, such as dimethylsulfoxide (DMSO) or methanol. As a result, the 
use of a chemical blockade can result in unwanted toxicity, which can complicate 
and confuse results.115 However, at appropriate doses and with appropriate controls, 
chemical inhibitors can be used without significant cellular damage. 
 
3.3.1. General Energy Dependence Blockade 
Adenosine triphosphate (ATP) is used by the cell as an energy source for many 
endocytosis-mediated uptake processes106 and sodium azide is a general inhibitor of 
most energy dependent mechanisms within the cell116 (including endocytosis) as it 
inhibits the production of ATP by interfering with ATP hydrolase in the 
mitochodria.117 With low doses and short pre-incubation times required in order to 
observe inhibition,118 sodium azide presents itself as an excellent candidate for initial 
investigation of microsphere uptake. In order to first establish an appropriate dosage, 
mouse melanoma B16F10 cells were pre-incubated with 20 mM sodium azide for 1 
hour prior to the addition of positive controls, known to be ingested by energy-
 48
dependent mechanisms to establish that the concentration of sodium azide was 
sufficient to block endocytosis. Lactosylceramide (LacCer), an important constituent 
of the plasma membrane, is widely accepted to be internalised by caveolae-mediated 
endocytosis15 and blood plasma protein, transferrin, is known to enter cells via the 
clathrin-mediated pathway.13 As such, BODIPY FL C5-LacCer and FITC-conjugated 
transferrin were incubated with sodium azide treated B16F10 cells and their uptake 
analysed by flow cytometry after 2 hours (Graph 3.1). Externally bound transferrin 
was removed by an acidic wash (pH 5.0)119 and externally bound LacCer was 
removed by washing cells with 1% bovine serum albumin (BSA) in PBS.120 
 
Graph 3.1. Positive Controls. Inhibition of LacCer (5 µM) and transferrin (70 µg/mL) uptake in 
B16F10 cells following treatment with 20 mM sodium azide. 
 
20 mM sodium azide was sufficient to cause an 86% reduction in transferrin uptake 
and a 96% decrease in LacCer uptake in B16F10 mouse melanoma cells. Thus, 
B16F10, human embryonic kidney (HEK293T) cells, human cervical cancer (HeLa) 
cells and mouse fibroblast (L929) cells were pre-incubated with 20 mM sodium 
azide prior to the addition of 0.2, 0.5 or 2 µm fluorescein labelled microspheres, 
(2.16), (2.17) and (2.18) respectively. In addition, mouse embryonic stem (E14) cells 
were treated with sodium azide to assess the energy dependence on beadfections in 
stem cells. Uptake was assessed after 3 hours in 0.2% trypan blue in Hank’s 
Balanced Saline Solution (HBSS), which is a well documented quencher of 
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extracellular fluorescence associated to fluorescein-like fluorophores (Chapter 2)101, 
121 and the results are summarised in Graphs 3.2a-e.  
 
Graph 3.2. Effect of Sodium Azide. Uptake of 2, 0.5 and 0.2 µm fluorescein microspheres under 
ATP depletion by 20 mM sodium azide in a) E14 mES; b) HEK293T; c) L929; d) HeLa and e) 
B16F10 cells. 
 
At concentrations of sodium azide that resulted in almost complete inhibition of 
transferrin and LacCer endocytosis, microsphere uptake was still prevalent in all the 
cell lines analysed and was virtually indistinguishable from control cells treated with 
microspheres in the absence of sodium azide. Indeed, in some cells (e.g. E14 cells) 
uptake was even mildly increased. This was confirmed by microscopy, showing 
B16F10 cells in Figure 3.2 as a representative example. 
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Figure 3.2. Microscopy of Sodium Azide Treated Cells. Pseudo confocal optical slices of B16F10 
cells pre-treated with 20 mM sodium azide and beadfected (86 µg/mL) for 3 hours with a. 2 µm; b. 
0.5 µm and c. 0.2 µm fluorescein microspheres. Scale bar is 400 µm. Inset images are 4× 
magnification. 
 
This suggests that, in all the cell lines studied, the mechanism by which microspheres 
of 2, 0.5 and 0.2 µm diameter enter cells is not dependent on ATP as an energy 
source. In consideration that endocytosis is an energy-dependent process, it 
additionally suggests that the microspheres are not ingested by endocytosis, a finding 
that is supported by the use of microspheres in intracellular sensing studies. 
However, a more detailed evaluation was required before an energy dependent 
mechanism could be wholly discounted. 
Since all the cell lines analysed for the uptake of microspheres under ATP 
depletion showed no significant changes in uptake levels at concentrations which 
near fully blocked transferrin and LacCer ingestion, one cell line was selected for a 
more detailed analysis of microsphere uptake. B16F10 mouse melanoma cells were 
selected as they are well studied and durable as well as having efficient uptake of 2, 
0.5 and 0.2 µm microspheres after short incubation times. 
 
3.3.2. Toxicity Assays of Chemically Treated Cells 
In consideration that toxicity associated with the use of chemical inhibitors can 
confuse the results obtained from an uptake study (as during cell death the membrane 
can become permeable allowing cellular influx of foreign material, e.g. 
microspheres), it was important to establish cellular viability following treatment 




Graph 3.3. Cellular Viability of Chemically Treated Cells. MTT assay results in B16F10 cells with 
a) Chemical inhibitors only (after 1 hour); b – d) Chemical inhibitors followed by microspheres b) 2 
µm microspheres; c) 0.5 µm microspheres; d) 0.2 µm microspheres. The concentrations of chemical 
inhibitor used were those used in uptake assays. Microsphere concentration was 86 µg/mL. ‘Control’ 
refers to untreated cells. 
 
B16F10 cells were found to be resilient to the addition of a variety of chemical 
inhibitors (targeting membrane cholesterol levels, caveolae and clathrin-mediated 
endocytosis and macropinocytosis), even following incubation with microspheres. 
The viability was more than 80% by MTT assay in all cases demonstrating that 
cellular function was reasonably unaffected by the addition of chemical inhibitors at 
the concentrations required to provide a blockade on energy-dependent processes. 
This demonstrated that microsphere uptake following chemical modulation of 
endocytosis was not due to membrane fragility or permeability associated to toxicity. 
 
3.3.3. Cholesterol Dependence 
Cholesterol is an important constituent of the cellular membrane that is often 
summoned during endocytosis and is considered to be vital to most endocytic 
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mechanisms.122 Inhibitors which can remove and/or inhibit the production of 
cholesterol include mβ-cyclodextrin (mβCD), which binds strongly to cholesterol 
present in the cellular membrane and removes it from the cell123 and lovastatin, 
which prevents the formation of new cholesterol by inhibiting 3-hydroxy-3-methyl-
glutaryl-CoA reductase (HMG-CoA reductase).124 As such, B16F10 mouse 
melanoma cells were pre-incubated with 10 mM mβCD and 1 µg/mL lovastatin 
(concentrations that were sufficient to block the uptake of transferrin and LacCer, 
Graph 3.4) for 1 hour prior to the addition of microspheres.  
 
Graph 3.4. Positive Controls. Inhibition of LacCer (5 µM) and transferrin (70 µg/mL) uptake by 
B16F10 cells following treatment with 10 mM mβCD and 1 µg/mL lovastatin. 
 
After 3 hours incubation with beads, uptake was assessed by flow cytometry in 0.2% 
trypan blue (Figure 3.3). At concentrations that significantly inhibited the uptake of 
transferrin and LacCer controls, no significant decreases in uptake could be observed 
for the microspheres, suggesting that uptake was not reliant on cholesterol mobility 
in B16F10 cells. 
 
3.3.4. Caveolae-Mediated Endocytosis 
Following from the findings that ATP depletion and cholesterol 
inhibition/sequestering failed to inhibit the uptake of microspheres in B16F10 cells, 
more specific analysis was made of individual endocytic mechanisms.  
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Figure 3.3. Effect of Cholesterol Depletion. B16F10 cells pre-treated with 10 mM mβCD and 1 
µg/mL lovastatin. Top: a. Uptake of 2, 0.5 and 0.2 µm fluorescein microspheres (86 µg/mL) by flow 
cytometry; Bottom: Pseudo-confocal microscopy of B16F10 cells under cholesterol depletion with b. 
2 µm; c. 0.5 µm and d. 0.2 µm fluorescein microspheres. Analysis was made after 3 hours. Scale bar 
is 50 µm. 
 
Caveolae mediated endocytosis results in the formation of flask-shaped invaginations 
into the lipid bilayer lined with the protein, caveolin.14 It can be selectively blocked 
with filipin III and genistein,125, 126 which sequester cholesterol from lipid rafts 
(which are essential for caveolae formation) and inhibit a tyrosine kinase (which is 
required to phosphorylate the proteins involved in caveolae formation) respectively. 
In order to establish the appropriate concentrations which result in the near-complete 
inhibition of caveolae-mediated endocytosis, B16F10 cells were pre-treated with a 
range of concentrations of filipin III and genistein followed by the addition of 
BODIPY-labeled LacCer (known to be ingested by this mechanism), with analysis 
by flow cytometry (Graph 3.5). Concentrations of 5 µg/mL filipin III and 200 µM 
genistein resulted in an approximate 97% reduction in uptake of LacCer.  
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Graph 3.5. Lactosylceramide Control for Caveolae-Mediated Endocytosis. Uptake of BODIPY-
LacCer (5 µM) after 2 hours in B16F10 cells with caveolae inhibition by filipin III (1 – 5 µg/mL) or 
genistein (50 – 200 µM). 
 
As such, cells were pre-treated with the inhibitors for 1 hour prior to the addition of 
2, 0.5 and 0.2 µm fluorescein labelled microspheres and flow cytometric analysis 
(Figure 3.4, top). However, microsphere uptake was unaffected by the inhibition of 
caveolae-mediated endocytosis at concentrations which resulted in the near-complete 
inhibition of LacCer uptake. Microscopic examination (Figure 3.4, bottom) was 
carried out to confirm microsphere uptake under caveolae-mediated endocytosis 
inhibition. These results suggest endocytosis linked to caveolae is not responsible for 
microsphere uptake, confirming the results achieved with sodium azide and 
mβCD/lovastatin. 
 
3.3.5. Clathrin-Mediated Endocytosis 
In consideration that caveolae invaginations into the cellular membrane are only 50 – 
100 nm in diameter127 it may not be surprising that microspheres, which are 4 to 40 
times larger than these regions, are not ingested via this mechanism. As such, 
clathrin-mediated endocytosis, which can result in the formation of larger sized 
vesicles largely dependent on the diameter of the cargo,12 was investigated. Clathrin-
mediated endocytosis is inhibited by treatment with chlorpromazine128 and by 
incubating cells under potassium free conditions.10  
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Figure 3.4. Effect of Caveolae Depletion. B16F10 cells pre-treated with 200 µM genistein and 5 
µg/mL filipin III. Top: a. Uptake of 2, 0.5 and 0.2 µm fluorescein microspheres (86 µg/mL) by flow 
cytometry; Bottom: Pseudo-confocal microscopy of B16F10 cells under caveolae-mediated 
endocytosis inhibition with b. genistein and 2 µm; c. genistein and 0.5 µm; d. genistein and 0.2 µm; e. 
filipin III and 2 µm; f. filipin III and 0.5 µm and g. filipin III and 0.2 µm fluorescein microspheres. 
Analysis was made after 3 hours. Scale bar is 100 µm.  
 
Chlorpromazine and potassium depletion are known to disrupt the clathrin-mediated 
pathway by preventing coated pit assembly. Again, flow cytometric analysis was 
used to determine the appropriate concentrations of chlorpromazine-mediated 
inhibition using FITC-conjugated transferrin (Graph 3.6). 
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Graph 3.6. Transferrin Control for Clathrin-Mediated Endocytosis. Uptake of FITC-transferrin 
(70 µg/mL) after 2 hours in B16F10 cells with clathrin inhibition by chlorpromazine (2 – 10 µg/mL) 
or potassium depleted conditions. 
 
As such, B16F10 cells were grown under potassium-free conditions (see 
Experimental for details) or treated with 10 µg/mL chlorpromazine (which resulted 
in an 86% reduction in transferrin uptake) for 1 hour prior to the addition of 2, 0.5 
and 0.2 µm microspheres. Analysis of uptake was via flow cytometry (Figure 3.5, 
top) in a trypan blue quenching solution. At concentrations which significantly 
inhibited transferrin uptake, microsphere entry into cells was virtually 
indistinguishable from controls where beads were incubated with cells in the absence 
of chlorpromazine or under potassium-supplemented conditions. Microscopy 
(Figure 3.5, bottom) confirmed microsphere uptake, establishing that clathrin 
mediated endocytosis is unlikely to be responsible for the ingestion of microspheres 
into cells.  
 
3.3.6. Microtubule Polymerisation 
Lipid raft mediated uptake and intracellular vesicular trafficking is thought to be 
dependent upon microtubule polymerisation and is known to be blocked by 
nocodazole.129 It was of interest as to what effect microtubules have on the uptake 
and transport of microspheres. 
 57
 
Figure 3.5. Effect of Clathrin Depletion. B16F10 cells pre-treated with 10 µg/mL chlorpromazine or 
potassium depletion. Top: a. Uptake of 2, 0.5 and 0.2 µm fluorescein microspheres (86 µg/mL) by 
flow cytometry; Bottom: Pseudo-confocal microscopy of B16F10 cells under clathrin-mediated 
endocytosis inhibition with b. chlorpromazine and 2 µm; c. chlorpromazine and 0.5 µm; d. 
chlorpromazine and 0.2 µm; e. potassium depletion and 2 µm; f. potassium depletion and 0.5 µm and 
g. potassium depletion and 0.2 µm fluorescein microspheres. Analysis was made after 3 hours. Scale 
bar is 100 µm.  
 
 
As such B16F10 cells were pre-incubated with 10 µg/mL nocodazole before the 
introduction of fluorescein microspheres. Uptake was analysed by flow cytometry 




Figure 3.6. Effect of Nocodazole. B16F10 cells pre-treated with 10 µg/mL nocodazole. Top: a. 
Uptake of 2, 0.5 and 0.2 µm fluorescein microspheres (86 µg/mL) by flow cytometry; Bottom: 
Pseudo-confocal microscopy of B16F10 cells under microtubule polymerisation inhibition with b. 2 
µm; c. 0.5 µm; d. 0.2 µm fluorescein microspheres. Scale bar is 200 µm. Inset images are a 4× 
magnification and analysis was performed after 3 hours. 
 
Inhibition via nocodazole had little effect on microsphere uptake, suggesting 
microtubule polymerisation and lipid raft mediated uptake are not fundamental to 
either the interaction of the microspheres with the cellular membrane or the passage 
of the microspheres across the lipid bilayer. Microscopy confirmed microsphere 
uptake (Figure 3.6, bottom) and taken together, these results further confirm that 
endocytosis is unlikely to be the mechanism by which microspheres are internalised 
within B16F10 mouse melanoma cells. 
 
3.3.7. Macropinocytosis 
Specific endocytosis pathways associated to caveolin or clathrin appear not to be 
responsible for microsphere uptake. Thus, it was of interest to examine a non-
specific endocytic pathway, such as macropinocytosis, whereby a ruffling-like 
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procedure by the cell membrane results in the formation of a vesicle, which may 
subsequently be internalised.130 Macropinocytosis can be blocked by incubation of 
cells with cytochalasin D131 and dimethylamiloride (DMA).132 Cytochalasin D 
interferes with F-actin elongation and consequently prevents the non-specific 
membrane ruffling that accounts for macropinocytosis. Whereas DMA is an inhibitor 
of Na+/H+ exchange, which influences the sodium ion concentration important to the 
stimulation of cells to undergo macropinocytosis. 
Thus, B16F10 cells were incubated with 10 µM cytochalasin D and DMA 
prior to the addition of 0.2, 0.5 and 2 µm microspheres and flow cytometric analysis 
(Figure 3.7, top) was performed to assess uptake. In the case of DMA, no significant 
reduction in microsphere uptake was observed and microscopy confirmed uptake 
(Figure 3.7, bottom). However, a contradictory result was obtained with cytochalasin 
D. In this case, over all microsphere diameters, a decrease in uptake was observed. 
This equated to a 26 – 63% reduction, dependent on the microsphere size. 0.5 µm 
microspheres showed the greatest decrease in uptake going from 47% uptake in 3 
hours to just over 17% under cytochalasin D conditions. Both 2 µm and 0.2 µm 
microspheres saw a decrease of 26% under cytochalasin D conditions.  
 
Figure 3.7. Effect of Macropinocytosis Inhibition. B16F10 cells pre-treated with 10 µM  
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cytochalasin D or 10 µM dimethylamiloride (DMA). Top: a. Uptake of 2, 0.5 and 0.2 µm fluorescein 
microspheres (86 µg/mL) by flow cytometry; Bottom: Pseudo-confocal microscopy of B16F10 cells 
under dimethylamiloride-mediated inhibition of macropinocytosis with b. 2 µm; c. 0.5 µm; d. 0.2 µm 
fluorescein microspheres. Analysis was performed after 3 hours. Scale bar is 100 µm.  
 
Microscopy, with staining of the actin filaments (which are degraded by incubation 
with cytochalasin D)133 with AlexaFluor-568 phalloidin,134 confirmed disruption of 
the actin cytoskeleton and lack of microsphere uptake in cells pre-treated with 
cytochalasin D (Figure 3.8).  
 
Figure 3.8. Microscopy of Cytochalasin D Treated Cells. B16F10 cells incubated under standard 
incubation conditions (a, c, e and g) and in the presence of cytochalasin D (b, d, f and h). a. and b. are 
control cells with no microspheres; c. and d. are with 2 µm FAM-beads; e. and f. are with 0.5 µm 
FAM-beads; g. and h. are with 0.2 µm FAM-beads. Actin filaments are stained with AlexaFluor 568-
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phalloidin and the cell nuclei are stained with Hoechst 33342. Microsphere concentrations was 86 
µg/mL and analysis was performed after 3 hours. Scale bar is 140 µm. 
 
Instead, the microspheres appeared clustered around the extracellular membrane of 
the cell, unable to cross to the intracellular environment. Cytochalasin D non-
specifically interferes with the polymerisation of actin, resulting in degradation. F-
Actin is an important protein involved in many transport processes and is a 
fundamental constituent of the cytoskeleton.135 Degradation may consequently have 
a negative impact on the cellular architecture, which may be important for 
microsphere uptake, for example in the interaction of microspheres with the cellular 
membrane.  
In consideration that dimethylamiloride, sodium azide and cholesterol 
inhibitors failed to decrease microsphere uptake it is unlikely that the results 
achieved with cytochalasin D are due to direct inhibition of macropinocytosis. 
Furthermore, macropinocytosis is an uptake mechanism seen mostly in professional 
phagocytic cells (which B16F10 are not). In addition to this, membrane ruffling 
resulting in macropinocytosis is seen mostly in the uptake of solutes and is 
improbable for large particulates such as microspheres.129, 136 
To further elucidate this finding, non-specific membrane ruffling was also 
disfavoured by allowing cells to grow to 100% confluency (which disfavours 
membrane ruffling through steric effects)137 before addition of fluorescent 
microspheres. Flow cytometry was used to determine microsphere uptake and a 
control was established with cells at 50% confluency (Graph 3.7). 
 
Graph 3.7. Effect of Membrane Ruffling. 2, 0.5 and 0.2 µm microsphere uptake in B16F10 cells  
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after 6 hours grown to 100% confluency (control is 50% confluency). Microsphere concentration was 
86 µg/mL for 100% confluency or 43 µg/mL for 50% confluent cells.  
 
Microsphere uptake was not affected by cell confluency, further suggesting that the 
non-specific membrane ruffling that may account for macropinocytosis is not 
responsible for microsphere intake into cells. This strongly suggests that the 
decreases in uptake observed after pre-incubation with cytochalasin D were due to a 
possible interference with the cellular cytoskeleton, which may result in a poorer 
interaction of the microspheres with the cell or may hinder the passage of 
microspheres across the bilayer. 
 
3.4. Temperature Dependence of Uptake 
 
Low temperatures have a substantial effect on cellular uptake processes. For 
example, energy dependent pathways are generally considered to be “blocked” by 
temperatures considerably lower than those found in normal incubations (as cellular 
reactions start to slow down).138 In addition, hardening of the lipid bilayer at lowered 
temperatures will slow some passive diffusive mechanisms due to the increased 
viscosity of the membrane.139 Accordingly, it was of interest to investigate the 
temperature dependence on microsphere uptake and, thus, B16F10 cells were 
incubated at 37, 20 and 4 ºC and entry of microspheres into the cells assessed after 3 
hours by flow cytometry and microscopy (see Figure 3.9). In all cases, uptake was 
dramatically lowered at 20 °C and the effect was even more pronounced at 4 °C. 
Figure 3.9 (far bottom) shows microspheres anchored to the extracellular regions of 
the cell but not yet in the intracellular environment. In consideration that general and 
specific endocytosis inhibitors failed to decrease uptake, it is likely that this 
reduction in uptake is due to hardening of the lipid bilayer and a decrease in 
membrane fluidity.  
These results suggest a plausible mechanism of microsphere uptake may be 
that the bead anchors to the extracellular matrix through ionic (due to the amino 
functionality) or hydrophobic (due to the polystyrene matrix) interactions and, after a 
period of time dependent upon the microsphere diameter, sinks into the bilayer and 
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makes its passage to the intracellular region. Such a mechanism would not be reliant 
upon ATP, cholesterol or vesicle formation associated to endocytosis but would 
require membrane fluidity and, in the initial stages, would rely on an intact 
cytoskeleton for efficient microsphere-cell contact. 
 
Figure 3.9. Effect of Temperature. Beadfections (86 µg/mL) in B16F10 cells after 3 hours. a. 
Uptake of 0.2, 0.5 and 2 µm fluorescein microspheres at 37, 20 and 4 ºC by flow cytometry. Bottom: 
Pseudo-confocal microscopy at 20 ºC with b./c. 2 µm; d./e. 0.5 µm; and f./g. 0.2 µm fluorescein 
microspheres. b, d and f are brightfield images and c, e and g are fluorescence images, showing 




3.5. Scanning Electron Microscopy 
 
In order to further study the interaction of microspheres with the extracellular 
membrane of cells, scanning electron microscopy (SEM) was performed on B16F10 
mouse melanoma cells incubated with unlabelled 2 µm microspheres (2.10) for 2 - 
24 hours (Figure 3.10).140 After 2 hours, the microspheres were seen anchored to the 
membrane of the cell. It is unlikely that microspheres just settle on the cell (as cells 
were subjected to extensive washing during SEM preparation, see Experimental for 
details) and so it is proposed that they “adhere” to the cell by some sort of ionic (as 
microspheres are amino functionalised) or hydrophobic interactions (as microspheres 
are composed of polystyrene chains).  
 
 
Figure 3.10. Scanning Electron Microscopy. Images of B16F10 cells incubated with 2 µm 
microspheres (black arrows) for 2 hours (top left) (scale bar is 10 µm), 6 hours (top right) (scale bar is 
5 µm) and 24 hours (bottom left) (scale bar is 10 µm). Microspheres are shown in the bottom right 
panel (scale bar is 2 µm). Microsphere concentration was 86 µg/mL. 
 
However, after 6 hours, the microspheres appear not only anchored to the cell but 
also appear to be grafted on (possibly coated by serum proteins). In addition, the 
microspheres appear to be “seeping” through the membrane of the cell and there is 
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no appearance of membrane ruffling or vesicular formation around the microspheres. 
At 24 hours, the microspheres appear clearly distorted with possible serum proteins 
grafted over their surface making their inherent spherical structure almost 
unrecognisable. Again, microspheres are seen seeping into the cell (red arrow) 
without the appearance of a vesicle around the beads. Figure 3.10 additionally shows 
microspheres not associated to the cell (bottom right panel), but associated to 
possible serum proteins, which appear to be grafting to the beads. These serum 
proteins (which aid the adhesion of cells to a biocompatible surface) may be aiding 
the adhesion of polystyrene microspheres to the cell, which may ultimately allow the 
microsphere to make its passage across the lipid bilayer. However, this explanation 
does not explain why microspheres enter cells efficiently under serum-free 
conditions and indicates that the circumstances under which microspheres and cells 
interact is a complex event. 
 
3.6. Endosomal and Lysosomal Markers 
 
Although chemical inhibition of endocytic pathways had little effect on microsphere 
uptake, it is difficult to wholly rule out this mechanism without further evidence. 
FM4-64 is a commercially available lipophilic styryl dye, which through anchorage 
into the lipid bilayer labels the membrane of the cell and any subsequently formed 
endosomal compartments.141 
B16F10 mouse melanoma cells were pre-incubated with FM4-64 followed by 
0.5 µm fluorescein microspheres and real-time confocal analysis was carried out over 
a period of 30 minutes (see Supporting Information on CD for the movie and Figure 
3.11). Initially, three microspheres can be seen anchored to the extracellular 
membrane of the cell (Figure 3.11 a and b) and after repeated re-orientation of their 
alignment into a “spear-like” arrangement, the microspheres (still associated to one 
another) cross the lipid bilayer rapidly without any appearance of an enclosed 
endosome (Figure 3.11 c and d). It was noted, however, that there was some 
membrane (or possibly FM4-64 stain) associated to the microspheres on one side. 
After 21 minutes incubation (Figure 3.11 e), the microspheres entered the 
cytoplasmic region of the cell causing a certain degree of membrane disruption. As 
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the microspheres entered the cytoplasmic region they move freely around and within 
7 minutes the associated membrane stain was largely lost (Figure 3.11 f). 
 
Figure 3.11. FM4-64 Staining. Real time confocal microscopy of a B16F10 cell stained with FM4-64 
incubated with 0.5 µm fluorescein microspheres: a. time = 0 minutes, microspheres anchored 
extracellularly; b. time = 0 minutes, enlarged image; c. time = 4.5 minutes, microspheres rearrange 
alignment; d. time = 15 minutes, microspheres pass the bilayer; e. time = 21 minutes, microspheres 
cause membrane disruption; f. time = 30 minutes, microspheres are cytoplasmic. 
 
This confirms that this is unlikely to be any classic endosomal localisation and is 
instead most likely some dislodged membrane, which during passage of the 
microspheres across the dye stained lipid bilayer has associated to the beads.  
To further demonstrate the lack of endosomal or lysosomal 
compartmentalisation of the microspheres within cells, B16F10 cells were treated 
with LysoTracker Red, a stain capable of marking acidic organelles,142 following 
incubation with 2, 0.5 and 0.2 µm Cy5 microspheres (Figure 3.12 and Scheme 3.1). 
 
Scheme 3.1. Cy5-Microspheres. Production of Cy5 microspheres, (3.4), (3.5) and (3.6), from  
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aminohexanoic microspheres, (3.1), (3.2) and (3.3). 
(i). 10 eq. Carboxy-Cyanine5 (Cy5), 10 eq. HOBt, 10 eq. PyBOP, 10 eq. DIPEA, DMF, 18 h, 25 ºC. 
 
Positive controls were established in a similar manner with LacCer and transferrin, 
which show co-localisation (yellow/orange colour, Figure 3.12) since they are 
known to be ingested by endocytosis. In contrast, there was no evident co-
localisation between microspheres and endosomes/lysosomes using any size 
microsphere. This was confirmed also in HEK293T, HeLa and E14 cells (Figure 
3.13). The lack of co-localisation with endosomal and lysosomal stains strongly 
supports a passive mechanism, whereby microspheres are attracted to the cell and 
anchor to the extracellular matrix of the membrane. Following a period of time 
where microspheres appear to re-orientate themselves they rapidly, without an 
energy requirement, cross the bilayer resulting in a small amount of membrane 
disruption which is rapidly recovered. 
 
 
Figure 3.12. LysoTracker Red. B16F10 cells incubated with Cy5 labelled 2 µm, 0.5 µm and 0.2 µm 
microspheres (cyan, 86 µg/mL) followed by LysoTracker Red (red). Controls were established with 




Figure 3.13. LysoTracker Red. HEK293T, HeLa and E14 cells treated with LysoTracker Red 
following 2, 0.5 or 0.2 µm Cy5 labelled microspheres (86 µg/mL). 
 
3.7. Membrane Leakage 
 
In the hypothesised mechanism, microspheres anchor to the extracellular membrane 
of the cell and force a hole in the membrane that allows the bead to passively pass 
through the lipid bilayer into the intracellular environment (Figure 3.14).  
 
Figure 3.14. Anchor-Mediated Uptake. Hypothesised uptake mechanism of microspheres. 
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The membrane disruption caused by the bead passage is then rapidly recovered, 
restoring the cellular membrane to normal. Extensive studies of microsphere toxicity 
by MTT assay and by gene expression profiling143 suggests limited toxicity, 
confirming that the disruption caused likely repairs very rapidly and does no lasting 
damage to the cell. 
 
3.7.1. Propidium Iodide 
If the microspheres do enter by this proposed mechanism, it is likely that an amount 
of membrane leakage occurs as the beads passage across. In order to analyse this 
effect, microspheres were incubated with HEK293T, B16F10, HeLa and L929 cells 
in the presence of propidium iodide (PI), an intercalating dye (Figure 3.15) often 
used in toxicity assays.144 
 
Figure 3.15. Propidium Iodide. Structure of intercalating dye, propidium iodide (PI). 
 
Propidium iodide is inherently fluorescent (emission maxima: 620 nm), but its 
fluorescence is increased 30 – 40 fold when it intercalates into DNA in the 
nucleus.145 However, propidium iodide is unable to cross the cellular membrane of 
healthy cells. It is only able to translocate the lipid bilayer when the cellular 
membrane becomes ‘leaky’ – for example in unhealthy, dying cells (hence its use in 
toxicity assays). Leakage of the membrane to propidium iodide may be induced by 
the influx of microspheres if the beads puncture a small hole in the lipid bilayer 
while crossing the cellular membrane. As such, Cy5 labelled microspheres were 
incubated with cells in the presence of propidium iodide for 3 hours. Flow cytometry 
was then used to select only the beadfected cells (based on the Cy5 fluorescence) and 
the propidium iodide staining of these cells was analysed (control cells were treated 
for 3 hours with propidium iodide, but without microspheres to give the background 
levels of staining). In order to exclude toxicity as the cause resulting in the influx of 
propidium iodide to beadfected cells, a control was establish where cells were 
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incubated with Cy5 microspheres for 3 hours followed by propidium iodide for 30 
minutes, in a manner traditionally applied in toxicity assays. In addition, to exclude 
the possibility that the microspheres swell with propidium iodide to facilitate its 
intracellular delivery, microspheres were incubated with propidium iodide alone and 
the fluorescence of the microspheres assessed. Fluorescence emission associated to 
propidium iodide could not be found co-localised with the microspheres, suggesting 
it is not possible for the microspheres to either adsorb or swell with this compound. 
Instead, in all cases, introduction of the microspheres resulted in increased leakage to 
propidium iodide and was found to be cell line and bead size dependent (Graph 3.8 
and Figure 3.16). 
HeLa and L929 cells showed the greatest increases in propidium iodide 
staining under bead treatment, while the fluorescence intensities of propidium iodide 
in HEK293T and B16F10 beadfected cells were less. The reason for this may be that 
the “puncture” made by the microspheres was repaired more rapidly in HEK293T 
and B16F10 cells than in HeLa or L929 cells, allowing less leakage. 
 
Graph 3.8. Leakage of Propidium Iodide into Beadfected Cells. a. HEK293T cells; b. B16F10 
cells; c. HeLa cells and d. L929 cells. ‘Negative control’ refers to untreated cells; ‘Control PI 3h’ 
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refers to un-beadfected control cells treated with propidium iodide (PI) for 3 hours; ‘2 µm + PI 3h’ 
refers to cells treated with 2 µm Cy5 microspheres together with propidium iodide for 3 hours; ‘0.5 
µm + PI 3h’ refers to cells treated with 0.5 µm Cy5 microspheres together with propidium iodide for 3 
hours; ‘0.2 µm + PI 3h’ refers to cells treated with 0.2 µm Cy5 microspheres together with propidium 
iodide for 3 hours. Microsphere concentration was 86 µg/mL; PI concentration was 14 µg/mL. 
 
 
Figure 3.16. Propidium Iodide Leakage. Flow cytometry histograms of the propidium iodide 
fluorescence in control cells (treated only with PI) and cells treated with 2, 0.5 and 0.2 µm Cy5 
labelled microspheres (86 µg/mL) together with propidium iodide (14 µg/mL). ‘PE-Texas Red’ shows 
PI fluorescence. 
 
In order to demonstrate that this increased fluorescence associated to propidium 
iodide influx was not possible with an endocytic mechanism of uptake, a further 
control was established using LacCer. BODIPY-LacCer was incubated with HeLa 
cells in the presence of propidium iodide for 3 hours before flow cytometry to assess 
the PI fluorescence intensity of those cells containing LacCer compared to control 
cells (treated with PI in the absence of LacCer). The results are summarized by 
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Graph 3.9 and show that there was no increase in the fluorescence intensity of 
propidium iodide in cells when they were treated with LacCer from control cells not 
treated with LacCer. Thus, endocytosis does not result in leakage of propidium 
iodide into the cell. 
 
Graph 3.9. Negative Control. Leakage of HeLa cells to propidium iodide (PI) (14 µg/mL) induced 
by the endocytosis of LacCer (5 µM). 
 
If propidium iodide is cytoplasmic when it enters the cell (as it would be for 
microsphere-induced leakage), it will traffic to the nucleus and intercalate with DNA 
resulting in an intense fluorescent signal. As such, microscopy was performed 
(Figure 3.17) to deduce if this was the case for microspheres and it was evident that 
the propidium iodide stain had reached the nucleus and had intercalated with DNA 
resulting in an intense fluorescence output.  
 
 
Figure 3.17. Propidium Iodide Microscopy. Propidium iodide (red) leakage into cells with 2 µm 
Cy5 microspheres (blue). a. HeLa cells (scale bar is 12 µm); b. L929 cells (scale bar is 9 µm). 
Microscopy performed after 3 hours. 
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3.7.2. Trypan Blue 
To further prove membrane leakage due to the transient puncture of microspheres, 
the experiment was repeated using trypan blue, another intercalating dye, which is 
unable to translocate the cell membrane146 (Graph 3.10 – 3.11 and Figure 3.18). 
When cells were incubated with microspheres and trypan blue, increases in 
fluorescence were observed as with propidium iodide (most notably so in HeLa cells) 
(Graph 3.11), further suggesting that microspheres facilitate trypan blue leakage into 
cells by causing a transient “puncture” of the cell membrane. As with propidium 
iodide, trypan blue localisation in the nucleus was confirmed by microscopy (Figure 
3.19) demonstrating that, upon its intracellular entry, trypan blue must have been 
cytoplasmic. In addition, LacCer, known to be ingested by caveolae-mediated 
endocytosis, was not able to facilitate trypan blue leakage into cells, showing that 
endocytosis-like mechanisms can not account for this transient, non-toxic membrane 
permeability as induced by microspheres. 
 
 
Graph 3.10. Negative Control. Leakage of HeLa cells to trypan blue (TB, 6 µg/mL) induced by the 





Graph 3.11. Leakage of Trypan Blue into Beadfected Cells. a. HEK293T cells; b. B16F10 cells; c. 
HeLa cells and d. L929 cells. ‘Negative control’ refers to untreated cells; ‘Control TB 3h’ refers to 
un-beadfected control cells treated with trypan blue (TB) for 3 hours; ‘2 µm + TB 3h’ refers to cells 
treated with 2 µm Cy5 microspheres together with trypan blue for 3 hours; ‘0.5 µm + TB 3h’ refers to 
cells treated with 0.5 µm Cy5 microspheres together with trypan blue for 3 hours; ‘0.2 µm + TB 3h’ 
refers to cells treated with 0.2 µm Cy5 microspheres together trypan blue for 3 hours. Microsphere 
concentration was 86 µg/mL; TB concentration was 6 µg/mL. 
 
 
These results strongly support a mechanism whereby microspheres puncture a small 
hole in the membrane as they passively pass across the lipid bilayer to the 
intracellular environment. However, the puncture is transient, heals rapidly and does 





Figure 3.18. Trypan Blue. Flow cytometry histograms of the trypan blue fluorescence in control cells 
(treated with TB only) and cells treated with 2, 0.5 and 0.2 µm fluorescein labelled microspheres (86 




Figure 3.19. Microscopy. Trypan blue (blue) leakage into cells with 2 µm FAM-microspheres 
(green). a. HeLa cells (scale bar is 13 µm); b. L929 cells (scale bar is 14 µm). Microscopy performed 






The mechanism by which non-phagocytic cells take up polymer microspheres is not 
well understood. Here, energy dependent endocytic mechanisms have been evaluated 
using chemical and microscopic techniques. 0.2, 0.5 and 2 µm microspheres were not 
found to be dependent on ATP or cholesterol and were not inhibited by a specific 
chemical blockade on caveolae or clathrin-mediated endocytosis. Furthermore, 
staining with endosomal/lysosomal markers (LysoTracker and FM4-64) showed no 
co-localisation with microspheres. This evidence strongly suggests that microspheres 
were ingested by a passive mechanism, whereby microspheres anchor to the 
extracellular matrix of cells before transiently puncturing the membrane to facilitate 
bead entry. As such, membrane leakage was assessed and evidenced by the influx of 
membrane impermeable intercalating dyes (propidium iodide and trypan blue) 
associated to the puncturing of the cell bilayer by the passive entry of microspheres. 
This result, whereby microspheres are determined to be cytoplasmic and not 
trapped within endosomes, widens the possible applications that microspheres may 





















A major advantage of microspheres is their ability to enter a wide range of cell lines 
with high efficiency.95 To further the use of microspheres in the bio-medical field, it 
would be of interest to develop microspheres which target specific organs in vivo, or 
which may allow cellular separations in a facile and rapid manner.  
Magnetic nanoparticles have been extensively studied in the biomedical and 
biochemical fields and they have a vast range of possible applications ranging from 
drug delivery to biosensors to Magnetic Resonance Imaging (MRI) contrast 
agents.147, 148, 149 Often iron oxide nanoparticles are used, however their use can be 
limited by lack of sufficient functionalisation and limited control over the particle 
size.150 However, their incorporation into functionalisable constructs has greatly 
enhanced their use. For example, in 2005 silica nanotubes were prepared containing 
an inner layer of magnetite (Fe3O4) with encapsulated human IgG,151 which 
successfully separated anti-human IgG from anti-bovine IgG. Also in 2005, magnetic 
nanowires were bound to the extracellular matrix of NIH-3T3 mouse fibroblast cells 
via integrins facilitating their phagocytosis. Subsequently, the intracellular wires 
were used to bias the movement of a population of cells in response to an externally 
applied magnetic field, so as to align cells in an array format demonstrating the 
affectivity of magnetic nanodevices in cellular manipulations.152 
The introduction of magnetic metal oxides within polymer spheres is 
something that has been reasonably well studied since they were first introduced in 
the 1970s.153, 154, 155 Similar to magnetic nanotubes (MNTs), paramagnetic materials 
enclosed within the polymer shell renders the entire microsphere paramagnetic and 
able to respond to an externally applied magnetic field. However, these particles 
have the advantage over MNTs of being easily functionalised and the size 
distribution can be controlled, producing a range of narrowly dispersed particle 
sizes.156, 157 Indeed, magnetic microspheres have already been used in a number of 
applications within the bio-medical research field, in bioassays amongst other 
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applications.158, 159, 160 They have additionally been commercialised in, for example, 
Magnetic Cell Sorting (MACS).161 In this technique, cells expressing an antigen are 
incubated with MACS® MicroBeads, which are small (50 nm) biodegradable 
superparamagnetic particles functionalised with the corresponding antibody. Thus, 
the MicroBeads anchor to the cell via an antigen/antibody interaction. The cells are 
then passed in a stream through a column transversing a powerful magnet, which 
positively selects those cells anchored to magnetic MicroBeads. Cells which are not 
labelled with MicroBeads are washed through the column, thus separating the cell 
populations. This technique can result in population purities of up to 95%162 and can 
be fully automated, sorting approximately 10 million cells per second. 
 
4.1.1. Preparation 
In the past, chemical metal deposition, suspension and emulsion polymerisation have 
been amongst the methods employed for the preparation of magnetic 
microspheres.163, 164, 165 Famously, Ugelstad and co-workers166 developed a procedure 
which has led to the now commercially available DynaBeads. However, this method 
requires a multi-step approach and can be complicated and lengthy in nature. As 
such, alternative methods have been sought for the production of magnetically 
manipulable microspheres. 
 
4.2. Dispersion Polymerisation 
 
Dispersion polymerisation presents a one-step procedure allowing the formation of 
mono-dispersed particles between 0.3 and 10 µm in diameter, while the introduction 
of metal oxide nanopowders in the dispersion allows the generation of magnetic 
particles.167 The high conversions obtained and the ease of manipulation of 
dispersion polymerisation makes it attractive as a method for preparing magnetic 
beads. However, it is well recorded that the introduction of foreign materials (e.g. 
iron oxide) into a polymerisation mixture can cause a disruption in the mechanism by 
which dispersion polymerisation occurs.160, 168, 169 As such, agglomeration or highly 
dispersed particles can result since mono-dispersity is heavily reliant on a rapid 
nucleation period,170 with which the iron oxide may interfere.171, 172, 173, 174 
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 As a result, polystyrene microspheres encapsulating iron oxide were prepared 
by a dispersion polymerisation approach and labelled with a fluorophore to allow 
intracellular uptake to be followed by fluorescence-based flow cytometry techniques, 
as with the non-magnetic microspheres discussed in Chapters 2 and 3. 
 
4.2.1. 0.3 µm Paramagnetic Microspheres 
Small sized cross-linked polystyrene microspheres encapsulating maghemite 
nanopowder (Fe2O3) were produced from a dispersion polymerisation procedure, 




Scheme 4.1. Magnetic Microspheres. Preparation of polystyrene microspheres (4.1), containing iron 
oxide nanopowder via dispersion polymerisation. 




The maghemite nanopowder contained particulates less than 50 nm in diameter and 
the solid required initial dispersion within the polymerisation mixture by sonication 
prior to the addition of the monomers to promote an even dispersion. High molecular 
weight PVP was used to promote the uniform precipitation of not only small sized 
polymer microspheres, but also efficiently stabilised, narrowly dispersed beads from 
the alcoholic media.  
 Under these conditions, 0.3 µm paramagnetic microspheres (4.1) were 
produced (Figure 4.1). 
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Figure 4.1. Laser Diffractometry Analysis. 0.3 µm paramagnetic microspheres (4.1) (S.D: 0.06 µm; 
C.V. 19.1%). 
 
Microspheres were noted to be narrowly dispersed with a coefficient of variation of 
19%. Scanning electron microscopy of the microspheres (Figure 4.2) showed they 
were spherical with a smooth surface. Iron oxide was not extensively evident on the 
surface of the microspheres,167 suggesting it was mostly encapsulated within the 
polymer matrix. To ensure there was no free iron oxide present, paramagnetic beads 
were treated with dilute hydrochloric acid (2 M) and washed sequentially with 
water.169 In addition, prior to analysis, microspheres were purified by magnetic 
sublimation to remove microspheres which had not encapsulated iron oxide. 
 
 
Figure 4.2. Scanning Electron Microscopy. 0.3 µm paramagnetic microspheres (4.1). a. en masse; 
b. 2× magnification of en masse image. Scale bars are 1 µm. 
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In order to determine the quantity of iron oxide captured within the microspheres, a 
technique known as Energy Dispersive X-Ray (EDX) analysis was performed 
(Figure 4.3).  
 
              4.2.1.1. Energy Dispersive X-Ray Analysis 
This technique can be used in conjunction with SEM analysis on dried, carbon- or 
gold-coated samples. In EDX, an electron beam is aimed at the surface of a sample 
and this results in the emission of X-Rays from the material. The energy of the X-
Rays emitted from the sample is dependent on the material itself and can allow the 
detection of not only the elements present, but their relative abundance in the 
material. However, it should be noted that, in general, EDX is not a sensitive enough 
technique to be able to detect elements below an atomic number of approximately 
eleven. 
 EDX analysis of 0.3 µm paramagnetic microspheres yielded an iron 
concentration of 3.7 wt.% of the microsphere bulk (Graph 4.1). This suggests that 
for every mg of microspheres there is approximately 37 µg of iron or 0.5 femto-
grams per microsphere (one microsphere weighs approximately 14 femto-grams). 
 
Figure 4.3. EDX Analysis. 0.3 µm paramagnetic microspheres (4.1) identifying the incorporation of 
iron within the microspheres at 3.7 wt.% (x-axis values in keV). 
 
 To qualitatively assess the properties of the paramagnetic microspheres in 
response to an externally applied field, 0.3 µm microspheres (4.1) were seated in a 
neodymium magnetic separator (Figure 4.4) (neodymium magnets are lightweight 
yet powerful magnets typically composed of neodymium, iron and boron). 
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Graph 4.1. Quantitative Energy Dispersive X-Ray. 0.3 µm paramagnetic microspheres (4.1) 
(Carbon: 68.7, Nitrogen: 21.0, Oxygen: 4.2, Iron: 3.7). Elemental analysis gave Carbon: 91%, 
Hydrogen: 8%, Nitrogen: 0.6%. 
 
 
Figure 4.4. Magnetic Sublimation. 0.3 µm paramagnetic microspheres (4.1) respond to an external 
magnetic field generated by a neodymium magnetic separator. 
 
Within 30 seconds, all magnetic particles moved in response to the applied magnetic 
field demonstrating that the encapsulated magnetic material within the polymer 
constructs renders the entire device paramagnetic and able to respond rapidly to an 
externally applied field over short distances (ca 1 cm). 
 
 4.2.1.2. Magnetic Hysteresis 
Encapsulation of iron oxide within the polymer construct may alter the magnetic 
properties of the paramagnetic material (maghemite). To ensure that the iron oxide 
microspheres behaved in a similar manner to free un-encapsulated iron oxide 
nanopowder, magnetic hysteresis analysis was performed. Magnetic hysteresis is the 
phenomenon that occurs when a magnetic field is applied to a ferri- or ferro-
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magnetic material. Initially, the atomic dipoles will align with the field and when the 
field is subsequently removed some of the alignment is retained by the sample, 
which may be said to have become “magnetised” (Figure 4.5). The magnetic field 
strength that has been retained by the sample is known as the “remanence” and, if a 
sample is behaving in a magnetically consistent fashion, the remanence will be 
constant (at constant field strength). In the case of paramagnetic and 
superparamagnetic samples, remanence is not observed as the material is unable to 
retain a magnetic field. 
 
 
Figure 4.5. Remanence. Magnetic hysteresis loop analysis of a ferri- or ferro-magnetic material, 




Magnetic hysteresis analysis (Graph 4.2) confirmed the microspheres exhibited the 
desired paramagnetic properties (no magnetic field was retained by the sample) as 
compared to free iron oxide nanopowder as the magnetic hysteresis curves are 
virtually indistinguishable. This confirms that the magnetic properties of iron oxide 




Graph 4.2. Magnetic Hysteresis Analysis. a. Iron oxide nanopowder; b. 0.3 µm paramagnetic 
microspheres (4.1). Analysis run at 300 K. ‘M’ indicates the magnetic flux density and ‘H’ indicates 
the magnetic field strength. 
 
4.2.2. Effect of PVP Molecular Weight 
Following the production of narrowly dispersed 0.3 µm paramagnetic microspheres 
(4.1) it was of interest to produce a range of bead sizes. Investigation centred on what 
effect lowering the molecular weight of PVP would have on the resulting 
paramagnetic microspheres. In the case of non-magnetic microspheres (Chapter 2), 
lowering the PVP molecular weight resulted in larger particles.78, 79, 80 As such, the 
PVP molecular weight was reduced to 40,000 Da and the effect on the diameter and 
dispersity of the polymer product was examined by laser diffractometry analysis 
(Figure 4.6) and SEM (Figure 4.7).  
  
 





Figure 4.7. Scanning Electron Microscopy. Images of 2 µm paramagnetic microspheres (4.2). a. en 
masse (scale bar is 20 µm); b. 4× magnification of en masse image. Red arrow shows poly-dispersity 
(scale bar is 5 µm). 
 
The mean diameter of microspheres was found to have increased to 2 µm but the 
population dispersity was also seen to spread (C.V. 92%), with agglomeration 
resulting in secondary peaks by laser diffractometry. 
However, the product was noted to be spherical by SEM (Figure 4.7) and of a 
mostly even size. Interestingly, the microspheres exhibited a slightly rough surface 
indicating that iron oxide deposits were likely coating the microsphere, as well as 
being encapsulated. In order to quantitatively confirm iron oxide encapsulation, EDX 
analysis was performed (Figure 4.8, Graph 4.4) and showed a 1.8 wt.% incorporation 
of iron. 
 
Figure 4.8. EDX Analysis. 2 µm paramagnetic microspheres (4.2) identifying the incorporation of 
iron within the microspheres at 1.8 wt.% (x-axis values in keV). 
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Graph 4.4. Quantitative Energy Dispersive X-Ray. 2 µm paramagnetic microspheres (4.2) (Carbon: 
73.1, Nitrogen: 19.8, Oxygen: 5.0, Iron: 1.8). Elemental analysis gave Carbon: 62% Hydrogen: 3% 
Nitrogen: 0.3%. 
 
Incorporation of DVB175, 176 may have led to the evidenced poly-dispersity, where 
several small sized microspheres were observed (Figure 4.7, red arrow). This effect is 
thought to be due to the continuous second nucleation period occurring due to the 
prolonged period of time required for DVB cross-linked primary particles to form and 
fully mature.177 This may be worsened by the use of iron oxide nanopowders in the 
dispersion leading to poly-dispersed microspheres. 
 
4.2.3. Effect of Divinylbenzene 
In order to produce a larger sized paramagnetic polymer product with a more even 
size distribution, a procedure previously developed by Zhang and co-workers177 
whereby DVB addition was made after the period of nucleation, was adopted. It is 
considered that the final size and quality of the polymer product which precipitates 
from the reaction mixture is decided in the early stages of the polymerisation, during 
the nucleation period. If the kinetics of the nucleation period are fast, the polymer 
product is more likely to be mono-dispersed.176 Introduction of DVB and iron oxide 
into the polymerisation is thought to slow the kinetics of the nucleation period and 
may, thus, result in poly-dispersed microspheres.175, 176, 177 However, if for example, 
DVB, is added after the nucleation period then cross-linking can still be achieved and 
a substantially detrimental effect on the dispersity of the polymer particles may be 
avoided. Using this “post-addition” method with PVP 40,000, 1.6 µm paramagnetic 
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microspheres (4.3) were precipitated from the reaction as found by laser 
diffractometry (Figure 4.9). 
 
 
Figure 4.9. Laser Diffractometry Analysis. 1.6 µm paramagnetic microspheres (4.3) (S.D: 1.05 µm; 
C.V. 65.6%). 
 
A peak 4 times the mean microsphere diameter was noted and is considered to be the 
aggregation of 3 – 4 microspheres, a probable direct result of the paramagnetic 
nature of the beads. SEM confirmed a regular size distribution (Figure 4.10) and also 
indicated a surface coating of iron oxide (evidenced by the furry nature of the 
microspheres). However, in this case, the iron oxide deposits appeared more 
substantial, as ‘lumps’ on the microsphere surface (Figure 4.10, red arrow). This 
phenomenon has previously been reported by Pich et al.178 as “pickering” on the 
surface of poly(styrene/acetoacetoxyethyl methacrylate) microspheres enriched with 
iron oxide. Taking into consideration that microspheres have an amino functionality, 
it is additionally conceivable that this is forming a complex with the iron resulting in 
a surface coating.  
 
Figure 4.10. Scanning Electron Microscopy. Images of 1.6 µm paramagnetic microspheres (4.3). a. en  
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masse (scale bar is 10 µm); b. 5× magnification of en masse image (Red arrow shows a slight surface 
coating of iron oxide and ‘pickering’) (scale bar is 2 µm). 
 
EDX analysis of the microspheres (Figure 4.11, Graph 4.5) confirmed the 
presence of iron, indicating its incorporation within the microspheres at 0.4 wt.%. 
 
 
Figure 4.11. EDX Analysis. 1.6 µm paramagnetic microspheres (4.3) identifying the incorporation of 
iron within the microspheres at 0.4 wt.% (x-axis values in keV). 
 
 
Graph 4.5. Quantitative Energy Dispersive X-Ray. 1.6 µm paramagnetic microspheres (4.3) 
(Carbon: 86.8, Nitrogen: 7.3, Oxygen: 3.4, Iron: 0.4). Elemental analysis gave Carbon: 91% 
Hydrogen: 8% Nitrogen: 0.5%. 
 
Using dispersion polymerisation, a range of paramagnetic microspheres have been 
prepared with diameters between 0.3 and 2 µm with amino functionalities and DVB 
cross-linking. EDX has been used to confirm the presence of iron within the 
constructs and was found to be between 0.4 – 4 wt.%. In addition, SEM was used to 
show that the microspheres had even, spherical morphologies. Furthermore, 
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magnetic hysteresis analysis was used to confirm that iron oxide trapped within the 
microspheres retained its paramagnetic behaviour. 
 
4.3. Cellular Uptake 
 
To fully appreciate the use of magnetic microspheres as cellular delivery devices, it 
was of interest to study the cellular uptake of these beads in a range of cell lines and to 
examine how well tolerated the particles were by cytotoxicity assays. 
As such, 0.3, 1.6 and 2 µm paramagnetic microspheres, (4.1), (4.3) and (4.2) 
respectively, were labelled with carboxyfluorescein via an aminohexanoic spacer unit 
rendering the microspheres fluorescent, yielding (4.7) (0.3 µm), (4.8) (1.6 µm) and 
(4.9) (2 µm). This allowed quantification of cellular uptake via fluorescence-based 
flow cytometric methods (Graph 4.6). Uptake was analysed in mouse melanoma 
(B16F10), E14 mouse stem cells, human embryonic kidney (HEK293T), human 
cervical cancer (HeLa), human erythroleukemic (K562) and mouse fibroblast (L929) 
cells after 6, 12 and 24 hours incubation (analysis was performed in 0.2% trypan blue 
to quench extracellular fluorescence). Similar to non-magnetic microspheres, cellular 
uptake was found to be cell line, bead size and incubation time dependent. 
Unsurprisingly, incubating the cells with the paramagnetic microspheres for 24 hours 
resulted in the highest uptake and was typically over 70%. K562 erythroleukemic cells 
showed the highest uptake over all bead sizes and HEK293T cells also showed a good 
uptake. In general, 2 and 0.3 µm microspheres tended to show a higher uptake than 1.6 
µm microspheres. However, the differences in uptake between the varyingly sized 
microspheres were minimal, with all the beads showing a reasonable uptake, which 
was additionally confirmed by microscopy (Figure 4.12). 
Mouse embryonic stem cells showed a good uptake of paramagnetic 
microspheres after 24 hours, particularly of the smaller sized beads (~ 90%), as seen 




Graph 4.6. Cellular Uptake. 2, 1.6 and 0.3 µm paramagnetic fluorescein microsphere beadfections 
after 6, 12 and 24 hours by a. B16F10; b. E14 mES; c. HEK293T; d. HeLa; e. K562 and f. L929 cells. 
Microsphere concentration was 86 µg/mL. 
 
 
Figure 4.12. Microscopy of Beadfected HeLa Cells. After 12 hours beadfection stained with 
AlexaFluor-568 phalloidin (actin filaments) and Hoechst 33342 (nuclei). a. 2 µm (4.9); b. 1.6  µm (4.8) 




Following from the successful uptake of paramagnetic microspheres in a range of cell  
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lines, it became important to analyse cellular viability following beadfection to 
examine whether the microspheres exerted any toxicity. To this end, MTT assays were 
carried out on beadfected and untreated control cells (Graph 4.7).  
 
Graph 4.7. Cellular Viability. MTT assays in B16F10, E14, HEK293T, HeLa, K562 and L929 cells 
with 2, 1.6 and 0.3 µm paramagnetic microspheres. ‘Control’ is untreated cells assumed to be 100% 
viable. Microsphere concentration was 86 µg/mL and MTTs were performed after 24 h. 
 
2 and 1.6 µm paramagnetic microspheres showed no substantial toxicity in any of the 
cell lines analysed, even with more sensitive cell lines (e.g. E14 or HEK293T), with 
over 80% viability in all cases. In contrast, 0.3 µm paramagnetic microspheres showed 
substantial toxicity (less than 50% viability) in all cell lines except L929 cells (where 
cell viability was over 80%). These smaller magnetic beads may exert their toxicity by 
over-loading the cell with iron oxide (0.3 µm paramagnetic microspheres had the 
highest iron content by weight) as they showed the highest uptake in many of the cell 
lines, especially after shorter time periods. Unfortunately, this toxicity limits their 
further use as intracellular delivery agents. 
 
 
4.5. Biased Cellular Movement 
 
It was of great interest to investigate whether, once internalised within cells, the 
magnetic beads could be used to bias cellular movement. The mass of a single, or even 
a cluster of microspheres is much less than the mass of a cell, so it would be a 
remarkable accomplishment if a microsphere could facilitate the biased movement of a 
 92
cell up to 150 times its volume (the volume of a 2 µm microsphere is approximately 
3.4 × 10-14 L, the volume of a cell is approximately 5.0 × 10-12 L).179 
As such, 2 µm paramagnetic beads (which had good uptake and no toxicity) 
labelled with fluorescein were incubated with HEK293T cells over 24 hours and the 
beadfected cells were sorted from non-beadfected cells using fluorescence activated 
cell sorting to collect a pure population of “mag-fected” cells containing paramagnetic 
microspheres. The ‘magnetic’ cells were then incubated over a neodymium magnet 
(Figure 4.13) and the cells assessed for their position with regards to the magnet. Cells 
were noted to have trafficked close to the position of the magnet and had adhered in a 
close formation around it (resulting in a higher density of cells close to the magnet). In 
contrast, very few cells adhered at further distances from the magnet (more than 2 cm) 




Figure 4.13. Biased Cellular Movement. ‘Magnetic’ cells were incubated over a neodymium magnet 
(a) in order to assess how cells react to an external magnetic field in vitro. b. Analysis of cells close to 
the magnet (< 5 mm); c. Analysis of cells far from the magnet (> 2 cm). Scale bar is 500 µm. 
 
Furthermore, ‘magnetic’ cells sorted via their beadfection with fluorescently tagged 
magnetic microspheres were collected from suspension and exposed to an external 
magnetic field en masse. Their movement in response to the magnetic field was 
Close to Magnet 
Far from Magnet 
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recorded and is shown in Figure 4.14 and 4.15 and in the Supplementary Information 
(real-time movie on CD). Within 1 minute, the cells (from an originally 
homogeneously dispersed suspension) (Figure 4.15, top left panel) localised to the 
magnet (Figure 4.15, bottom left panel) demonstrating that paramagnetic 
microspheres internalised within cells have the power to bias the movement of cells 
towards an externally applied magnetic field. 
 
 
Figure 4.14. Real-Time. Biased movement of HEK293T cells mag-fected with 2 µm paramagnetic 
microspheres with time (left to right).  
 
 
Figure 4.15. Magnetic Cells. a. From a homogeneous solution “mag-fected” cells being to aggregate 
and are attracted to the external magnet; b. “Mag-fected” cells cluster at the external magnet. 
 
Furthermore, no evidence could be found of microspheres leaving the cell when the 
magnetic field was applied and the cells could be repeatedly moved in response to the 
magnetic field. This result demonstrates that not only do magnetic microspheres 
efficiently enter cells, but they are additionally capable of “magnetising” the cell and 
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Magnetically susceptible microspheres in the size range of 0.3 – 2 µm have been 
produced by a dispersion polymerisation procedure. Size variation was achieved by 
alteration of the stabiliser molecular weight and the monomer addition procedure. 
Incorporation of 4-vinylbenzylamine.HCl allowed production of amino functionalised 
microspheres and the use of divinylbenzene provided highly cross-linked microspheres 
that were stable in several solvents including DMF and DMSO. This allowed the 
microspheres to be fluorescently labelled with carboxyfluorescein, which allowed their 
intracellular translocation to be followed by flow cytometry and microscopy. The 
uptake of paramagnetic microspheres was successful in all the cell lines investigated, 
which included standard suspension and adherent cells and mouse embryonic stem 
cells. The larger sized microspheres (2 and 1.6 µm) did not negatively affect cell 
viability. However, 0.3 µm beads were noted to detrimentally affect cell viability. 
HEK293T cells were mag-fected with 2 µm paramagnetic microspheres and the 
movement of the cells was biased by the application of an external magnetic field. The 
cells responded rapidly and significantly to the magnetic field demonstrating the 
power microspheres have to move cells many times larger than themselves. Such 
















Small mono-disperse particles have previously been demonstrated to have a range of 
applications in the biomedical and biochemical fields, such as in DNA 
sequencing,180, 181 cellular analysis, biochemical reaction multiplexing95 as well as 
carriers of in vitro cellular sensors.67 Many methods may be employed to prepare 
microspheres, however, dispersion polymerisation (although complicated to fully 
appreciate mechanistically) is perhaps the most easy to manipulate by varying the 
polymerisation conditions. For example, the solubility of the steric stabiliser (e.g. 
PVP) may be altered by the addition of polar and non-polar solvents to the alcoholic 
base media or by the reaction temperature and stirring speeds. 95, 42, 43, 71   In Chapter 
2, the addition of water in ethanol facilitated the production of 0.4 – 0.5 µm 
microspheres, whereas addition of toluene resulted in the formation of 1.8 µm 
microspheres. This ease of “manipulability” together with the ability to form mono-
dispersed particles and the typically excellent yields and conversions obtained75, 76 
makes dispersion polymerisation a particularly attractive method for preparing 
polymeric materials. Following the successful variation of microsphere diameter by 
the introduction of co-solvents, further investigations allowed the effect of alternative 
solvents on the size and morphology of the polymer particles produced to be 
investigated.  
 
5.2. The Effect of Co-Solvents 
 
Although its effect on the mechanism of dispersion polymerisation is not fully 
understood, it may be hypothesised that the addition of polar and non-polar co-
solvents may facilitate an increase or decrease in the solubility of the stabiliser, PVP. 
As a consequence, this may have an enhancing or reducing effect on particle 
stabilisation, resulting in the production of varyingly sized microspheres and, under 
the addition of some solvents, particles with morphological abnormalities. 
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5.2.1. Addition of Diethylketone 
The addition of 2% n-butanol was shown to result in the production of narrowly 
dispersed 0.7 µm microspheres (Chapter 2). As such, alternative solvents with 
comparable polarity were investigated, such as diethylketone. Polymerisations were 
carried out, as described in Chapter 2, using styrene, DVB, VBAH and AIBN with 
PVP as a stabiliser. Under these conditions with 2% diethylketone, laser 
diffractometry indicated the precipitation of particles of 2.3 µm (5.1) in diameter 
with a coefficient of variance of 40% (2% n-butanol in ethanol gave microspheres 
with a C.V. of 13%) (Figure 5.1). SEM confirmed the particle size (Figure 5.2) but 
additionally indicated that some of the ‘microspheres’ prepared by this method had 
an unusual structure and appeared heavily swollen and dimpled (Figure 5.2, red 




Figure 5.1. Laser Diffractometry. Histogram of 2.3 µm microspheres (5.1) prepared by dispersion 
polymerisation in 2% diethylketone in ethanol (S.D. 0.9 µm, C.V. 39.8%). 
 
There was no obvious reason for the production of these particles and their 
mechanism of formation was not fully understood. It appeared that normal 
microspheres were capable of forming under these conditions (Figure 5.2, yellow 
arrow), but the polymerisation mixture also facilitated the production of large 
swollen (possibly hollow) microspheres, which (under their own weight) appeared to 
collapse, resulting in a dimpled morphology. 
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Figure 5.2. Scanning Electron Microscopy. (5.1) prepared by dispersion polymerisation in 2% 
diethylketone in ethanol. Scale bar is 10 µm. Red arrow shows dimpled micro-particles; Yellow arrow 
shows polydispersed microspheres. 
 
The unusual result obtained from adding diethylketone to the polymerisation 
mixture prompted the investigation of further solvents and consideration of how they 
could affect the product morphology. 
 
5.2.2. Addition of Isopropyl Alcohol 
With the addition of 2% IPA to ethanol, laser diffractometry indicated the production 
of narrowly dispersed 1.8 µm microspheres (5.2) (Figure 5.3). However, in contrast, 
SEM analysis showed the production of poly-dispersed, irregularly shaped, swollen 
and dimpled microspheres (Figure 5.4). 
 
 
Figure 5.3. Laser Diffractometry. Histogram of 1.8 µm microspheres prepared by dispersion 
polymerisation with 2% IPA in ethanol (5.2) (S.D. 0.28 µm, C.V. 15.8%). 
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Figure 5.4. Scanning Electron Microscopy. Microspheres prepared by dispersion polymerisation in 
2% IPA in ethanol (5.2). Scale bar is 2 µm. 
 
In this instance, the size distribution information from the laser diffractometry of 
microspheres in solution and that from a vacuum dried sample of the microspheres 
prepared for SEM did not match. This result may suggest that, similar to 
diethylketone, the addition of IPA to the polymerisation mixture interferes with the 
production of robust microspheres. As such, the microspheres may swell with fluid 
and upon drying under vacuum collapse in on themselves (under their own weight). 
This may be correlated to the dimpled nature of the microspheres using diethylketone 
or IPA. The occurrence of this perhaps suggests that the ‘microspheres’ are 
extensively porous or possibly even hollow (or swollen with fluid). 
 
5.2.3. Addition of Tetrahydrofuran 
Further study was made using tetrahydrofuran (THF), which is less polar than 
diethylketone and IPA. Accordingly, 5% THF in ethanol resulted in 1.6 µm 
microspheres (5.3) by laser diffractometry (Figure 5.5), which were subsequently 
determined by SEM (Figure 5.6) to be a poly-dispersed array of microspheres and 
unusually shaped particles. In this case, polymer constructs exhibiting a central hole 
were noted to be amongst the array of microspheres, although they were a minority 
population. Their diameter was found to be approximately 3 µm by SEM and the size 
of the central hole was approximately 1 µm. In addition, swollen, dimpled 
microspheres were also noted to be present, similar to those formed from the addition 
of IPA and diethylketone. 
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Figure 5.5. Laser Diffractometry. Histogram of 1.6 µm microspheres prepared by dispersion 
polymerisation in 5% THF in ethanol (5.3) (S.D. 0.3 µm, C.V. 21%). 
 
 
Figure 5.6. Scanning Electron Microscopy. Microspheres prepared by dispersion polymerisation in 
5% THF in ethanol (5.3). a. en masse. Red arrow shows doughnut-like structures. Scale bar is 10 µm; 
b. 10× magnification of en masse image. Scale bar is 2 µm. 
 
This may substantiate that, during drying under vacuum, swollen microspheres 
become unstable and collapse inward under their own weight generating, initially, 
dimpled microspheres and finally yielding a “micro-doughnut” morphology. Indeed 
this hypothesis was corroborated by analysing the particle diameter via laser 







5.3. Addition of 1,4-Dioxane 
 
Varying the solvent in which dispersion polymerisation occurs has been shown to 
have a profound effect on not only the size, but also the quality and shape of the 
polymer product precipitated. As such, the effect that an additional solvent, 1,4-
dioxane, had on the polymer product was investigated adding 0.5 – 10% to ethanol. 
This resulted in the production of varyingly sized particles from 1.2 – 9.1 µm in 
diameter, (5.4) – (5.14), as found by laser diffractometry (Figure 5.7). Interestingly, 
SEM analysis of particles prepared with 5% 1,4-dioxane in ethanol revealed the 
production of particles with a uniform doughnut-like morphology (5.9) (Figure 5.8). 
 
 
Figure 5.7. Laser Diffractometry. Histograms of microspheres, (5.4) – (5.14), prepared with a. 0.5% 
(5.4) (mean 5.5 µm, S.D. 7.8 µm, C.V. 141%); b. 1% (5.5) (mean 1.7 µm, S.D. 1.2 µm, C.V. 71%); c. 
2% (5.6) (mean 2.1 µm, S.D. 0.5 µm, C.V. 22%); d. 3% (5.7) (mean 6.3 µm, S.D. 13.7 µm, C.V. 
218%); e. 4% (5.8) (mean 1.6 µm, S.D. 0.3 µm, C.V. 18%); f. 5% (5.9) (mean 4.8 µm, S.D. 10.8 µm, 
C.V. 227%); g. 6% (5.10) (mean 2.0 µm, S.D. 0.5 µm, C.V. 24%); h. 7% (5.11) (mean 9.1 µm, S.D. 
12.5 µm, C.V. 137%); i. 8% (5.12) (mean 1.2 µm, S.D. 1.0 µm, C.V. 83%); j. 9% (5.13) (mean 1.4 




Figure 5.8. Scanning Electron Microscopy. Micro-doughnuts prepared with 5% 1,4-dioxane (5.9). 
a. en masse micro-doughnuts. Scale bar is 20 µm; b. 4× magnification of en masse image. Scale bar is 
5 µm. 
 
Other percentages of 1,4-dioxane resulted in the production of poly-dispersed 
microspheres (Figure 5.9), except, 7% 1,4-dioxane in ethanol, which also resulted in 
the formation of micro-doughnuts (5.11). However, in this instance, the micro-
doughnuts were produced alongside poly-dispersed microspheres.  
 
 
Figure 5.9. Scanning Electron Microscopy. (5.4) – (5.8) and (5.10) – (5.14), prepared with 1,4-
dioxane as the co-solvent. a. 0.5% (scale bar is 10 µm); b. 1% (scale bar is 20 µm); c. 2% (scale bar is 
20 µm); d. 3% (scale bar is 20 µm); e. 4% (scale bar is 20 µm); f. 6% (scale bar is 20 µm); g. 7% 
(scale bar is 20 µm); h. 8% (scale bar is 10 µm); i. 9% (scale bar is 10 µm) and j. 10% (scale bar is 10 
µm) 1,4-dioxane in ethanol.  
 102
5.3.1. Micro-Doughnuts  
By SEM the micro-doughnuts were found to be 3 µm in diameter with a 1 µm central 
hole, a result corroborated by laser diffractometry analysis, where a sharp peak was 
present at 3 µm (Figure 5.7 f). This suggests that, unlike diethylketone, IPA and 
THF (where the in-solution laser diffractometry analysis did not support the vacuum-
dried SEM analysis), the micro-doughnuts were stable in solution and formed during 
the polymerisation process (or upon cooling of the reaction mixture) rather than 
being formed during vacuum drying. This was confirmed, examining the micro-
doughnuts in solution by microscopy.  
Although the mechanism by which the micro-doughnuts form is not fully 
understood, it appears that not only the solvent plays a crucial role in their formation. 
 
5.3.2. Divinylbenzene 
Divinylbenzene exhibits its cross-linking activity by anchoring the growing 
polystyrene chains together resulting in ‘hardening’ of the particle and rendering it 
more stable (Scheme 5.1). This allows reactions to be performed on the particles in 
aggressive solvents, such as DMF. 
 
Scheme 5.1. DVB Cross-Linking. Divinylbenzene anchors polystyrene chains together, generating 
stable microspheres. 
 
To prevent the premature polymerisation of DVB, it is packaged with an inhibitor (in 
this case, 4-tert-butylcatechol at 1000 ppm), which may be removed by sequential 
washing with 25% sodium hydroxide and water, resulting in a colour change of the 
DVB solution from clear colourless to bright yellow. However, it was noted that, 
over a period of several months storage (at 4 ºC), the yellow colour subsided, giving 
a pale straw colour (Figure 5.10, right). In order for micro-doughnuts to form, 5% 
1,4-dioxane had to be used in combination with “aged” DVB (pale straw colour). 
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Figure 5.10. Divinylbenzene. DVB containing t-butylcatechol (left); DVB freshly washed free of t-
butylcatechol (middle); DVB washed free of t-butylcatechol and stored at 4 ºC for > 1 month (right). 
 
When dioxane is used with freshly washed DVB, poly-dispersed microspheres 
resulted (Figure 5.11a). If DVB was not added to the polymerisation mixture, 
microspheres precipitated (Figure 5.11b). 
 
 
Figure 5.11. Scanning Electron Microscopy. Microspheres prepared with a. 5% 1,4-dioxane and 
freshly washed DVB; b. 5% 1,4-dioxane but in the absence of DVB. Scale bars are 10 µm. 
 
To investigate the differences between the DVB solutions shown in Figure 5.10, 
DVB containing 4-tert-butylcatechol, DVB freshly washed free of 4-tert-
butylcatechol and the DVB used to prepare micro-doughnuts were analysed and 
compared by HPLC and NMR. Interestingly, NMR showed that the DVB solutions 
were indistinguishable. However, HPLC analysis of the DVB solutions showed an 
impurity peak present in DVB used to prepare micro-doughnuts (retention time: 3.8 
minutes), which was not extensively present in either freshly washed DVB or DVB 
containing 4-tert-butylcatechol (Figure 5.12c, black arrow). However, it is unclear 
what this contaminant is, since it was not significant enough to be detected by NMR 
and thus is unlikely to be due to short chain DVB oligomers. 
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Figure 5.12. HPLC Analysis. a. DVB containing t-butylcatechol; b. DVB freshly washed with 25% 
NaOH/water; c. DVB washed with 25% NaOH/water and stored at 4 ºC for > 1 month. λ = 254 nm. 
 
5.3.3. Mechanism of Micro-Doughnut Formation 
As with diethylketone, IPA and THF, it is plausible that microspheres originally 
precipitate from the homogeneous solution. However, the microspheres may have 
inefficient cross-linking from DVB and thus begin to swell with solvent. As they 
distend they may become unstable, unable to support their own weight. As this 
occurs, the microsphere may collapse inward resulting in at first a dimpled 
morphology and subsequently a ring-shaped structure. This theory is supported by 
the presence of unusually shaped particles, which appear as elongated micro-
doughnuts (Figure 5.13).  
 
Figure 5.13. Scanning Electron Microscopy. Elongated doughnuts (red arrows). Scale bar is 1 µm. 
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Doughnut-like structures have previously been generated using a number of 
techniques, such as electrohydrodynamic atomization or the so-called “breath 
figure” technique.182, 183, 184, 185 Electrohydrodynamic atomization (EHDA) is 
largely an electrospray technique, whereby a high voltage is applied to a nozzle 
through which a solution is pumped. At the tip of the nozzle a liquid cone is 
generated, from which mono-dispersed droplets are released. The diameter of the 
droplets (and thus of the final product) are dependent on many factors, including 
the density and the conductivity of the pumped fluid.186 In the ‘breath figure’ 
technique, which is applied to the production of porous constructs, water micro-
droplets are condensed onto a solution surface containing polymers. The 
polymers present in this cast solution then precipitate around the water droplets 
generating honeycomb-like structures.187 However, in both these techniques the 
doughnut-like particles were typically generated within a sea of other particles 
and were non-homogeneous in size and shape. Using dispersion polymerisation 
the doughnut products were mono-dispersed and the shape was highly uniform. 
 
5.3.4. Preparation of Fluorescent Micro-Doughnuts 
Micro-doughnuts incorporated vinylbenzylamine giving an amine loading of 9.6 
µmolg-1 and allowed labelling of the micro-doughnuts with a fluorophore (Scheme 
5.2). 
 
Scheme 5.2. FAM-Doughnuts. Labelling of amino micro-doughnuts (5.9) with fluorescein (5.16) via 
an aminohexanoic analogue (5.15). 
(i). 10 eq. Fmoc-Ahx-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 10 minutes, 25 ºC, 18 h; (ii). 20% 
piperidine/DMF; (iii). 10 eq. 5(6)-carboxyfluorescein, 10 eq. PyBOP, 10 eq. HOBt, 10 eq. 
DIPEA, 1 minute, 25 ºC 18 h. 
Fluorescein micro-doughnuts (5.16) were analysed by confocal microscopy to 
establish if the 1 µm central hole transversed the particle or if it was merely a 
surface defect (Figure 5.14 and the Supplementary Information on CD for 
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movie). This established not only that the micro-doughnut hole translocated the 
entire construct but it also confirmed that labelling of the micro-doughnut with 
fluorescein transversed the entire particle and was not just surface bound. This 
indicated the chemical accessibility of amino functionalities throughout the entire 
micro-doughnut. It additionally demonstrated the stability of the micro-
doughnuts, since coupling reactions were performed in DMF. 
 
Figure 5.14. Confocal Microscopy. 3-D reconstruction of a fluorescein micro-doughnut (5.16). 
 
5.4. Cellular Uptake 
 
Microspheres exhibited highly efficient cellular uptake in a number of cell lines, 
including stem cells (Chapter 3). It was therefore of interest to examine what affect 
the doughnut-like morphology would have on cellular uptake. As such, 
carboxyfluorescein labelled micro-doughnuts (5.16) were incubated with a variety of 
mammalian cells (mouse fibroblast (L929) cells, mouse macrophage (RAW264) 
cells, human embryonic kidney (HEK293T) cells, human cervical cancer (HeLa) 
cells, mouse melanoma (B16F10) cells, erythroleukemic (K562) cells and mouse 
stem cells (E14)) for 6, 12 and 24 hours at a concentration of 86 µg/mL (analogous 
to the concentration of microspheres used in a typical uptake analysis). Uptake was 
quantified by flow cytometry using 0.2% trypan blue to quench extracellular 
fluorescence110 thus ensuring that only those particles that entered the cells were 
detected. The results have been summarised by Graph 5.1 and interestingly, uptake 
was found to vary widely between the cell lines with only RAW264 macrophages, 
HEK293T and L929 cells showing a reasonable uptake of micro-doughnuts (93 – 
33% after 24 hours). Furthermore, in general the uptake of micro-doughnuts in cells 
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was lower than microspheres. For example, the uptake of micro-doughnuts in 
HEK293T cells after 24 hours was found to be 50%, however, the uptake of 
microspheres (at the same mass/mL and after the same incubation time) was 
generally more than 90%. However, analogous to microspheres, it was found to be 
incubation time and concentration dependent (Graph 5.2).  
 
Graph 5.1. Doughnut-Fection. Uptake of (5.16) by L929, RAW264, HEK293T, HeLa, B16F10, 
K562 and E14 cells after 6, 12 and 24 at 86 µg/mL. 
 
Graph 5.2. Concentration Dependence. Uptake of fluorescein micro-doughnuts (5.16) in HEK293T 
cells as a function of time (6 – 24h) and concentration (21 – 86 µg/mL). 
 
As with microspheres, it should be noted that micro-doughnuts were in great excess 
over cells (approximately 3000:1) and altering the concentration of micro-doughnuts 
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present does not have as substantial an effect as may be at first expected, as it is 
already at a near-saturation level. 
Internalisation was additionally confirmed by pseudo-confocal microscopy 
and a representative example of RAW264 cells is shown in Figure 5.15, where 
cellular appetite for the doughnuts was excessive. This resulted in over-loading of the 
cells (Figure 5.15b-c) due to the active phagocytic nature of RAW264 cells, unless 
highly controlled concentrations were used (Figure 5.15a). 
 
 
Figure 5.15. Excessive Consumption? Uptake of micro-doughnuts by RAW264 cells a. fluorescein 
micro-doughnut (5.16) in RAW264 cell stained with AlexaFluor568-phalloidin (actin filaments) and 
Hoechst 33342 (nucleus). Microscopy was performed after 3 hours (21 µg/mL); Right: RAW264 cell 
heavily laden with Rhodamine B labelled micro-doughnuts (5.17) (shown in red) (scale bar is 20 µm) 
b. Fluorescence image only; c. Fluorescence image merge with brightfield. Microscopy performed 




As shown in Figure 5.15, RAW264 cells ingested large quantities of micro-
doughnuts resulting in cellular over-loading. In RAW264 cells, this type of uptake is 
understandable as they are a phagocytic cell line ‘designed’ to ingest and degrade 
foreign materials. However, it is vital that micro-doughnuts taken up by cells do not 
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cause detrimental cytotoxicity if they are to be applied as cellular delivery/tracking 
devices. To this affect, MTT assays were carried out on “doughnut-fected” cells 
(Graph 5.3) to establish cellular viability. 
 
Graph 5.3. Cellular Viability. MTT viability assays of dough-fected cells, compared to untreated 
control cells assumed to be 100% viable (‘Control’). Analysis was performed after 24 h. 
 
Micro-doughnuts did not cause any cytotoxicity in vitro and cellular viability was 
more than 80% in all cases and was more commonly found to be more than 90%. 
 
5.6. Cell Specificity 
 
During these investigations, an interesting pattern was noted in the cellular uptake of 
micro-doughnuts. Where microspheres are largely indiscriminate, entering most cell 
lines with high efficiency, micro-doughnuts seemed to be more cell line specific. 
They were seen to enter macrophage cells (RAW264), human embryonic kidney 
cells (HEK293T) and mouse fibroblast cells (L929) with good efficiency but their 
uptake in HeLa, B16F10, E14 and K562 cells was poor (< 20%). 
The differences in uptake of micro-doughnuts and microspheres (0.5 and 2 
µm) in a range of cell lines are summarised by Graph 5.4. Although the 
microspheres showed little discrimination in terms of cellular uptake, the doughnuts 




Graph 5.4. Microsphere vs Micro-Doughnut. Uptake of micro-doughnuts vs (left) 0.5 µm 
microspheres and (right) 2 µm microspheres as determined by flow cytometry in RAW264, 
HEK293T, L929, HeLa, B16F10, E14 and K562 cells. A concentration of 86 µg/mL (micro-
doughnuts and microspheres) was used and uptake measured after 24 h. 
 
To illustrate this discrimination a multiplexing experiment was established, where 
cells were beadfected with fluorescently labelled microspheres so that different cells 
could be discriminated based on their fluorescent read-out (Figure 5.16). Thus, 
HEK293T cells were “beadfected” with Cy5 labelled microspheres and B16F10 cells 
with dansyl labelled microspheres. The cells were mixed and re-grown over 24 
hours. Rhodamine B labelled micro-doughnuts (5.17) were added to the mixed cell 
culture and after 24 hours, flow cytometry was performed to ascertain which cell line 
contained micro-doughnuts based on the fluorescent ‘tracking’ microspheres. A 
control was established whereby fluorescein microspheres were added to mixed cell 
cultures to establish the difference in uptake between the two cell lines in 
competition for an additional microsphere. No specificity was noted for this 
microsphere, with approximately 70 – 80% uptake in each case (Figure 5.17), 
demonstrating that HEK293T and B16F10 cells had the same capability of taking up 
additional beads when in competition. 
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Figure 5.16. Multiplexing. Cells in competition for micro-doughnuts: HEK293T vs B16F10. 
 
 
Figure 5.17. Microsphere Multiplexing. FACS histograms of mixed cell cultures beadfected with a 
fluorescein microsphere. Left: HEK293T cells showed 72% ± 0.1% uptake of the fluorescein bead 
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(‘APC-A’ = Cy5 fluorescence, ‘FITC-A’ = fluorescein fluorescence); Right: B16F10 cells showed 
78% ± 2% uptake of the fluorescein bead (‘Violet1-A’ = dansyl fluorescence). 
 
However, in the case of the uptake of micro-doughnuts, HEK293T cells 
overwhelmingly took up these particles (42% of cells were “doughnut-fected”) 
preferentially over B16F10 cells (13% of cells were doughnut-fected) (Figure 5.18). 
 
 
Figure 5.18. Doughnut Multiplexing. FACS histogram of mixed cell cultures incubated with 
rhodamine micro-doughnuts. Left: HEK293T cells showed a doughnut uptake of 42% ± 3%; Right: 
B16F10 cells showed a doughnut uptake of 13% ± 0.5%. ‘PE-A’ = rhodamine B fluorescence. 
 
 
This result was confirmed by microscopy (Figure 5.19), where HEK293T cells 
beadfected with Cy5 microspheres (blue) were seen to have taken up the micro-
doughnuts (red), whereas B16F10 cells with dansyl microspheres (yellow) were not 
seen to contain micro-doughnuts. 
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Figure 5.19. Preferential Doughnut-Fection. a. B16F10 cells beadfected with dansyl microspheres 
(yellow) and HEK293T cells beadfected with Cy5 beads (blue) and “doughnut-fected” with rhodamine 
B doughnuts (red); b. HEK293T cell co-labelled with a Cy5 bead (blue) and rhodamine B doughnut 
(red). 
 
This cell specific uptake opens up extremely interesting avenues in the fields of cell 
separation and site specific targeting and addresses the lack of specificity 
microspheres have with respect to their entry into cells. 
 
5.7. In Vivo 
 
Even when cell specificity can be demonstrated in vitro, the situation in the animal 
model is much more complex. As such, results obtained in cell cultures can vary 
widely from those obtained in vivo. It was therefore important to investigate if the 
cell specificity noted in in vitro cell cultures was conserved in vivo. As such, the in 
vivo fate of Cy7 labelled micro-doughnuts (Scheme 5.3) was determined after 
intravenous injection (tail vein injection, 30 µg) into a 6 week old mouse (all animal 
experiments were undertaken by Dr. Kev Dhaliwal with an approved licence from 
the Animal Scientific Procedure Division of the Home Office, London, U.K.).  
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Scheme 5.3. Cy7-Doughnuts. Preparation of Cy7 micro-doughnuts (5.18) via the aminohexanoic 
counterpart. 
(i). 10 eq. Fmoc-Ahx-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 10 minutes,18 h, 25 ºC; (ii). 20% 
piperidine/DMF; (iii). 10 eq. Carboxy-Cy7, 10 eq. HOBt, 10 eq. PyBOP, 10 eq. DIPEA, DMF, 18 h, 
25 ºC. 
 
After 4 hours, the doughnuts were detected solely in the liver region (Figure 5.22) 
and not in other organs. Presumably, cells circling in the bloodstream (macrophages) 
took up the micro-doughnuts which were then trafficked to the liver, where they 
became localised. This may be an attempt to detoxify the blood of foreign material, 
whereby phagocytic cells are activated to ingest the micro-doughnuts and then 
transport them to the liver in an attempt to degrade them.   
 
 
Figure 5.20. In Vivo. a. Optical whole body image of Cy7 labelled doughnuts (yellow) in the liver. 
Food (chlorophyll - green) is shown in the gut; b. Histology on cryostat sections of the liver showing 
rhodamine B doughnuts (red, black arrows) in the liver parenchyma. 
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As was found in Chapter 2, microspheres were found dispersed in the liver, spleen 
and lungs following intravenous injection and were unable to show selectivity for 
any specific organ. The specificity of micro-doughnuts for the liver opens up the 
opportunity to use these particles in therapy for conditions that affect the liver (for 
example liver disease) as therapeutics can be selectively delivered to the area of 
need. Perhaps more importantly, no adverse effects were observed in the animal 
following injection.  
In order to determine the location of the micro-doughnuts within the liver, 
histology was performed showing that the doughnuts were within the liver 
parenchyma (Figure 5.20), or the main body of the liver. This result is consistent 
with the micro-doughnuts trafficking to the liver as a result of being ingested by cells 




In conclusion, polymeric composites with an unusual structure were produced via the 
dispersion polymerisation of styrene in 5% dioxane in ethanol, with accessible amino 
functionalities distributed throughout the doughnut matrix. Their selective cellular 
uptake has been demonstrated in a variety of cell lines and, when in competition, 
their selectivity for one cell line over another is clear. Additionally, their selective 
nature was demonstrated in vivo, where intravenously injected micro-doughnuts were 
noted to localise specifically in the liver suggesting they are ingested by circulating 
cells and trafficked there using the cell almost as a Trojan horse. More importantly, 
they were not seen to exhibit any toxic effects in the animal model. This 
demonstrates that micro-doughnuts could have applications in site-specific delivery, 
as selective cell tags or could even be applied in cellular separations. 
However, it must be noted that micro-doughnuts form under extremely 









Microspheres (0.2 – 2 µm) have been shown to rapidly and efficiently enter a range 
of cell lines, including stem cells (Chapter 2) and their uptake has been established 
to not be an energy dependent process. Furthermore, the microspheres are not seen 
trapped within endosomes (Chapter 3) and instead exhibit cytoplasmic localisation 
which is beneficial for several reasons. Firstly, cargo which becomes trapped within 
endosomes can be trafficked to acidic lysosomes, which have aggressive equipment 
(e.g. nucleases and proteases) that can result in the degradation of the cargo. As such, 
for many delivery devices to function, they require administration of endosomal 
disrupting agents. Secondly, some specific cargos, for example enzymes or siRNA, 
require cytoplasmic localisation for function.188  
 
6.1.1. The RNAi Pathway 
siRNA (short interfering RNA or small interfering RNA) are short (typically 18 – 21 
nucleotides long) double stranded pieces of RNA. They are produced naturally and 
are involved in a pathway known as RNA interference (RNAi).189, 190 Since its 
discovery in the 1990s191 interest has grown exponentially due to the applications it 
may have in the biomedical field, for example in the silencing of genes that are 
known to cause a diseased state. 
The RNAi pathway starts with cytoplasmic double stranded siRNA forming a 
construct with a multi-protein unit forming a complex known as the RNA-Induced 
Silencing Complex or, more commonly, RISC.192 Although it is not fully understood 
it is considered that the RISC facilitates the dissociation of the double stranded 
siRNA and the sense strand (the anti-guide or passenger strand) may then be 
degraded by the RISC.193 Thus, the protein together with the anti-sense strand of the 
siRNA (the guide strand) forms an activated RNA-Induced Silencing Complex, 
which seeks out endogenous mRNA with a complementary sequence to the guide 
strand (Figure 6.1). When the mRNA hybridises with the anti-sense siRNA strand a 
 117
chain of events are triggered which results in the degradation of the mRNA strand, 
possibly by a type of RNase.194 
 
Figure 6.1. RNAi. The RNA Interference pathway. 
As a consequence, the protein which is coded for by the mRNA is not made and 
there is a decrease in its concentration (described as knockdown or gene silencing). 
Under conditions where a gene is responsible for causing the diseased-state, the 
degradation capability of siRNA may be harnessed as a therapy.195, 196  
 
6.1.2. Delivery of Therapeutic siRNA 
Non-natural siRNA is not able to translocate the cellular membrane itself due to the 
negative charge associated to the phosphate backbone (Figure 6.2) and thus requires 
a delivery vehicle. Although viral approaches197 have been shown to be widely 
effective, safety implications rule out their wide spread use. The most commonly 
used viruses are adenoviruses, lentiviruses and retroviruses. Adenoviruses are DNA 
viruses capable of entering a wide range of mammalian cells via their interaction 
with the coxsackie adenovirus receptor (CAR) followed by integrin mediated 
endocytosis. It then traffics to the nucleus where its DNA becomes expressed. 
Lentiviruses and retroviruses are positive-strand RNA viruses that are capable of 
integrating their genome into the host chromosomes. Again, these viruses are capable 
of entering an extensive range of mammalian cells. 
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Figure 6.2. siRNA. Example structure of double stranded siRNA with a negatively charged phosphate 
backbone. ‘B’ = nucleobase. 
 
Non-viral vectors have also been investigated; amongst these are cationic lipids and 
carbon nanotubes.198, 199 Cationic lipids have subsequently been commercialised 
under a variety of names, including Lipofectamine™ and HiPerFect™. However, 
they can require specialist transfection conditions (for example, serum-free and 
antibiotic-free) and care must be taken to avoid substantial cytotoxicity.102 Carbon 
nanotubes have successfully been used to perform in vitro gene silencing in a number 
of cell lines including primary human T cells, where they were employed in the 
knockdown of CXCR4 and CR4 receptors.198 However, there are questions related to 
the toxicity of carbon nanotubes,39 they can be problematic to functionalise200 and 
they are widely considered to be internalised by endocytosis meaning endosomal 
disrupting agents must be employed in order to release the siRNA to the cytoplasmic 
region before it is degraded in the endosome/lysosome.36 
To research further into the range of therapeutic applications siRNA can 
have, there is a greater need for an efficient, non-toxic delivery device that can 
facilitate the cytoplasmic delivery of siRNA. 
 
6.2. Microspheres as Delivery Devices of siRNA 
 
Microspheres have previously been demonstrated as efficient delivery agents of 
biological cargos, including sensors, proteins and dye molecules.67, 68 As well as 
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having high uptake efficiency in a wide range of cells, they also have been shown to 
be non-toxic at appropriate concentrations95 and may be easily functionalised. These 
traits make microspheres particularly applicable to siRNA delivery. 
 
6.2.1. Enhanced Green Fluorescent Protein 
An easily measurable and well studied knockdown target is enhanced Green 
Fluorescent Protein (EGFP). Transformed cell lines, for example human cervical 
cancer (HeLa) cells, can be easily genetically modified to code for the permanent 
production of GFP, which renders the cells fluorescent (excitation at 488 nm, 
emission at 509 nm). Silencing of the gene which codes for the production of GFP 
can be easily quantified by flow cytometry and visualised by microscopy, making it 
an easily validated target. 
In order to study microsphere mediated EGFP silencing, a number of siRNA 
sequences were first generated, which should facilitate silencing of the gene 
responsible for the production of GFP in both HeLa and ES cells (Figure 6.4).201, 202 
 
 
Figure 6.4. siRNA Sequences. Silencing of the EGFP gene with homologous siRNA sequences 
(target sequence: 5’-GCU GAC CCU GAA GUU CAU-3’).203 
 
In order to establish which of the 3 sequences facilitated efficient GFP silencing, 
human cervical cancer cells permanently expressing EGFP (HeLa-EGFP) were 
transfected with the 3 sequences using the commercially available transfection agent, 
Lipofectamine™ 2000 (Graph 6.1). Sequence GFP-1 delivered the most efficient 
gene silencing (48% maximal) and was thus employed in further studies.  
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Graph 6.1. Lipofection. Silencing of EGFP in HeLa-EGFP cells using siRNA (GFP-1, GFP-2, GFP-
3, 20 pmol) transfected with Lipofectamine™ 2000. Positive GFP refers to untreated HeLa-EGFP 
cells (average fluorescence over 72 hours). 
 
6.2.2. siRNA Coupling to Microspheres 
6.2.2.1. Fluorescently Labelled siRNA 
In order to facilitate the linkage of siRNA (GFP-1) to microspheres and to quantitate 
this coupling, siRNA functionalised with an amino residue on the 5’ end of the sense 
strand (passenger strand) and a TAMRA fluorophore (excitation at 542 nm, emision 
at 568 nm) on the 5’ anti-sense strand was adopted and coupled to 2, 0.5 and 0.2 µm 
polystyrene microspheres using standard solid phase techniques (Scheme 6.1). Using 
fluorescently labelled siRNA allowed the success of coupling to be measured by 
flow cytometry (Figure 6.3) and was found to be successful for 0.5 and 0.2 µm 
microspheres. However, it was not possible to couple siRNA efficiently to 2 µm 
microspheres despite repeated attempts. It is unclear why siRNA did not couple well 
to the larger sized microspheres, which were shown to be of good quality by SEM 
(Chapter 2) and had an amine loading of 6.7 µmolg-1 by quantitative ninhydrin test, 
sufficient for significant siRNA loading. 
An additional advantage of using fluorescent siRNA is that the approximate 
loading of siRNA per microsphere could be calculated by analysis of the supernatant 




Scheme 6.1. siRNA Microspheres. Coupling of siRNA to 2 µm (2.10), 0.5 µm (2.7.2) and 0.2 µm 
(2.12) microspheres via a non-cleavable succinic linkage, yielding (6.3.1), (6.3.2) and (6.3.3). 
(i). 10 eq. Fmoc-PEG-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (ii). 20% piperidine/DMF, 3 
× 20 min, 25 ºC; (iii). 10 eq. Succinic anhydride, 10 eq. DIPEA, DMF, 18 h, 25 ºC; (iv). 10 eq. 
EDAC, MES (pH 5.5), 2 h, 25 ºC; (v). TAMRA labelled or unlabelled amino-siRNA, sterile RNase 
Free water, 24 h, 25 ºC. 
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Figure 6.3. siRNA Coupling to Microspheres. Left: FACS histograms of a. uncoupled control 
microspheres; b. 2 µm-TAMRA siRNA microspheres (6.3.1); c. 0.5 µm-TAMRA siRNA 
microspheres (6.3.2); d. 0.2 µm-TAMRA siRNA microspheres (6.3.3) (‘PE-A’ refers to TAMRA 
fluorescence); Right: e. TAMRA fluorescence intensity as found by flow cytometry. 
 
As such, the supernatant from siRNA/microsphere couplings (which contained 
residual TAMRA labelled siRNA not coupled to the 0.2 and 0.5 µm microspheres) 
was analysed by spectrofluorimetry and compared to calibration samples of known 
siRNA concentrations. Thus, the quantity of siRNA coupled to the microspheres was 
calculated. 
 
0.2 µm siRNA Microspheres 
The supernatant resulting from the coupling of TAMRA-siRNA to 0.2 µm 
microspheres was analysed and the emission maximum recorded at 580 nm. The 
fluorescence emission obtained correlated to 40 pico-mol of siRNA that was not 
coupled to microspheres. The quantity of siRNA originally added to 0.2 µm 
microspheres was 1 nmol, which indicates that 0.96 nmol of siRNA was successfully 
coupled to the microspheres. The beads have a solid content in solution of 3% (30 
mg/mL) and 3 mg were used in the coupling of siRNA (or 7.2 × 1011 beads, based on 
a number of particles per gram204 of 2.4 × 1014). Hence, it can be established that 
there was 1.3 × 10-21 mol of siRNA per bead and this relates to 783 chains of siRNA 
per microsphere. Using 86 µg/mL of 0.2 µm microspheres in cell experiments, this 
would give a siRNA concentration of 28 nM per culture (see Experimental for 
details). If one microsphere entered a cell (assuming an intracellular volume of 5000 
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µ3)179 and released all the on-bead siRNA cytoplasmically, this would yield an 
intracellular concentration of 0.3 nM siRNA. Given that the RNAi pathway is 
catalytic (one guide strand can facilitate the degradation of many mRNA strands) this 
is an excellent intracellular concentration. 
 
0.5 µm siRNA Microspheres 
In a similar manner, the quantity of siRNA on 0.5 µm microspheres was calculated 
and gave 13,244 chains of siRNA per microsphere and a siRNA culture 
concentration of 28 nM. If one 0.5 µm microsphere entered a cell and released all the 
on-bead siRNA, this would yield an intracellular concentration of 4 nM. Although 
this is more than 10 times more than that of 0.2 µm microspheres, it must be noted 
that less 0.5 µm microspheres enter a typical cell than 0.2 µm beads. 
 
6.2.3. On-Bead siRNA Stability 
A further advantage of using TAMRA labelled siRNA in the microsphere couplings 
was that the fluorescent label could be used to study the siRNA stability under 
varying culture conditions by flow cytometry. As such, 0.2 and 0.5 µm TAMRA 
siRNA microspheres were incubated (37 ºC) for between 30 minutes and 24 hours in 
Phosphate Buffered Saline (PBS, pH 7.4), complete culture media (supplemented 
with 10% foetal bovine serum and 100 units/mL penicillin and streptomycin) and 
serum-free culture media. Fluorescence was measured by flow cytometry and 
compared to an untreated control sample (Figure 6.4 and Graph 6.2). TAMRA 
labelled siRNA microspheres were stable under all conditions, except serum 
supplemented culture conditions. Under these circumstances, the siRNA appeared 
degraded after as little as 30 minutes. In contrast, serum-free conditions provided a 
stable environment for the siRNA microspheres, even after 24 hours.  
It is not surprising that siRNA microspheres were not stable under serum-
supplemented conditions. Foetal bovine serum (FBS) contains a range of nucleases 
capable of resulting in the degradation of sensitive RNAs and, since the microsphere 
does not offer any physical protection for the siRNA, it is unsurprising that it 
becomes degraded. This result indicates that microspheres should be incubated with 
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cells under serum-free conditions during gene silencing experiments to prevent the 
premature degradation of siRNA. 
 
Graph 6.2. siRNA On-Bead Stability. 0.2 and 0.5 µm TAMRA siRNA microspheres (6.3.3 and 
6.3.2 respectively) after 24 hour treatment with PBS, complete media and serum-free media at 37 ºC 
as found by flow cytometry. ‘Negative Control’ is uncoupled microspheres; ‘TAMRA Positive’ are 
untreated 0.2 and 0.5 µm microspheres coupled with TAMRA siRNA. 
 
 
Figure 6.4. siRNA On-Bead Stability. Flow cytometry histograms of 0.2 and 0.5 µm TAMRA 
siRNA microspheres ((6.3.3) and (6.3.2) respectively) after 24 hour treatment with complete media 
 125
and serum-free media at 37 ºC. ‘Positive Controls’ are 0.2 and 0.5 µm microspheres coupled to 
TAMRA siRNA and untreated; ‘Negative Control’ refers to uncoupled microspheres. 
 
6.2.4. Microsphere Mediated Delivery of siRNA 
6.2.4.1. Non-Cleavable Linkages 
TAMRA-labelled siRNA was coupled to microspheres via a non-cleavable amide 
linkage for reasons of stability. However, modification of siRNA with a fluorophore 
(in particular when it is incorporated into the anti-sense strand) can result in a poor 
knockdown efficiency when compared to the non-fluorescent counterparts, as was 
found lipofecting HeLa-EGFP cells with labelled and unlabelled GFP-1 siRNA and 
making analysis after 72 hours by flow cytometry (Graph 6.3).205  
 
Graph 6.3. TAMRA-siRNA. Gene silencing with fluorescent and non-fluorescent GFP-1 (28 nM) 
transfected into HeLa-EGFP cells by Lipofectamine™ 2000. Analysis performed after 72 hours. 
‘Positive GFP’ refers to untreated HeLa-EGFP control cells. 
 
For this reason, non-fluorescent siRNA was coupled to 0.2 and 0.5 µm microspheres 
in the same manner as the TAMRA labelled siRNA (Scheme 6.1). 
 
6.2.4.2. Cleavable Linkages 
It is not well established whether siRNA needs to be freed from its delivery device in 
order to function efficiently. As such, an alternative linkage was additionally used, 
whereby siRNA was coupled to the microspheres via a disulphide linker, which 
could be cleaved intracellularly by endogenous glutathione (Scheme 6.2).  
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Scheme 6.2. Cleavable siRNA and FAM Microspheres. Coupling of siRNA and fluorescein to 0.2 
and 0.5 µm microspheres via a cleavable disulphide linkage, yielding (6.5.1)/(6.5.2) – (6.6.1)/(6.6.2). 
(i). 10 eq. Fmoc-PEG-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (ii). 20% piperidine/DMF, 3 
× 20 min, 25 ºC; (iii). 10 eq. Dithiodipropionic acid, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (iv). 
10 eq. HOBt, 10 eq. DIC, DMF, 2 h, 25 ºC; (v). 10 eq. Fluoresceinamine, DMF, 18 h, 25 ºC; (vi). 10 
eq. EDAC, MES (pH 5.5), 2 h, 25 ºC; (vii). amino-siRNA, sterile RNase Free water, 24 h, 25 ºC. 
 
In order to establish the cleavage of the disulphide linker, fluorescein was coupled to 
0.2 and 0.5 µm microspheres, yielding (6.5.2) and (6.5.1) respectively. (6.5.2) and 
(6.5.1) were subsequently treated with 10 mM dithiothreitol (DTT) or glutathione ex 
vitro (Figure 6.5 and Graph 6.4). After 1 hour treatment with DTT, the fluorescence 
associated with fluorescein decreased by 55% on 0.5 µm microspheres and 75% on 
0.2 µm microspheres. Use of glutathione facilitated a decrease in fluorescence 
intensity of 50% on 0.5 µm microspheres and 60% on 0.2 µm microspheres after 1 
hour. After 24 hours, the fluorescence intensity had decreased to a base value that 
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likely related to the cleavage of all the fluorescein from the surface of the 
microspheres. 
 
Figure 6.5. Disulphide Cleavage. FACS histograms of 0.2 and 0.5 µm fluorescein microspheres 
((6.5.2) and (6.5.1) respectively) treated with DTT and glutathione (10 mM) for 24 h. ‘Positive 
Control’ refers to FAM-coupled untreated microspheres; ‘Negative Control’ refers to uncoupled 
microspheres. 
 
Graph 6.4. Disulphide Cleavage. Dissociation of fluorescein from 0.2 and 0.5 µm disulphide  
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microspheres ((6.5.2) and (6.5.1) respectively) by treatment with 10 mM DTT or 10 mM glutathione 
in PBS, after 1, 6 and 24 hours. Under the same conditions succinic-FAM microspheres retained their 
fluorescence. 
 
In order to study the cleavage of the disulphide linkage in vitro, HeLa cells were 
beadfected with 0.2 (6.5.2) and 0.5 µm (6.5.1) disulphide-FAM microspheres and 
intracellular cleavage was assessed by microscopy (Figure 6.6). The fluorescein dye 
originally associated to microspheres was noted to be dispersed within the 
cytoplasmic region of the cell, indicating the successful dissociation of fluorescein 
from the microspheres indicative of disulphide cleavage. In contrast, microspheres 
linked to fluorescein via a non-cleavable succinic linkage ((6.7.1) and (6.7.2)) 
(Scheme 6.3) showed a localisation of fluorescence associated with the microspheres 
and not dispersed within the cell (Figure 6.7). 
 
 
Figure 6.6. Microscopy of Disulphide Cleavage. a. 0.2 µm (6.5.2) and b. 0.5 µm (6.5.1) disulphide-
FAM microspheres (86 µg/mL) in HeLa cells after 12 hours. Left are fluorescence images showing 
dye dispersion into the cell cytoplasm; Right are brightfield images showing cell location. Scale bar is 
100 µm.  
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Scheme 6.3. Succinic-FAM Microspheres. Coupling of fluorescein to microspheres, via a non-
cleavable amide linkage yielding (6.7.1) and (6.7.2). 
(i). 10 eq. Fmoc-PEG-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (ii). 20% piperidine/DMF, 3 
× 20 min, 25 ºC; (iii). 10 eq. Succinic anhydride, 10 eq. DIPEA, DMF, 18 h, 25 ºC; (iv). 10 eq. HOBt, 
10 eq. DIC, DMF, 2 h, 25 ºC; (v). 10 eq. Fluoresceinamine, DMF, 18 h, 25 ºC. 
 
 
Figure 6.7. Microscopy of Non-Cleavable Microspheres. a. 0.5 µm (6.7.1) and b. 0.2 µm (6.7.2) 
(86 µg/mL) uptake by HeLa cells after 12 hours. Actin filaments are labelled with AlexaFluor-568 
phalloidin and nuclei are stained with Hoechst 33342. Scale bar is 100 µm. Inset images are a 4× 
magnification. 
 
6.3. Toxicity of Microspheres for siRNA Delivery  
 
One major problem associated with some cellular delivery agents is cytotoxicity, 
with concerns over liposome transfection agents and carbon nanotubes. As such, it 
was important to establish that siRNA microspheres do not cause toxicity in cells 
over the incubation periods required for gene silencing experiments (72 hours) 
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(Graph 6.5). As such, MTT assays were used to show that no detrimental 
cytotoxicity was evident in either HeLa or E14 cells beadfected with 0.2 or 0.5 µm 
amide (succinic) or disulphide microspheres and cellular viability was >80% in all 
cases, even after 72 hours, indicating the applicability of microspheres to gene 




Graph 6.5. Cellular viability. a. HeLa and b. E14 cells beadfected (43 and 86 µg/mL) for 72 hours 
with siRNA microspheres (6.3.2), (6.3.3), (6.6.1) and (6.6.2) and analysed by MTT assay. ‘Control’ 
indicates untreated. 
 
6.4. Gene Silencing of EGFP in HeLa Cells 
 
6.4.1. Beadfection of HeLa Cells with Labelled siRNA 
Following the successful linkage of TAMRA-labelled siRNA to 0.5 and 0.2 µm 
microspheres ((6.3.2) and (6.3.3) respectively) its in vitro fate was studied. As such, 
HeLa-EGFP cells were incubated with siRNA microspheres and analysed for GFP 
expression by flow cytometry and microscopy (Figure 6.8 – 6.10). After 24 hours, 
some cells containing siRNA microspheres appeared decreased in EGFP 
fluorescence (Figure 6.8, white arrows) and siRNA beads could be observed as 
localised fluorescent points. However, after 48 – 72 hours the TAMRA labelled 
siRNA, which was originally localised on the microsphere, appeared dispersed into 
the cell and the microspheres no longer appeared extensively fluorescent (Figure 
6.9). This may suggest that the anti-sense strand (which is TAMRA labelled) has 
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become disassociated from the sense strand (and, thus disengaged from the 
microsphere). This is possibly facilitated by the interaction of the on-bead siRNA 
with the RISC. 
 
 
Figure 6.8. Microscopy of TAMRA-siRNA Microspheres. a. 0.2 µm (6.3.3) TAMRA siRNA 
microspheres after 24 h; b. 0.5 µm (6.3.2) TAMRA siRNA microspheres after 24 h. Scale bar is 200 
µm. Inset is 5× magnification. Microsphere concentration was 86 µg/mL. 
 
 
Figure 6.9. siRNA Release. Microscopy of HeLa-EGFP cells beadfected with a. 0.5 µm (6.3.2) 
TAMRA siRNA microspheres after 72 h; b. 0.2 µm (6.3.3) TAMRA siRNA microspheres after 72 h. 
Scale bar is 50 µm. Microsphere concentration was 86 µg/mL. 
 
Quantitative analysis by flow cytometry showed silencing of EGFP in HeLa 
cells after 48 hours using 0.2 (6.3.3) and 0.5 µm (6.3.2) microspheres linked to 
TAMRA-labelled siRNA and the GFP intensity was reduced by 47% and 65% 
respectively. This result indicates that a cleavable linker is not essential to EGFP 
silencing as the RISC appears to be capable of selecting the anti-sense siRNA and 




Figure 6.10. Gene Silencing with TAMRA-siRNA Microspheres. Left: Flow cytometry histograms 
after 72 hours a. untreated control cells; b. cells treated with 0.5 µm (6.3.2) TAMRA siRNA 
microspheres; c. cells treated with 0.2 µm (6.3.3) TAMRA siRNA microspheres; d. Decrease in EGFP 
fluorescence intensity after 24, 48 and 72 hours as analysed by flow cytometry, following treatment 
with 0.5 (6.3.2) or 0.2 µm (6.3.3) TAMRA siRNA microspheres. Microspheres were added to give a 
siRNA concentration of 28 nM (86 µg/mL microspheres). ‘Negative GFP’ are untreated HeLa cells; 
‘Positive GFP’ are untreated HeLa-EGFP cells. 
 
6.4.2. Beadfection of HeLa Cells with Unlabelled siRNA 
As discussed, siRNA that is fluorescently labelled does not generally offer as an 
efficient gene silencing as non-fluorescent siRNA. As such, EGFP silencing in HeLa 
cells was repeated with non-fluorescent siRNA linked to 0.2 and 0.5 µm 
microspheres via disulphide ((6.6.2) and (6.6.1) respectively) and non-cleavable 
(succinic) linkers ((6.3.3) and (6.3.2) respectively). Analysis was made by flow 
cytometry and microscopy over 24 – 72 hours (Graph 6.6 and Figure 6.11 – 6.12). 
No significant gene silencing was noted after 24 hours, however, after 48 hours a 
knockdown of 80 – 90% was noted in cells incubated with siRNA microspheres. 
After 72 hours this was increased to 90 – 93%. No significant differences could be 
seen between the amide and disulphide linkages. This suggests that, in this case, 
cleavage of the double strand from the microsphere was not required and the RISC 
may facilitate the release of the guide strand (which is not covalently linked to the 
microsphere), as seen with TAMRA-siRNA microspheres. 
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Graph 6.6. EGFP Silencing in HeLa Cells. Reduction in EGFP fluorescence in HeLa-EGFP cells 
after 24, 48 and 72 hours after treatment 0.2 and 0.5 µm microspheres with siRNA coupled via amide 
(succinic) ((6.3.3) and (6.3.2) respectively) or disulphide linkages ((6.6.2) and (6.6.1) respectively). A 
positive control was established with Lipofectamine™ 2000 (28 nM). ‘Negative GFP’ refers to HeLa 
cells that do not express EGFP. ‘Positive GFP’ refers to untreated HeLa-EGFP cells. 
 
 
Figure 6.11. EGFP Silencing in HeLa Cells. FACS histograms of HeLa-EGFP cells after 72 hours, 
a. Untreated cells; b. Cells treated with 0.2 µm microspheres with siRNA via an amide linkage 
(6.3.3); c. Cells treated with 0.2 µm microspheres with siRNA via a disulphide linkage (6.7.2); d. 
Cells treated with 0.5 µm microspheres with siRNA via an amide linkage (6.3.2); e. Cells treated with 






Figure 6.12. Microscopy of Gene Silencing. HeLa-EGFP cells after 72 h. a. untreated control cells; 
b. incubated in the presence of 0.2 µm amide-siRNA microspheres (6.3.3); c. incubated in the 
presence of 0.2 µm disulphide-siRNA microspheres (6.6.2); d. incubated in the presence of 0.5 µm 
amide-siRNA microspheres (6.3.2); e. in the presence of 0.5 µm disulphide-siRNA microspheres 
(6.6.1). Scale bar is 350 µm. Inset are phase contrast images, showing approximately 70 – 80% cell 
confluency. Microsphere concentration was 86 µg/mL. 
 
6.4.3. Controls for Gene Silencing 
In order to demonstrate the significance of these results, several controls were 
additionally established to demonstrate that the knockdowns obtained were true and 
not due to a secondary effect resulting in EGFP fluorescence reduction. These 
included siRNA not complementary to EGFP mRNA lipofected with 
Lipofectamine™ 2000 and also beadfected with 0.2 and 0.5 µm microspheres, beads 
without siRNA and siRNA (GFP-1) without a carrier system (Graph 6.7). 
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Graph 6.7. Gene Silencing Controls. EGFP fluorescence intensity following addition of siRNA 
(GFP-1) lipofected with Lipofectamine™ 2000 (‘Lipofectamine 2000 positive’), siRNA (not for 
EGFP silencing) lipofected with Lipofectamine™ 2000 (‘Lipofectamine 2000 negative’), siRNA 
(GFP-1) without a carrier system (‘Free siRNA’), microspheres without siRNA (‘Free microspheres’) 
and microspheres loaded with siRNA that should not cause EGFP silencing (‘Microspheres with 
negative siRNA’). In each case (as appropriate) 86 µg/mL of microspheres were added to cell cultures 
and the siRNA concentration was 28 nM. ‘Control’ refers to untreated HeLa-EGFP cells. 
 
 
Excluding those employing Lipofectamine™ 2000, none of the controls showed an 
appreciable decrease in EGFP fluorescence intensity from the control cells (untreated 
HeLa-EGFP cells). In the case of Lipofectamine™ 2000, the positive control 
(lipofecting siRNA GFP-1) showed the expected reduction in EGFP, which was 
optimal after 48 hours. However, the negative control (lipofecting siRNA not 
complementary to EGFP mRNA) also caused a decrease in EGFP expression by 
approximately 20%. In contrast, siRNA not targeted against EGFP and beadfected 
did not result in any decrease in EGFP fluorescence. This suggests that toxicity 
associated to Lipofectamine™ 2000 may have resulted in some non-specific 






6.5. Gene Silencing of EGFP in Embryonic Stem Cells 
 
Further to the successful gene silencing of EGFP observed in HeLa cells, the 
capability of siRNA microspheres to beadfect ES cells with siRNA for GFP 
knockdown was examined.  
 
6.5.1. Beadfection of ES Cells with Labelled siRNA 
ES-EGFP cells (expressing EGFP on their membrane) were analysed for their uptake 
of siRNA laden microspheres using 0.2 (6.3.3) and 0.5 µm (6.3.2) TAMRA siRNA 
microspheres. Assessment of uptake was determined qualitatively by microscopy 
(Figure 6.13).  
 
 
Figure 6.13. TAMRA-siRNA in ES-EGFP Cells. Uptake of TAMRA siRNA microspheres, (6.3.2) 
and (6.3.3), in ES-EGFP cells after 24 hours: a. 0.5 µm; b. 0.2 µm. Inset are magnifications. Bead 
Concentration: 86 µg/mL. Scale bar is 50 µm. 
 
Uptake was deemed successful, although appeared less prevalent than in HeLa-EGFP 
cells. Subsequently, following beadfection with TAMRA siRNA microspheres, 
EGFP expression was assessed by flow cytometry (Figure 6.14) and was observed to 
be decreased after 48 – 72 hours by a maximum of 50% for both diameters of 
microsphere (0.2 and 0.5 µm). Similar to HeLa cells, this result indicates that it is not 
essential that the siRNA is disengaged from the microsphere as the RISC is able to 




Figure 6.14. Gene Silencing with TAMRA-siRNA Microspheres. Left: Flow cytometry histograms 
after 72 hours a. untreated control cells; b. cells treated with 0.5 µm (6.3.2) TAMRA siRNA 
microspheres; c. cells treated with 0.2 µm (6.3.3) TAMRA siRNA microspheres; d. Decrease in EGFP 
fluorescence intensity after 24, 48 and 72 hours as analysed by flow cytometry, following treatment 
with 0.5 (6.3.2) or 0.2 µm (6.3.3) TAMRA siRNA microspheres. Microspheres were added to give a 
siRNA concentration of 28 nM (86 µg/mL microspheres). ‘Negative GFP’ are untreated ES cells; 
‘Positive GFP’ are untreated ES-EGFP cells. 
 
6.5.2. Beadfection of ES Cells with Unlabelled siRNA 
ES-EGFP cells were additionally beadfected with unlabelled siRNA microspheres 
(with succinic (6.3.2), (6.3.3) and disulphide (6.6.1), (6.6.2) linkages) and protein 
expression measured over 24 – 72 hours. The effect on EGFP expression was 
analysed by flow cytometry and microscopy (Figure 6.15-6.16, Graph 6.8).  
EGFP silencing with unlabelled siRNA mediated by microspheres was 
successful in embryonic stem cells (up to 60%) and more prevalent than with the use 
of TAMRA labelled siRNA as expected. In general, disulphide-siRNA microspheres 
appeared to be more efficient than amide-siRNA microspheres, suggesting that in the 
case of stem cells cleavage of the siRNA from the delivery device is important, 
although not essential. In addition, 0.5 µm microspheres appeared to more efficiently 
silence EGFP in stem cells than 0.2 µm microspheres. However, this may be due to 
the increased quantity of siRNA coupled to 0.5 µm microspheres (ca 13,000 
molecules) compared to 0.2 µm microspheres (ca 800 molecules), or may be due to a 
better uptake of 0.5 µm siRNA microspheres over 0.2 µm microspheres. 
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Figure 6.15. EGFP Silencing in ES-EGFP Cells. FACS histograms of ES-EGFP cells after 72 
hours: a. untreated cells; b. 0.5 µm (6.3.2) amide-siRNA microspheres; c. 0.5 µm (6.6.1) disulphide-
siRNA microspheres; d. 0.2 µm (6.3.3) amide-siRNA microspheres; e. 0.2 µm (6.6.2) disulphide-
siRNA microspheres. Microsphere concentration was 86 µg/mL. 
 
 
Graph 6.8. EGFP Silencing in ES-EGFP Cells. EGFP fluorescence in mouse embryonic stem cells 
after 24, 48 and 72 hours treated with 0.5 and 0.2 µm amide (succinic)/disulphide microspheres. 
‘Negative Control’ are untreated cells that do not express EGFP. ‘Positive Control’ are untreated ES-





Figure 6.16. Microscopy of Gene Silencing. ES-EGFP cells after 72 h. a. untreated control cells; b. 
incubated in the presence of 0.2 µm succinic-siRNA microspheres (6.3.3); c. incubated in the presence 
of 0.2 µm disulphide-siRNA microspheres (6.6.2); d. incubated in the presence of 0.5 µm succinic-
siRNA microspheres (6.3.2); e. incubated in the presence of 0.5 µm disulphide-siRNA microspheres 
(6.6.1). Scale bar is 100 µm. Inset are phase contrast images, showing approximately 70 – 80% cell 
confluency. Microsphere concentration was 86 µg/mL.  
 
In the case of ES-EGFP cells, gene silencing with microspheres was comparable with 
the silencing achieved with commercially available lipofection products (Graph 
6.8). 
 
6.5.3. Controls for Gene Silencing 
As with HeLa-EGFP cells, several controls were established to ensure the EGFP  
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silencing achieved was a true result and not an artefact of some unspecific effect. As 
such, ES-EGFP cells were incubated with siRNA without a carrier system, siRNA 
complementary and non-complementary to EGFP lipofected (Lipofectamine™ 
2000), siRNA non-complementary to EGFP beadfected and microspheres without 
siRNA (Graph 6.9). It was noted that, as with HeLa-EGFP cells, Lipofectamine™ 
2000 as a carrier system caused some decrease in GFP expression itself. However, 
this was seen to recover after 48 – 72 hours. All other controls did not affect GFP 
expression. 
 
Graph 6.9. Controls of Gene Silencing. EGFP fluorescence intensity following addition of siRNA 
(GFP-1) lipofected with Lipofectamine™ 2000 (‘Lipofectamine 2000 positive’), siRNA (not for 
EGFP silencing) lipofected with Lipofectamine™ 2000 (‘Lipofectamine 2000 negative’), siRNA 
(GFP-1) without a carrier system (‘Free siRNA’), microspheres without siRNA (‘Free microspheres’) 
and microspheres loaded with siRNA that will not cause EGFP silencing (‘Microspheres with 
negative siRNA’). In each case, as appropriate, 86 µg/mL microspheres were added to cell cultures 
and the siRNA concentration was 28 nM.  
 
6.6. A Dual-Functionalised System 
 
6.6.1. Silencing of EGFP in HeLa Cells by Selection 
Although the reduction in GFP intensity was clear with microspheres, it was 
considered that a more accurate assessment of the knockdown would be to obtain a 
system where the beadfected cells could be assessed independently from non-
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beadfected cells. In this manner, cells containing siRNA could be assessed 
independently from cells that did not contain siRNA. 
To this affect, a dual-labelled system was investigated. Here, lysine was 
employed to allow multi-functionalisation of the microspheres with a fluorophore 
distinguishable from GFP (Cy5) and siRNA. This system allowed for functionality, 
for example siRNA, but also meant the microsphere could be tracked via the Cy5 
label (Scheme 6.4).  
 
Scheme 6.4. Dual-Functionalisation. Preparation of dual-labelled 0.5 µm Cy5-co-siRNA 
microspheres (6.12.1) and (6.13.1). 
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(i). 10 eq. Fmoc-Lys-(Dde)-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 h, 25 ºC; (ii). 20% 
piperidine/DMF, 3 × 20 min, 25 ºC; (iii). 10 eq. Fmoc-PEG-OH, 10 eq. HOBt, 10 eq. DIC, DMF, 18 
h, 25 ºC; (iv). Hydroxylamine.HCl, imidazole, NMP, 1 h, 25 ºC; (v). 5 eq. Carboxylated-Cy5, 5 eq. 
HOBt, 5 eq. DIC, DMF, 18 h, 25 ºC; (vi). 20% piperidine/DMF, 3 × 20 min, 25 ºC; (vii). 10 eq. 
Succinic anhydride, 10 eq. DIPEA, 18 h, 25 ºC or 10 eq. Dithiodipropionic acid, 10 eq. HOBt, 10 eq. 
DIC, DMF, 18 h, 25 ºC; (viii). 10 eq. EDAC, MES (pH 5.5), 2 h, 25 ºC; ix. amino-siRNA, sterile 
RNase Free water, 24 h, 25 ºC. 
 
Thus, HeLa-EGFP cells were treated with Cy5-co-siRNA 0.5 µm microspheres with 
both the cleavable (disulphide) (6.12.1) and non-cleavable (succinic) (6.13.1) forms. 
EGFP silencing was analysed after 24, 48 and 72 hours by flow cytometry (Graph 
6.10) selecting those cells positive for Cy5 fluorescence and, hence, beadfected cells 
containing siRNA. Gene silencing was observed after 24 hours where EFGP was 
between 30% (disulphide) and 40% (succinic) reduced. This knockdown was more 
prevalent at 48 and 72 hours where reductions of up to approximately 90% were 
noted in both the cases of amide (succinic) and disulphide microspheres. 
 
 
Graph 6.10. Cell Selection. GFP Intensity in HeLa-EGFP cells after 24, 48 and 72 h incubation with 
Cy5-co-siRNA microspheres ((6.12.1) and (6.13.1)) as found by flow cytometry (inset: FACS dot 
plot). ‘Negative GFP’ refers to HeLa cells not expressing EGFP. ‘Positive GFP’ refers to untreated 
HeLa-EGFP cells. Microsphere concentration was 86 µg/mL. 
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EGFP gene silencing was confirmed by confocal microscopy where cells containing 




Figure 6.17. Microscopy. HeLa-EGFP cells beadfected with dual functionalised microspheres (86 
µg/mL): a. HeLa-EGFP cells incubated in the presence of Cy5-co-siRNA succinic 0.5 µm 
microspheres (6.13.1) after 72 h. Scale bar is 50 µm; c. HeLa-EGFP cells incubated in the presence of 
Cy5-co-siRNA disulphide 0.5 µm microspheres (6.12.1) after 72 h. Scale bar is 60 µm. 
 
 
Using this system, a reduction in EGFP expression could be detected after 24 hours, 
where when using the unlabelled system a decrease in fluorescence intensity could 
not be observed after such a short time and was only extensively observed after 48 – 
72 hours.. Presumably, this is due to a poorer uptake after 24 hours resulting in the 
knockdown signal being ‘diluted’ by un-beadfected cells and thus renders it 
undetectable. 
 
6.6.2. Uptake of siRNA-Laden Microspheres in HeLa Cells 
In addition to allowing for a more accurate assessment of the EGFP knockdown, the 
Cy5-co-siRNA microsphere system also allowed quantification of the uptake of 
microspheres when they were loaded with siRNA (Graph 6.11).  
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Graph 6.11. siRNA Microspheres. Uptake of Cy5-co-siRNA 0.5 µm microspheres, (6.12.1) and  
(6.13.1), in HeLa-EGFP cells after 24, 48 and 72 hours incubation. Microsphere concentration was 86 
µg/mL. 
 
Uptake was as much as 80% after 72 hours, but siRNA coupled microspheres did 
show a slower uptake than microspheres without siRNA. However, this result was to 
be expected given the negatively charged nature of siRNA, which will inherently 





In conclusion, green fluorescent protein expressed in human cervical cancer (HeLa) 
and mouse embryonic stem cells was successfully silenced using siRNA covalently 
coupled to 0.5 and 0.2 µm microspheres via cleavable and non-cleavable linkers. 
Microspheres showed no apparent toxicity at appropriate concentrations, even after 
72 hours incubation with cells. In addition, an improved system employing dual Cy5-
co-siRNA labelled 0.5 µm microspheres allowed independent evaluation of only 
those cells that had been beadfected with siRNA, yielding much more accurate 
knockdown data. This system also allowed for a truer determination of siRNA-laden 
microsphere uptake, which was found to approach 80% after 72 hours. 
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In consideration that microspheres were capable of delivering siRNA 
efficiently to two diverse cell lines, without toxicity whilst yielding prolonged 
protein silencing, this indicates that these particles are particularly applicable to the 
























Chapter 7: Experimental Section 
 
7.1. General Information 
 
1H-NMR and 13C-NMR were recorded at 250 MHz and 63 MHz respectively on a 
Bruker ARX-250 system. Chemical shifts (δ) are quoted in ppm and were referenced 
to residual non-deuterated solvent. Electrospray mass spectra were recorded using 
a VG Platform Quadrupole Electrospray Ionisation mass spectrometer. Only major 
peaks (m/z) are shown with their intensity to the base peak. HPLC analysis was 
performed on an Agilent Technologies 1100 modular HPLC system with detection 
by U.V. absorbance. Elution was made with Solvent A (0.1% TFA in deionised 
water) and Solvent B (0.042% TFA in acetonitrile) and the method (Supelco 
Discovery) was as follows: the material under investigation was eluted through a C-
18 column (50 mm × 2.1 mm × 5 µm) at 1 mL/min with a gradient of 10% Solvent 
B/90% Solvent A to 90% Solvent B/10% Solvent A over 3 min, followed by 2 min 
isocratic at 90% Solvent B/10% Solvent A. Spectra were recorded at 254 nm, unless 
otherwise stated. IR spectra were recorded on a Bruker Tensor 27 with a golden-gate 
accessory on solid samples. The following abbreviations were used to denote peak 
morphology: s (strong), m (medium), w (weak) and b (broad). Melting points were 
determined on an electrothermal hot stage apparatus. Laser diffractometry analysis 
of microspheres and microparticles was carried out on a Beckman Coulter LS 230 in 
deionised water. UV/Vis spectrophotometry was performed on an Agilent 8453 
spectrophotometer using a 60% EtOH blank and recording absorbance at 570 nm for 
quantitative ninhydrin tests and a 20% piperidine/DMF blank measuring absorbance 
at 302 nm for Fmoc tests. Scanning electron microscopy (SEM) and Energy 
dispersive X-ray (EDX) analysis were performed on a Philips XL30CP with PGT 
Spirit X-ray analysis for EDX. 0.2 µm microspheres (2.12) and 0.3 µm magnetic 
microspheres (4.1) were analysed on a Jeol JSM 5600. Cell experiments were 
carried out in a HERAsafe KS 18 class II negative-flow cabinet from Heraeus. Cell 
cultures were performed in a HERAcell 150 incubator from Heraeus. Flow 
cytometry was performed on a BD Biosciences FACSAria® system using the BD 
 147
FACSDiva software for analysis or a DakoCytomation CyAn™ ADP system with 
Summit software for analysis. Cell viability was assessed using a Bio-Rad 
microplate reader (Version 1.15) measuring absorbance at 570 nm. Fluorescence 
Spectrofluorometry was carried out on a FluoroMax system and the data analysed 
using Microsoft Excel. Real-Time microscopy was performed on a DeltaVision 
microscope equipped with an incubation chamber (37 ºC/5% CO2). Microscopy and 
Confocal microscopy were performed on a Zeiss Axiovert 200M pseudo confocal 
microscope with a 100 W Hg lamp or a Leica Inverted Confocal Microscope with a 
DM IRE2 microscope stand and analysed using Improvision Volocity acquisition 
software. Magnetic sublimations were performed with a neodymium magnetic 
separator from Bang’s Laboratories. In vivo imaging was performed on a Kodak FX-
PRO Reflectance system using multi-spectral un-mixing software. Histology was 
performed on cryostat sections using a Zeiss Axiovert S100 inverted microscope. 
 
Carboxylated Cy5 and Cy7 fluorophores, Fmoc-amino carboxy-poly(ethylene 
glycol) (Fmoc-PEG-OH) and Fmoc(Dde)-Lysine-OH were from the Bradley and 

















7.2. General Methods 
 
7.2.1. Monomer Preparation 
Prior to use, styrene (50 mL, Sigma-Aldrich) and DVB (50 mL, Sigma-Aldrich) were 
treated with 25% aq. NaOH (2 × 100 mL, then 2 × 50 mL) and washed with 
deionised water (2 × 100 mL, then 2 × 50 mL). The monomers were dried over 
MgSO4, filtered and stored at 4 ºC until their use. 
 
7.2.2. Microsphere Washings 
For microsphere preparation, see the Experimental to Chapter 2. 
After precipitation from the polymerisation mixture (70 mL), microspheres were 
isolated by centrifugation (Table 7.1) and washed sequentially with methanol (2 × 
50 mL) and deionised water (2 × 50 mL). Where polymerisation were performed on 
a Radley carousel (reaction volume: 5 mL) microspheres were washed with methanol 
(2 × 5 mL) and deionised water (2 × 5 mL). Finally, microspheres were stored in 
deionised water at 4 ºC. Prior to on-bead reactions, the microspheres were isolated by 
centrifugation and washed in the solvent of the reaction (3 × 1 mL). 
 
Table 7.1. Centrifugal speeds and time of centrifugation for polystyrene microspheres.204 * 2.11 was 
centrifuged in 1 mL aliquots. 
 
7.2.3. Solid Content of Bead Suspension 
A known volume of the suspension of microspheres in deionised water was placed in 
a (pre-weighed) petri-dish, covered with aluminium foil and dried under vacuum at 
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50 ºC for 18 hours. The sample was weighed and the solid content ascertained as 
according to Equation 7.1. 
 
% solid content (sc) = (m / Vs) × 100 
Equation 7.1. Analysis of microsphere solid content of suspension (% sc), where ‘m’ is the mass of 
microspheres recovered (g) and ‘Vs’ is the volume of the suspension dried (mL).204 
 
7.2.4. Preparation of Samples for Particle Size Distribution 
Microspheres (200 µL, 2% sc) were suspended in 2% polyoxyethylenesorbitan 
monolaurate in deionised water (200 µL) and sonicated (20 min). Microspheres in 
solution were then added, in a drop-wise manner, to a LS 230 laser diffractometer 
chamber as according to the manufacturer’s instructions.  
 
7.2.5. Preparation of Samples for Scanning Electron Microscopy and EDX 
Microspheres (25 µL, 2% sc) were dried on carbon-coated stubs under vacuum (50 
ºC, 5 hours) and gold coated by sputtering (approximately 20 nm layer) prior to 
analysis. 
 
7.2.6. Preparation of Samples for Elemental Analysis 
Microspheres (100 µL, 2% sc) were spread over a petri-dish, covered with 
aluminium foil and dried under vacuum (50 ºC, 5 hours). Dried microspheres (> 1 
mg) were analysed for their carbon, hydrogen and nitrogen content. 
 
7.2.7. Qualitative Ninhydrin Test 
Microspheres were suspended in methanol (25 µL, 2% sc) and solid particles 
obtained by centrifugation. To this, ninhydrin reagent A (10 µL) and ninhydrin 
reagent B (5 µL) (see below) were added and sonicated (1 min) before heating to 100 
ºC for 3 min. A blue colour was indicative of a positive result (free amines) and a 
yellow colour indicated a negative result (no free amines). 
 
7.2.8. Quantitative Ninhydrin Test 
Microspheres were suspended in methanol (150 µL, 2% sc) and solid particles 
obtained by centrifugation. To this, ninhydrin reagent A (6 drops) and ninhydrin 
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reagent B (2 drops) (see below) were added and sonicated (1 min) before heating to 
100 ºC for 3 min. After this time, 60% aq. ethanol (0.4 mL) was added and the 
suspension sonicated (1 min) before centrifugation. The supernatant was collected 
and the solid microspheres were washed with 60% aq. ethanol (2 × 0.4 mL), 
collecting the supernatant after each wash. The supernatants were combined and the 
absorbance measured at 570 nm. The amine loading on microspheres was found from 
Equation 7.2. 
 
Loading (µmolg-1) = (A570 × V) / (ε570 × m) × 1×106 
Equation 7.2. Analysis of amine loading, where ‘A570’ is the absorbance of the supernatant measured 
at 570 nm, ‘V’ is the volume of the measured solution (mL), ‘ε570’ is the molar extinction coefficient 
at 570 nm (15000 M-1cm-1) and ‘m’ is the mass of microspheres analysed (mg).204 
 
Ninhydrin Reagent A 
Solution 1: Phenol (40 g) was dissolved in ethanol (10 mL) with gentle warming 
before stirring over Amberlite mixed-bead resin MB-3 (4 g) for 45 min. The solution 
was obtained by filtration. 
Solution 2: Potassium cyanide (65 mg) was dissolved in deionised water (100 mL) 
and an aliquot (2 mL) of this solution was diluted with pyridine (38 mL, freshly 
distilled from ninhydrin) and stirred over Amberlite mixed-bead resin MB-3 (4 g). 
The solution was obtained by filtration and added to ‘Solution 1’, yielding ‘Reagent 
A’. 
Ninhydrin Reagent B 
Ninhydrin (2.5 g) was dissolved in ethanol (50 mL), yielding ‘Reagent B’. 
 
7.2.9. Fmoc Loading Test 
Microspheres (100 µL, 2% sc) were washed with DMF (Section 7.2.2) and 
suspended in DMF (50 µL) prior to the addition of Fmoc-Ahx-OH (10 eq.) pre-
activated with DIC (10 eq.) and HOBt (10 eq.) in DMF (50 µL). The microspheres 
were mixed on a rotary wheel at 25 ºC for 18 hours prior to sequential washing with 
DMF (3 × 100 µL). Microspheres were treated with 20% piperidine/DMF (200 µL, 3 
× 20 min) and washed with DMF (3 × 200 µL), collecting the supernatants after each 
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wash. The supernatants were combined and the absorbance recorded at 302 nm. The 
amine loading on microspheres was determined from Equation 7.3. 
 
Loading (µmolg-1) = (A302 × V) / (ε302 × m) × 1×106 
Equation 7.3. Analysis of amine loading, where ‘A302’ is the absorbance of the supernatant measured 
at 302 nm, ‘V’ is the volume of the measured solution (mL), ‘ε302’ is the molar extinction coefficient 
at 302 nm (7800 M-1cm-1) and ‘m’ is the mass of microspheres analysed (mg).206 
7.2.10. Purification of Magnetic Microspheres 
Following polymerisations (see Experimental to Chapter 4), microspheres were 
washed as described in Section 7.2.2 and treated with 2 M aq. HCl (5 mL, 2 × 10 
min). Microspheres were subsequently washed with deionised water (2 × 5 mL) and 
purified by magnetic sublimation using a neodymium magnetic separator. 
7.2.11. Magnetic Hysteresis Loop Analysis 
Microspheres (100 µL, sc 2%) were dried under vacuum in a petri-dish covered in 
aluminium foil at 50 ºC for 18 hours. Analysis was performed on 1 mg of solid 
microspheres at 300 K and compared to 1 mg of iron (III) oxide nanopowder at 300 
K. 
 
7.2.12. Cell Culture 
All cells were cultured in the appropriate culture medium at 37 ºC/5% CO2 
(Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich) for RAW264, 
HEK293T, B16F10 and L929 and Roswell Park’s Memorial Institute (RPMI-1640, 
Sigma-Aldrich) medium for HeLa, HeLa-EGFP, K562 and Jurkat) supplemented 
with 10% foetal bovine serum (FBS, Biosera), 100 U/mL penicillin and streptomycin 
and 4 mM L-glutamine (Gibco). E14t2g cells207 were grown in Glasgow’s Modified 
Eagle Medium (GMEM, Sigma-Aldrich) supplemented with 10% FBS, 0.25% 
sodium bicarbonate (Gibco), 0.1% non-essential amino acids (Gibco), 2 mM L-
glutamine (Gibco), 1 mM sodium pyruvate (Gibco), 0.1 mM β-mercaptoethanol 
(Gibco) and 100 U/mL Leukaemia Inhibitory Factor (LIF, Gibco). Cells were 
cultured in T-75 flasks (Nunc) until 70 – 80% confluency (E14 cells were cultured in 
a T-25 flask coated with 0.1% gelatine/PBS). At this time (for adherent cell lines), 
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the old growth media was removed and the cells were washed with PBS (10 mL) and 
harvested via trypsination (trypsin/EDTA, Gibco) (1 mL) at 37 ºC. The detached 
cells were collected in fresh growth media (4 mL) and diluted to the appropriate cell 
density for experiments in fresh growth media. An aliquot was re-seeded to a T-75 
flask for re-growth. 
In the case of suspension cells, the cells were collected from the T-75 flask by pipette 
and isolated by centrifugation (1200 rpm, 4 min), washed with PBS (10 mL) and 
finally diluted to the appropriate cell density for experiments in fresh growth media. 
 
7.2.13. Haemocytometry 
Cell densities were determined by haemocytometry. An aliquot (10 µL) of cells 
detached from a T-75 flask and collected in growth media (total volume: 5 mL) was 
mixed with 0.2% trypan blue (40 µL, Sigma-Aldrich) and pipetted into a Bright 
Line™ haemocytometer (an etched glass device with an H-shaped moat forming two 
cell-counting areas (with 4 quadrants in each area), with surface features enhanced 
by Neubauer rulings, Sigma-Aldrich). Cell concentrations and the densities required 
for experiments were determined by Equations 7.4 and 7.5 respectively. 
 
Concentration (cell/mL) = (N / Q) × 5×104 
Equation 7.4. Concentration of cell/mL by haemocytometry, where ‘N’ is the total number of cells 
counted and ‘Q’ is the number of quadrants counted. 
 
VExp (mL) = (VTot × CWell) × (1000 / VWell) / CTot 
Equation 7.5. Volume of cells detached from T-75 flask (VExp) required in an experiment a total 
medium volume of VTot and a concentration per well of CWell. VWell is the volume required per well 
and CTot is the concentration of cells/mL as calculated in Equation 7.4. 
 
7.2.14. Beadfection of Adherent Cell Lines 
Cells were suspended to the appropriate cell density in fresh growth media before 
seeding onto polystyrene well-plates (Nunc). Cells were incubated (37 ºC/5% CO2) 
for 24 hours to allow adhesion.  
Separately, microspheres were dispersed in fresh growth media to a concentration of 
86 µg/mL unless otherwise stated. The old media was removed from cells and 
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replaced with fresh media containing microspheres. Cells were incubated in the 
presence of microspheres (37 ºC/5% CO2) for 6 – 24 hours (unless otherwise stated) 
prior to analysis. 
 
7.2.15. Beadfection of Suspension Cell Lines 
Cells were suspended to the appropriate cell density in fresh growth media before 
seeding onto polystyrene well-plates (Nunc). Microspheres were added to cells to 
give a concentration of 86 µg/mL (unless otherwise stated). Cells were incubated in 
the presence of microspheres (37 ºC/5% CO2) for 6 – 24 hours (unless otherwise 
stated) prior to analysis. 
 
7.2.16. Flow Cytometry 
In preparation for flow cytometric analysis, the old media was removed from cell 
cultures and the cells were washed with PBS and harvested by trypsination at 37 ºC 
(trypsin/EDTA). Detached cells were collected in growth media and the cell pellet 
collected by centrifugation (1200 rpm, 4 min). Cells were re-suspended in 2% 
FBS/PBS or 0.2% trypan blue/HBSS (where extracellular quenching of fluorescein 
was desired) (minimum 300 µL). Samples were analysed by flow cytometry 
according to the fluorophores under investigation (Table 7.2) using the BD 
Biosciences FACSDiva software. Untreated cells were defined as having 0% uptake. 
 
Table 7.2. BD Biosciences FACSAria® system specifications (lasers and band pass filters) and 
corresponding fluorophores. 
 
7.2.17. Toxicity Assays 
Cells were cultured as described (Section 7.2.13) and seeded onto a 96-well plate at  
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a density of 1 × 104 cells/well (volume per well: 100 µL). The last row of the well-
plate was used as a blank (no cells seeded). Cells were incubated (37 ºC/5% CO2) for 
24 hours prior to beadfection (Sections 7.2.15 and 7.2.16) at concentrations of 75 
and 150 µg/mL. After 24 hours (unless otherwise stated), the old media was removed 
and replaced with fresh phenol red-free culture media (supplemented as described in 
Section 7.2.13) (90 µL) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT, Sigma-Aldrich) (10 µL). Cells were incubated for 5 hours at 37 
ºC/5% CO2. After this time, MTT solubilising solution (10% Triton-X, 0.1 N HCl in 
isopropanol) (100 µL) was added and the 96-well plate was gently shaken for 5 
hours. Absorbance was measured at 570 nm. Untreated cells were considered to be 
100% viable and cell viability was calculated from Equation 7.6. 
 
% Viable Cells = (AbsExp / AbsCont) × 100 
Equation 7.6. Viability of cells by MTT assays, where ‘AbsExp’ refers to the absorbance at 570 nm of 
cells treated with microspheres and ‘AbsCont’ refers to the absorbance at 570 nm of untreated control 
cells. 
 
7.2.18. Microscopy and Cell Staining 
Cells were cultured and beadfected as described in Sections 7.2.13, 7.2.15 and 
7.2.16. In preparation for microscopy, cells were washed with PBS and, if no 
staining was required (see below), microscopy was directly performed in 2% 
FBS/PBS or 0.2% trypan blue/HBSS. 
Nuclei Staining with Hoechst 33342 
Following washing with PBS, cells were treated with Hoechst 33342 (1 µg/mL, 
Sigma-Aldrich) for 10 min at 25 ºC. Cells were washed three times with PBS. 
Microscopy was performed in 2% FBS/PBS. 
Cellular Fixation 
PBS washed cells were fixed with 3% para-formaldehyde (20 min, 25 ºC) and 
washed three times with PBS. Microscopy was performed in PBS. 
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Actin Filament Staining with AlexaFluor®-568 Phalloidin 
Fixed cells were treated with AlexaFluor®-568 phalloidin (1 U/mL, Invitrogen) for 
15 min at 25 ºC. Cells were washed with PBS three times prior to microscopy. 






























7.3. Experimental for Chapter 2 
 




In a typical experiment, 4-vinylbenzyl chloride (21.1 mL, 0.15 mol, Sigma-Aldrich) 
was dissolved in DMF (75 mL) with potassium phthalimide (27.8 g, 0.15 mol, 
Sigma-Aldrich) and stirred (350 rpm) for 15 hours at 50 ºC. After this time, the 
solution was poured into sodium hydroxide (1.5 mol dm-3, 1500 mL), facilitating 
precipitation of the crude product, which was isolated by vacuum filtration. The solid 
was dissolved in ethyl acetate (300 mL) and the solvent removed in vacuo. The pure 
product was obtained following re-crystallisation from methanol, vacuum filtration 
and drying of the resulting colourless crystals under vacuum. 
Mass Yield: 27.4 g 
% Yield: 70% 
Mp: 100 ºC (Lit.208 107 – 108 ºC) 
Rf: (Hexane:EtOAc, 3:1) 0.48 
HPLC: (S50D, λ = 220 nm) 98% pure, retention time 4.07 min 
IR: 1700 cm-1 (m) 
Mass Spectrometry: (ES, MeOH) m/z 286 (100%, [M + Na+]), 318 (15%, [M + Na+ 
+ MeOH]+) 
1H-NMR: (CDCl3, 250 MHz) δ (ppm): 4.75 (s, 2H, H-g), 5.15 (d, 1H, J = 11.8 Hz, 
H-acis), 5.64 (d, 1H, J = 18.5 Hz, H-atrans), 6.60 (dd, 1H, J = 11.8, 18.5 Hz, H-b), 7.28 
(d, 2H, J = 8.5 Hz, H-d), 7.33 (d, 2H, J = 8.5 Hz, H-e), 7.63 (dd, 2H, J = 2.9, 5.5 Hz, 
H-k), 7.77 (dd, 2H, J = 3.1, 5.3 Hz, H-j)   
(2.5) 
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13C-NMR: (CDCl3, 63 MHz) δ (ppm): 41.7 (C-g), 114.5 (C-a), 123.7 (C-j), 126.9 
(C-d), 129.2 (C-e), 132.5 (C-i), 134.4 (C-k), 136.2 (C-f), 136.7 (C-b), 137.6 (C-c), 
168.4 (C-h) 
 
7.3.2. Preparation of 4-Vinylbenzyl Amine, (2.3.1) 
 
 
In a typical experiment, 4-vinylbenzyl phthalimide (6.4 g, 0.024 mol) was suspended 
in nitrogen-purged ethanol (34 mL) and heated to reflux under nitrogen for 30 min. 
Hydrazine hydrate (2.3 mL, 0.05 mol, Sigma-Aldrich) was added via a self-
equilibrating dropping funnel and the reaction mixture was stirred for 3 hours. After 
this time, the by-product was removed by vacuum filtration and the filtrates were 
concentrated in vacuo. The resulting crude product was treated with aqueous 
potassium hydroxide (1.5 mol dm-3, 50 mL) and extracted with diethyl ether (3 × 50 
mL). The organic fractions were combined and washed with 2% potassium carbonate 
(50 mL) before drying over magnesium sulphate and concentrated in vacuo to give 
an orange oil. 
Mass Yield: 1.7 g 
% Yield: 52% 
Rf: (Diethyl ether) 0.24 
HPLC: (S50D, λ = 220 nm) 100% pure, retention time 2.24 min 
IR: 2975 cm-1 (m, b) 
Mass Spectrometry: (ES, MeOH) m/z 117 (100%, [M - NH2]+), 134 (12%, [M + 
H]+) 
1H-NMR: (CDCl3, 250 MHz) δ (ppm): 3.70 (s, 2H, H-g), 5.10 (d, 1H, J = 10.9 Hz, 
H-acis), 5.55 (d, 1H, J = 17.6 Hz, H-atrans), 6.53 (dd, 1H, J = 10.9, 17.6 Hz, H-b), 7.10 
(d, 2H, J = 8.2 Hz, H-d), 7.20 (d, 2H, J = 8.1 Hz, H-e) 
(2.3.1) 
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13C-NMR: (CDCl3, 63 MHz) δ (ppm): 46.5 (C-g), 113.8 (C-a), 126.8 (C-d), 127.6 
(C-e), 136.6 (C-f), 136.9 (C-b), 143.2 (C-c). 
 
7.3.3. Preparation of 4-Vinylbenzyl Amine.HCl, (2.3.2) 
 
 
In a typical experiment, 4-vinylbenzyl amine (1.7 g, 0.01 mol) was dissolved in 
diethyl ether (150 mL) and acidic isopropanol (HCl, 6N) was added drop-wise at 0 
ºC until salt precipitation was complete. The hydrochloride salt was collected by 
vacuum filtration and dried under vacuum. Commonly, the free amine (2.3.1) was 
not isolated and vinylbenzylamine.HCl was precipitated directly, as above. 
Mass Yield: 0.8 g 
% Yield: 46% 
Mp: 180 ºC (Lit.209 160 – 170 ºC) 
Rf: (Diethyl ether) 0.095 
HPLC: (S50D, λ = 220 nm) 100% pure, retention time 2.30 min 
IR: 2975 cm-1 (m, b) 
Mass Spectrometry: (ES, MeOH) m/z 117 (100%, [M – NH3Cl]+), 134 (16%, [M - 
Cl]+) 
1H-NMR: (D2O, 250 MHz) δ (ppm): 4.30 (s, 2H, H-g), 5.50 (d, 1H, J = 10.2 Hz, H-
acis), 6.03 (d, 1H, J = 17.0 Hz, H-atrans), 6.94 (dd, 1H, J = 10.2, 17.0 Hz, H-b), 7.55 (d, 
2H, J = 8.2 Hz, H-d), 7.70 (d, 2H, J = 8.2 Hz, H-e) 
13C-NMR: (D2O, 63 MHz) δ (ppm): 43.2 (C-g), 115.7 (C-a), 127.2 (C-d), 129.6 (C-









In a typical polymerisation, poly(vinyl pyrrolidone) (PVP, Mw 10,000, 29,000, 
40,000 and 360,000; 70 µmol, 0.2 mol% with regards to styrene, Sigma-Aldrich) was 
dissolved in nitrogen-purged ethanol (70 mL). To this, nitrogen-purged styrene (3.7 
mL, 32 mmol, 1 eq.) with divinylbenzene (DVB; 0.06 mL, 0.4 mmol, 1.3 mol% with 
regards to styrene), vinylbenzylamine.HCl (VBAH; 0.16 g, 0.9 mmol, 2.8 mol% with 
regards to styrene) and 2,2′-Azobis(2-methylpropionitrile) (AIBN; 0.1 g, 0.6 mmol, 
1.9 mol% with regards to styrene, Sigma-Aldrich) were added and the resultant 
mixture stirred (350 rpm) at 25 ºC under nitrogen. After 2 hours, the temperature was 
increased to 70 ºC and the reaction stirred (350 rpm) under nitrogen at this 
temperature for 18 hours, facilitating the precipitation of microspheres. The reaction 
mixture was allowed to cool before microspheres were collected by centrifugation 
(Table 7.1) and washed with methanol (2 × 50 mL) and deionised water (2 × 50 
mL). Microspheres were stored in deionised water at 4 ºC. 
 
Table 7.3. Microspheres Prepared with Varying PVP Mw. Yield, size distribution (by laser 
diffractometry), amine loading (by quantitative ninhydrin test, Fmoc test results are included in 
parentheses) and elemental analysis of (2.6.1), (2.6.2), (2.6.3) and (2.6.4). 
 
(2.6.1) – (2.6.4) 
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7.3.5. Preparation of Microspheres and the Addition of Water, (2.7.1) – (2.7.3) 
Polymerisations were performed in a 12-tube Radley carousel fitted with a water 
condenser and nitrogen inlet valves. 
In a typical polymerisation, poly(vinyl pyrrolidone) (Mw 40,000; 0.2 g, 5 µmol, 0.2 
mol% with regards to styrene) was dissolved in nitrogen-purged ethanol : deionised 
water (94:6, 97:3 and 92:8, 5 mL). To this, nitrogen-purged styrene (0.3 mL, 2.6 
mmol, 1 eq.) with DVB (4.3 µL, 29 µmol, 1.3 mol% with regards to styrene), VBAH 
(0.01 g, 64 µmol, 2.8 mol% with regards to styrene) and AIBN (7 mg, 43 µmol, 1.9 
mol% with regards to styrene) were added and the resultant mixture stirred (350 rpm) 
at 25 ºC under nitrogen. After 2 hours, the temperature was increased to 70 ºC and 
the reaction stirred (350 rpm) under nitrogen at this temperature for 18 hours, 
facilitating the precipitation of microspheres. The reaction mixture was allowed to 
cool before microspheres were collected by centrifugation (Table 7.1) and washed 
with methanol (2 × 10 mL) and deionised water (2 × 10 mL). Microspheres were 
stored in deionised water at 4 ºC. 
 
Table 7.4. Microspheres Prepared with Varying PVP Mw. Yield, size distribution (by laser 
diffractometry), amine loading (by quantitative ninhydrin test, Fmoc test results are included in 
parentheses) and elemental analysis of (2.7.1), (2.7.2) and (2.7.3). 
 
7.3.6. Preparation of Microspheres and the Addition of n-Butanol, (2.8) 
Polymerisations were performed as shown in Section 7.3.5 forming microspheres 
(2.7.1) – (2.7.3). However, ethanol : n-butanol (98:2, 5 mL) was used as the 
polymerisation solvent. 
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Yield: 0.07 g (25%). 
Size Distribution (by laser diffractometry): Mean 0.7 µm, S.D. 0.1 µm, C.V. 13%. 
Amine Loading (quantitative ninhydrin test): 8.7 µmolg-1. 
Amine Loading (Fmoc test): 7.8 µmolg-1. 
Elemental Analysis: C 92.1, H 7.4, N 0.4 (Amine Loading: 0.29 mmolg-1). 
 
7.3.7. Preparation of Microspheres and the Addition of Dimethoxyethane, (2.9) 
Polymerisations were performed as shown in Section 7.3.5 forming microspheres 
(2.7.1) – (2.7.3). However, ethanol : dimethoxyethane (98:2, 5 mL) was used as the 
polymerisation solvent. 
Yield: 0.1 g (36%). 
Size Distribution (by laser diffractometry): Mean 1.4 µm, S.D. 0.4 µm, C.V. 31%. 
Amine Loading (quantitative ninhydrin test): 5.0 µmolg-1. 
Amine Loading (Fmoc test): 5.0 µmolg-1. 
Elemental Analysis: C 91.4, H 7.8, N 0.5 (Amine Loading: 0.36 mmolg-1). 
 
7.3.8. Preparation of Microspheres and the Addition of Toluene, (2.10) 
Polymerisations were performed as shown in Section 7.3.5 forming microspheres 
(2.7.1) – (2.7.3). However, ethanol : toluene (96:4, 5 mL) was used as the 
polymerisation solvent. 
Yield: 0.1 g (36%). 
Size Distribution (by laser diffractometry): Mean 1.8 µm, S.D. 0.3 µm, C.V. 16%. 
Amine Loading (quantitative ninhydrin test): 6.7 µmolg-1. 
Amine Loading (Fmoc test): 6.0 µmolg-1. 
Elemental Analysis: C 91.5, H 8.1, N 0.5 (Amine Loading: 0.36 mmolg-1). 
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7.3.9. Preparation of Microspheres by Emulsion Polymerisation, (2.11) – (2.12) 
In a typical polymerisation, styrene (0.3 mL, 2.6 mmol, 1 eq.), DVB (7.3 µL, 50.7 
µmol, 2 mol% with regards to styrene), VBAH (8.7 mg, 65 µmol, 2.5 mol% with 
regards to styrene) and magnesium sulphate (1 mg, 8.3 µmol, 0.3 mol% with regards 
to styrene) were emulsified in boiled nitrogen-purged deionised water (cooled to 25 
ºC, 5 mL). The mixture was bubbled with nitrogen and stirred (350 rpm) at 25 ºC for 
30 min before being heated to 80 ºC and stirred under nitrogen for 20 min. After this 
time, 2,2’-Azobis-2-methyl propionamide (V-50, 4 mg, 14 µmol, 0.6 mol% with 
regards to styrene, Sigma-Aldrich) was added in deionised water (50 µL) and the 
emulsification stirred (350 rpm) at 80 ºC under nitrogen for 1 hour (2.11) and 2 hours 
(2.12). The reaction mixture was allowed to cool before microspheres were collected 
by centrifugation (Table 7.1) and washed with methanol (2 × 10 mL) and deionised 
water (2 × 10 mL). Microspheres were stored in deionised water at 4 ºC. 
 
Table 7.5. Microspheres Prepared with Varying PVP Mw. Yield, size distribution (by laser 
diffractometry), amine loading (by quantitative ninhydrin test, Fmoc test results are included in 
parentheses) and elemental analysis of (2.11) and (2.12). 
 
7.3.10. Preparation of Aminohexanoic-Microspheres, (2.13) – (2.15) 
 
 
0.2 (2.12), 0.5 (2.7.2) and 2 µm (2.10) amino functionalised microspheres (1 mL, 
solid content: 2%, 16.7, 29 and 6.7 µmolg-1 respectively, 1 eq.) were washed in 
dimethylformamide (DMF, 3 × 1 mL) and suspended in DMF (0.5 mL). Separately, 
(2.13) – (2.15) 
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Fmoc-aminohexanoic acid (10 eq., see Table 7.6, Iris Biotech GmbH) was dissolved 
in DMF (0.5 mL) with diisopropylcarbodiimide (DIC, 10 eq., see Table 7.6, Sigma-
Aldrich) and mixed for 10 min at 25 ºC before the addition of 1-
hydroxybenzotriazole hydrate (HOBt, 10 eq., see Table 7.6) and mixed for 10 min at 
25 ºC. The solution was then added to amino microspheres (2.12, 2.7.2 and 2.10) and 
the suspension mixed on a rotary-wheel at 25 ºC for 18 hours. The resultant 
microspheres were washed with DMF (3 × 1 mL), methanol (3 × 1 mL) and 
deionised water (3 × 1 mL) and reaction completion was confirmed by a negative 
qualitative ninhydrin test. Fmoc deprotection was carried out on microspheres 
washed with DMF (3 × 1 mL) with 20% piperidine/DMF (1 mL), requiring 3 cycles 
of 20 min to afford deprotection (as evidenced by qualitative and quantitative 
ninhydrin test). Microspheres were washed sequentially with DMF, methanol and 
deionised water yielding 2.13 (0.2 µm), 2.14 (0.5 µm) and 2.15 (2 µm). 
Aminohexanoic-microspheres were stored in deionised water at 4 ºC. 
 
Table 7.6. Quantities of Fmoc-aminohexanoic acid (Fmoc-Ahx-OH), DIC and HOBt used for 
couplings with 0.2, 0.5 and 2 µm microspheres. Reagents were used in a 10 equivalent excess over 
microsphere loadings. 
Amine Loading (quantitative ninhydrin test): 2.13: 16 µmolg-1; 2.14: 23 µmolg-1; 
2.15: 6.0 µmolg-1. 
 
7.3.11. Preparation of Fluorescein-Microspheres, (2.16) – (2.18) 
 
(2.16) – (2.18) 
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0.2 (2.13), 0.5 (2.14) and 2 µm (2.15) aminohexanoic-microspheres (1 mL, solid 
content: 2%, 16.0, 23.0 and 6.0 µmolg-1 respectively, 1 eq.) were washed in 
dimethylformamide (DMF, 3 × 1 mL) and suspended in DMF (0.5 mL). Separately, 
5(6)-carboxyfluorescein (10 eq., see Table 7.7, Sigma-Aldrich) was dissolved in 
DMF (0.5 mL) with (Benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBOP, 10 eq., see Table 7.7, GL Biochem (Shanghai)), 
HOBt (10 eq., see Table 7.7) and diisopropylethylamine (DIPEA, 10 eq., see Table 
7.7) and mixed for 1 min prior to addition to microspheres (2.13 – 2.15). The 
suspension was mixed on a rotary-wheel at 25 ºC for 18 hours. The resultant 
microspheres were washed with DMF (3 × 1 mL), methanol (3 × 1 mL) and 
deionised water (3 × 1 mL) and reaction completion was confirmed by a negative 
qualitative ninhydrin test, yielding 2.16 (0.2 µm), 2.17 (0.5 µm) and 2.18 (2 µm). 
Fluorescein-microspheres were stored in deionised water at 4 ºC. 
 
Table 7.7. Quantities of 5(6)-carboxyfluorescein, PyBOP, HOBt and DIPEA used for couplings with 
0.2, 0.5 and 2 µm microspheres. Reagents were used in a 10 fold excess over microsphere loadings. 
7.3.12. Cellular Uptake of Fluorescein-Microspheres, (2.16) – (2.18) 
Cells were seeded onto a 24-well plate at a density of 3 × 104 cells/well (volume of 
culture media per well: 350 µL). After 24 hours, beadfections were carried out 
according to the general procedures using 86 µg/mL and analysis of uptake made 
after 6, 12 and 24 hours incubation by flow cytometry in 0.2% trypan blue/HBSS 
(general procedures). 
7.3.13. Microscopy of Beadfected Cells 
Cells were seeded onto a 12-well plate at a density of 6 × 104 cells/well (volume of 
culture media per well: 800 µL). After 24 hours, beadfections were carried out 
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according to the general procedures using 86 µg/mL and microscopy performed after 
24 hours (general procedures). Cells were fixed and stained with AlexaFluor-568 
phalloidin and Hoechst 33342 and imaged in 2% FBS/PBS on a Zeiss Axiovert 200 
M pseudo-confocal microscope. 
7.3.14. Concentration Dependence on Uptake 
Beadfections and flow cytometry were carried out as according to the general 
procedures using 30, 60 and 86 µg/mL and analysis performed after 24 hours.  
7.3.15. Extracellular Quenching of Beadfected B16F10 Cells 
Beadfections were carried out as according to the general procedures with (2.16), 
(2.17) and (2.18) at a concentration of 86 µg/mL. After 10 min, 30 min, 1 hour, 3 
hours, 6 hours, 12 hours and 24 hours cells were analysed via flow cytometric 
analysis in 2% FBS/PBS or 0.2% trypan blue/HBSS. Microscopy was performed as 
described in the general procedures after 24 hours and after 30 min in 2% FBS/PBS, 
then 0.2% trypan blue/HBSS and the fluorescence output of the images compared. 
7.3.16. Serum-Free Cellular Uptake 
Cell cultures and beadfections were carried out as according to the general 
procedures. However, cells were incubated in the appropriate culture media without 
supplementation with foetal bovine serum. Analysis of uptake was made after 6 and 
24 hours by flow cytometry as described in the general procedures.  
7.3.17. In Vivo 
Animal studies were carried out at the Queen’s Medical Research Institute, Centre of 
Inflammation, Little France, Edinburgh by Dr. K. Dhaliwal under licence from the 
Animal Scientific Procedure Division of the Home Office, London, U.K. 
Cy7 labelled microspheres were sterilised by UV and a single intravenous injection 
of Cy7 microspheres (tail vein injection, 30 µg) was made into a 6 week old mouse 
and after 4 hours whole body optical imaging was performed using multi-spectral un-
mixing software to determine the fluorescence emissions.  
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7.4. Experimental for Chapter 3 
 
7.4.1. Preparation of Cy5-Microspheres (3.4) – (3.6) 
 
0.2 (3.4), 0.5 (3.5) and 2 µm (3.6) Cy5-labelled microspheres were prepared in the 
same manner as carboxyfluorescein microspheres (Sections 7.3.10 and 7.3.11) using 
carboxylated Cyanine 5 (5 eq.) in place of 5(6)-carboxyfluorescein.  
 
7.4.2. Chemical Inhibition of Uptake of (2.16), (2.17) and (2.18)  
Cell cultures and beadfections were carried out as described in the general 
procedures, seeding cells onto a 24-well plate at a density of 3 × 104 cells/well (well 
volume: 350 µL) using 86 µg/mL of (2.16), (2.17) and (2.18). Analysis was carried 
out after 3 hours by flow cytometry (general procedures). Controls were established 
with untreated cells and cells treated with microspheres in the absence of chemical 
inhibitors. Additional analysis was carried out by microscopy in 0.2% trypan 
blue/HBSS as described in the general procedures (using a Zeiss Axiovert 200M 
pseudo-confocal microscope). Microscopy of cytochalasin D-treated cells was 
carried out in PBS following staining with Hoechst 33342, fixation in para-




E14, HEK293T, L929, HeLa and B16F10 cells were treated with sodium azide (20 




(3.4) – (3.6) 
 167
Cholesterol Depletion 
B16F10 cells were treated with mβ-cyclodextrin (10 mM, Sigma-Aldrich) and 
lovastatin (1 µg/mL, Tocris Cookson) in serum-free culture media for 1 hour prior to 
beadfection. 
 
Caveolae-Mediated Endocytosis Inhibition 
B16F10 cells were treated with filipin III (5 µg/mL, Sigma-Aldrich) or genistein 
(200 µM, Sigma-Aldrich) in serum-free culture media for 1 hour prior to 
beadfection. 
 
Clathrin-Mediated Endocytosis Inhibition 
B16F10 cells were treated with chlorpromazine (10 µg/mL, Sigma Aldrich) in 
serum-free culture media for 1 hour prior to beadfection. Alternatively, cells were 
washed (3 × 350 µL) and incubated under potassium depleted conditions via a 
potassium-free buffer (140 mM NaCl, 20 mM Hepes, 1 mM CaCl2, 1 mM MgCl2, 1 
mg/mL D-glucose, pH 7.4).  
 
Macropinocytosis Inhibition 
B16F10 cells were treated with cytochalasin D (10 µM, Tocris Cookson) or 
dimethylamiloride (DMA, 10 µM, Sigma-Aldrich) in serum-free culture media for 1 
hour prior to beadfection. 
 
Inhibition of Membrane Ruffling 
B16F10 cells were seeded at a high density (6 × 104 cell/well) and grown to 
approximately 100% confluency prior to beadfection (86 µg/mL). A control was 
established where cells were grown to approximately 50% confluency (seeding 3 × 
104 cell/well) and beadfected with 43 µg/mL microspheres. Analysis of uptake was 
performed after 6 hours. 
 
Microtubule Polymerisation Inhibition 
B16F10 cells were treated with nocodazole (10 µg/mL, Tocris Cookson) in serum-
free culture media for 1 hour prior to beadfection.  
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7.4.3. Toxicity Assays 
MTT toxicity assays were carried out as according to the general procedures. Cells 
were pre-treated with chemical inhibitors (for 1 hour) prior to beadfection (86 
µg/mL) and incubations were run over 3 hours before analysis. 
 
7.4.4. Real-Time Microscopy 
Cells (grown on 24 mm glass coverslips at a density of 1 × 105 cells/coverslip) were 
stained with FM4-64 (5 µg/mL, Invitrogen) in ice cold HBSS (without magnesium or 
calcium) for 1 min. After this time, the staining solution was removed and fresh 
phenol red-free media was added containing 0.5 µm fluorescein-microspheres (2.17) 
(43 µg/mL). The glass coverslip was mounted on a DeltaVision RT microscope fitted 
with an incubation chamber (37 ºC/5% CO2) and cells were imaged confocally (100 
nm slices) repeatedly over 30 min. Fluorescein-microspheres were excited using a 
490/20nm excitation filter and collecting emission using a 528/38 nm band-pass filter 
and FM4-64 was excited using a 555/28 nm excitation filter and collecting emission 
using a 617/73 nm band-pass filter. 
 
7.4.5. Lysosomal Staining 
Cells (grown on 24 mm glass coverslips at a density of 1 × 105 cells/coverslip) were 
beadfected with Cy5-microspheres ((3.4) – (3.6), 86 µg/mL) added in fresh media 
and incubated with cells for 12 hours. After this time, the old media was removed 
and the beadfected cells were washed with PBS (1 mL) prior to the addition of 
LysoTracker Red DND-99 (50 pM, 1 mL, Invitrogen). Cells were incubated for a 
further 2 hours (37 ºC/5% CO2) before washing with PBS (1 mL). Glass slides were 
mounted on a Leica inverted confocal microscope in 2% FBS/PBS. Cy5-
microspheres were excited with a 633 nm red diode laser and emission collected at 
640 – 700 nm. LysoTracker Red DND-99 was excited using a 543 nm HeNe laser 
and emission collected at 580 – 600 nm. Positive controls were established in the 





7.4.6. Uptake of BODIPY-LacCer and FITC-Transferrin 
B16F10 cells were seeded to a 24-well plate at a density of 3 × 104 cells/well 
(volume of culture media per well: 350 µL). 
After 24 hours, the old media was removed and replaced with fresh media containing 
sodium azide (20 mM). Cells were incubated at 37 ºC/5% CO2 for 1 hour prior to the 
addition of BODIPY-LacCer (5 µM, Invitrogen) or FITC-Transferrin (70 µg/mL, 
Invitrogen) (controls were established with untreated cells and cells treated with 
LacCer or transferrin but not treated with any chemical inhibitors). Cells were 
incubated for a further 2 hours. After this time the old media was removed and cells 
incubated with LacCer were washed with 1% bovine serum albumin (BSA) in PBS 
(2 × 200 µL) and cells incubated with transferrin were washed with an acidic buffer 
(pH 5.0, 2 × 200 µL). Cells were washed with PBS and trypsinised in the usual 
manner and re-suspended for flow cytometry in 2% FBS/PBS. Untreated cells were 
considered to have an uptake of 0%. 
A similar procedure was used adding mβ-cyclodextrin (10 mM) and lovastatin (1 
µg/mL) for cholesterol depletion. Uptake of transferrin was additionally analysed 
under clathrin-mediated endocytosis inhibition using chlorpromazine (10 µg/mL) and 
potassium depletion (see general procedures). Uptake of LacCer was analysed under 
caveolae-mediated endocytosis inhibition using filipin III (5 µg/mL) and genistein 
(200 µM). 
 
7.4.7. Temperature Dependence on Uptake 
B16F10 cells were seeded onto a 24-well plate at a density of 3 × 104 (volume of 
culture media per well: 350 µL). 
After 24 hours, the old media was removed and replaced with fresh media containing 
fluorescein-microspheres ((2.16) – (2.18), 86 µg/mL). Cells were incubated for 3 
hours at 37, 20 or 4 ºC prior to washing, trypsination and flow cytometry as 
described in the general procedures. Microscopy of the cells was performed in 2% 
FBS/PBS as described in the general procedures. 
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7.4.8. Scanning Electron Microscopy of Beadfected Cells 
 B16F10 cells were seeded onto a 24 mm glass coverslip at a density of 2 × 105 
cells/well (volume of culture media per well: 1.5 mL). 
After 24 hours, the old media was removed and replaced with fresh media containing 
2 µm fluorescein-microspheres, (2.18) (86 µg/mL). After 2, 6 and 24 hours cells 
were washed with PBS (1 mL) and fixed with 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4, 1 mL) at room temperature for 2 hours. After washing 
with 0.1 M cacodylate buffer (2 × 1 mL), the cells were post-fixed with 1% osmium 
tetroxide (1 mL) for 1 h at room temperature, dehydrated through graded ethanol (50, 
70, 90 and 100%) and critical point dried in CO2. The glass coverslips were mounted 
onto carbon-coated stubs and gold coated by sputtering prior to analysis by SEM.  
 
7.4.9. Membrane Leakage to Propidium Iodide 
Cells were seeded onto a 24-well plate at a density of 3 × 104 cells/well (volume of 
culture media per well: 350 µL). 
After 24 hours, the old media was removed and replaced with fresh media containing 
Cy5-microspheres ((3.4) – (3.6), 86 µg/mL) and propidium iodide (14 µg/mL, 
Sigma-Aldrich). After 3 hours, the old media was removed and the cells were 
washed and harvested for flow cytometric analysis in 2% FBS/PBS (general 
procedures). Controls were established with untreated cells, cells treated only with 
Cy5 microspheres, cells treated with only propidium iodide (for 3 hours and for 30 
min), cells treated with Cy5-microspheres for 3 hours followed by propidium iodide 
for 30 min and cells treated with BODIPY-LacCer and propidium iodide. 
Microscopy was performed on cells as according to the general procedures in 2% 
FBS/PBS exciting Cy5-microspheres with a red diode 633 nm laser and collecting 
emission at 640 – 700 nm. Propidium iodide was excited with an argon 488 nm laser 




7.4.10. Membrane Leakage to Trypan Blue 
Cultures were performed replacing propidium iodide with trypan blue (6 µg/mL) and 
fluorescein-microspheres is replace of Cy5-microspheres. Controls were established 
as for propidium iodide. 
Microscopy was performed on cells washed with PBS in 2% FBS/PBS exciting 
Fluorescein-microspheres with an argon ion 488 nm laser and collecting emission at 
510 – 530 nm. Trypan blue was excited with a red diode 633 nm laser and collecting 

















7.5. Experimental to Chapter 4 
7.5.1 Preparation of Magnetic Microspheres, (4.1) 
 
 
Polymerisations were performed on a 12-tube Radley carousel fitted with a water 
condenser and nitrogen inlet valves. 
In a typical polymerisation, PVP (Mw 360,000; 1.8 g, 5 µmol, 0.2 mol% with regards 
to styrene) was dissolved in nitrogen-purged ethanol : deionised water (93:7, 5 mL). 
Iron oxide nanopowder (Fe2O3, 8.2 mg, 52 µmol, 2 mol% with regards to styrene, 
Sigma-Aldrich) was dispersed in the solution by sonication (10 min). To this, 
nitrogen-purged styrene (0.3 mL, 2.6 mmol, 1 eq.) with DVB (4.3 µL, 29 µmol, 1.3 
mol% with regards to styrene), VBAH (8.7 mg, 64 µmol, 2.8 mol% with regards to 
styrene) and AIBN (7 mg, 43 µmol, 1.9 mol% with regards to styrene) were added 
and the resultant mixture stirred (350 rpm) at 25 ºC under nitrogen. After 2 hours, the 
temperature was increased to 70 ºC and the reaction stirred (350 rpm) under nitrogen 
at this temperature for 18 hours, facilitating the precipitation of the microspheres. 
The reaction mixture was allowed to cool before microspheres were collected by 
centrifugation (Table 7.1) and were washed and purified according to the general 
procedures. Magnetic microspheres were stored in deionised water at 4 ºC. 
Yield: 0.03 g (11%). 
Size Distribution (by laser diffractometry): Mean 0.3 µm, S.D. 0.06 µm, C.V. 19%. 
Amine Loading (quantitative ninhydrin test): 9.5 µmolg-1. 
Amine Loading (Fmoc test): 5.3 µmolg-1. 






7.5.2. Preparation of Magnetic Microspheres, (4.2) by PVP 40,000 
Polymerisations were performed as according to Section 7.5.1 using PVP with a 
molecular weight of 40,000 (0.2g, 5 µmol, 0.2 mol% with regards to styrene). 
Yield: 0.03 g (11%). 
Size Distribution (by laser diffractometry): Mean 2.0 µm, S.D. 2.0 µm, C.V. 92%. 
Amine Loading (quantitative ninhydrin test): 4.9 µmolg-1. 
Amine Loading (Fmoc test): 4.3 µmolg-1. 
Elemental Analysis: C 61.5, H 3.2, N 0.3 (Amine Loading: 0.21 mmolg-1). 
 
7.5.3. Preparation of Magnetic Microspheres, (4.3) by DVB Post-Addition 
Polymerisations were performed as according to Section 7.5.1 using PVP with a 
molecular weight of 40,000 (0.2g, 5 µmol, 0.2 mol% with regards to styrene) and 
adding DVB (4.3 µL, 29 µmol, 1.3 mol% with regards to styrene) after heating to 70 
ºC and stirring at this temperature until a very faint opaque solution resulted. 
Yield: 0.13 g (46%). 
Size Distribution (by laser diffractometry): Mean 1.6 µm, S.D. 1.1 µm, C.V. 66%. 
Amine Loading (quantitative ninhydrin test): 18.3 µmolg-1. 
Amine Loading (Fmoc test): 18.0 µmolg-1. 
Elemental Analysis: C 90.6, H 7.5, N 0.5 (Amine Loading: 0.36 mmolg-1). 
 
7.5.4. Preparation of Aminohexanoic-Magnetic Microspheres, (4.4) – (4.6) 
 
 (4.4) – (4.6) 
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Aminohexanoic-magnetic microspheres were prepared from (4.1), (4.3) and (4.2) as 
according to Section 7.3.10, yielding (4.4), (4.5) and (4.6) respectively. 
Aminohexanoic-microspheres were stored in deionised water at 4 ºC. 
Amine Loading (quantitative ninhydrin test): (4.4): 9.0 µmolg-1; (4.5): 17.9 µmolg-1; 
(4.6): 4.3 µmolg-1. 
 
7.5.5. Preparation of Fluorescein-Magnetic Microspheres, (4.7) – (4.9) 
 
 
Fluorescein labelled magnetic microspheres were prepared from aminohexanoic 
magnetic microspheres (4.4), (4.5) and (4.6), yielding (4.7), (4.8) and (4.9) 
respectively as according to Section 7.3.11. Fluorescein-microspheres were stored in 
deionised water at 4 ºC. 
 
7.5.6. Biased Cellular Movement 
Petri-Dish 
HEK293T cells were cultured (in a 6-well plate at a density of 2 × 105 cell/well) and 
beadfected with (4.8) fluorescein microspheres (general procedures). After 24 hours, 
cells were washed with PBS (1 mL) and harvested via trypsination (trypsin/EDTA, 
100 µL). Detached cells were collected in growth media (900 µL) and the cell pellet 
obtained by centrifugation (1200 rpm, 4 min). Cells were re-suspended in growth 
media (DMEM, 1 mL) and sorted based on their beadfection with fluorescein 
microspheres using a BD Biosciences FACSAria® system. Beadfected cells were 
collected in a sorting chamber containing growth media and isolated after sorting by 
(4.7) – (4.9) 
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centrifugation (1200 rpm, 4 min). Beadfected cells were re-suspended in growth 
media (2 mL) and seeded to a petri-dish (35 mm diameter) over a neodymium disc 
magnet (1 cm diameter). Beadfected cells were incubated over the magnet at 37 
ºC/5% CO2 for 24 hours. After this time, microscopy was performed at random 
positions close to (< 5 mm) and far from (> 2 cm) the magnet. 
Magnetic Sublimation of Cells 
HEK293T cells were cultured, beadfected and sorted as described above. After 
sorting, cells were collected by centrifugation (1200 rpm, 4 min) and re-suspended in 
2% FBS/PBS (1 mL) with a cell density of approximately 6 × 106 cell/mL. The cell 
suspension was transferred to a 1.5 mL eppendorf and placed in a neodymium 
magnetic separator. Attraction of the beadfected ‘magnetic’ cells to the external 














7.6. Experimental for Chapter 5 
 
7.6.1. Preparation of Particles by Addition of Diethylketone, (5.1) 
Polymerisations were carried out according to Section 7.3.5. However, precipitation 
of particles was from ethanol : diethylketone (98:2, 5 mL). 
Yield: 0.09 g (32%). 
Size Distribution (by laser diffractometry): Mean 2.3 µm, S.D. 0.9 µm, C.V. 40%. 
Amine Loading (quantitative ninhydrin test): 7.1 µmolg-1. 
Amine Loading (Fmoc test): 7.0 µmolg-1. 
Elemental Analysis: C 91.8, H 4.4, N 0.3 (Amine Loading: 0.21 mmolg-1). 
 
 
7.6.2. Preparation of Particles by Addition of Isopropyl Alcohol, (5.2) 
Polymerisations were carried out as above with precipitation from ethanol : IPA 
(98:2, 5 mL). 
Yield: 0.14 g (50%). 
Size Distribution (by laser diffractometry): Mean 1.8 µm, S.D. 0.3 µm, C.V. 16%. 
Amine Loading (quantitative ninhydrin test): 9.2 µmolg-1. 
Amine Loading (Fmoc test): 9.0 µmolg-1. 
Elemental Analysis: C 91.8, H 7.8, N 0.5 (Amine Loading: 0.36 mmolg-1). 
 
 
7.6.3. Preparation of Particles of Addition of Tetrahydrofuran, (5.3) 
Polymerisations were carried out as above with precipitation from ethanol : THF 
(95:5, 5 mL). 
Yield: 0.1 g (36%). 
Size Distribution (by laser diffractometry): Mean 1.6 µm, S.D. 0.3 µm, C.V. 21%. 
Amine Loading (quantitative ninhydrin test): 5.2 µmolg-1. 
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Amine Loading (Fmoc test): 4.9 µmolg-1. 
Elemental Analysis: C 91.1, H 7.7, N 0.5 (Amine Loading: 0.36 mmolg-1). 
 
 
7.6.4. Preparation of Particles by Addition of 1,4-Dioxane, (5.4) – (5.14) 
Polymerisations were carried out as above with precipitation from ethanol : 1,4-
dioxane (99.5:0.5 – 90:10, 5 mL). Addition of 5% dioxane in ethanol facilitated 
precipitation of micro-doughnuts (5.9). 
 
Table 7.8. Micro-Doughnut Preparation. Yield, size distribution (by laser diffractometry), amine 
loading (by quantitative ninhydrin test, Fmoc test results are included in parentheses) and elemental 
analysis of (5.4) - (5.14). (5.9) are micro-doughnuts. 
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7.6.5. Preparation of Aminohexanoic Micro-Doughnuts, (5.15) 
 
 
Aminohexanoic micro-doughnuts (5.15) were prepared from (5.9) in the same 
manner as aminohexanoic microspheres (Section 7.3.10). Aminohexanoic-micro-
doughnuts were stored in deionised water at 4 ºC. 
Amine Loading (quantitative ninhydrin test): 9.0 µmolg-1. 
 
7.6.6. Preparation of Fluorescein, Rhodamine B and Cy7 Micro-doughnuts, (5.16) – 
(5.18) 
                    
 
 
Fluorescein, rhodamine B and Cy7 micro-doughnuts (5.16), (5.17) and (5.18) 
respectively were prepared from (5.15) in the same manner as fluorescein 









7.6.7. Preparation of Dansyl Microspheres 
 
0.5 µm aminohexanoic microspheres (2.14) (1 mL, solid content: 2%, 23.0 µmolg-1) 
were washed in dimethylformamide (DMF, 3 × 1 mL) and suspended in DMF (0.5 
mL). Separately, dansyl-chloride (1.2 mg, 4.6 µmol, 10 eq., Sigma-Aldrich) was 
dissolved in DMF (0.5 mL) with DIPEA (0.8 µL, 4.6 µmol, 10 eq.) and mixed for 1 
min prior to addition to microspheres (2.14). The suspension was mixed on a rotary-
wheel at 25 ºC for 18 hours. The resultant microspheres were washed with DMF (3 × 
1 mL), methanol (3 × 1 mL) and deionised water (3 × 1 mL) and reaction completion 
was confirmed by a negative qualitative ninhydrin test. Dansyl-microspheres were 
stored (in foil) in deionised water at 4 ºC. 
 
7.6.8. Doughnut-Fection of Cells 
Doughnut-fections were carried out in a similar manner to beadfections (general 
procedures), using 86 µg/mL fluorescein micro-doughnuts and performing 
incubations over 6, 12 and 24 hours prior to analysis by flow cytometry (in 0.2% 
trypan blue/HBSS) as described in the general procedures.  
 
7.6.9. Microscopy of Doughnut-fected Cells 
Microscopy and staining of doughnut-fected cells was carried out as according to the 
general procedures in 2% FBS/PBS using a Leica inverted confocal microscope. 
In the case of multiplexing assays, cells were imaged by confocal microscopy 
exciting rhodamine B doughnuts with a 543 nm HeNe laser and collecting emission 
at 560 nm – 650 nm, exciting dansyl microspheres with a 405 nm laser and collecting 
emission at 450 nm – 550 nm and exciting Cy5 microspheres with a 633 nm red 
diode laser and collecting emission at 650 nm – 700 nm. 
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7.6.10. Micro-doughnut Multiplexing 
HEK293T and B16F10 cells were cultured in DMEM as described in the general 
procedures. Cells were seeded at a density of 3 × 104 cell/well to a 24-well plate. 
After 24 hours, HEK293T cells were beadfected with 0.5 µm Cy5 microspheres (86 
µg/mL) and B16F10 cells were beadfected with 0.5 µm dansyl microspheres (86 
µg/mL). Cells were incubated with microspheres (37 ºC/5% CO2) for 24 hours. After 
this time the cells were sorted based on their Cy5 or dansyl fluorescence collecting 
only beadfected cells. These cells (approximately 1 × 105) were isolated by 
centrifugation and mixed in DMEM growth media (1.5 mL) before seeding at a 
density of 3 × 104 to a 24-well plate. After 24 hours, 0.5 µm fluorescein 
microspheres (2.17) (86 µg/mL) or rhodamine micro-doughnuts (5.17) (86 µg/mL) 
were added to mixed cell cultures and incubated for a further 24 hours. After this 
time, analysis was made by flow cytometry (general procedures) to determine uptake 
of (2.17) and (5.17) by HEK293T (Cy5 positive) and B16F10 (dansyl positive) cells. 
 
7.6.11. In Vivo Doughnut-fection 
All animal studies (including histology) were carried out at the Queen’s Medical 
Research Institute, Centre of Inflammation, Little France, Edinburgh by Dr. K. 
Dhaliwal.  
Cy7 labelled micro-doughnuts (5.18) were sterilised by UV prior to animal studies 
and all animal experiments were undertaken with an approved licence from the 
Animal Scientific Procedure Division of the Home Office, London, U.K. 
A single intravenous injection of Cy7 micro-doughnuts (tail vein injection, 30 µg) 
was made into a 6 week old mouse and after 4 hours whole body optical imaging was 
performed using multi-spectral un-mixing software to determine the fluorescence 
emissions. Cy7 micro-doughnuts were artificially coloured yellow. Chlorophyll was 
administered orally to show gut location. 
 
7.6.12. Histology of Doughnut-fected Liver 
After 4 hours of in vivo doughnut-fection, the liver was excised from the animal and 
frozen over solid carbon dioxide. The frozen organ was then thinly sliced into 5 – 10 
µm sections, which were mounted onto glass microscope slides and imaged. 
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7.7. Experimental for Chapter 6 
 
7.7.1. siRNA Sequences 
Three unfunctionalised siRNA sequences (Qiagen) were lipofected (Lipofectamine™ 
2000, Invitrogen) for EGFP gene silencing assessment. siRNA sequences (GFP-1 
and negative) were subsequently purchased functionalised with an amine (via a C-6 
linker, Microsynth) at the 5’ end of the sense strand to facilitate coupling to 
microspheres. In the case of TAMRA siRNA, the fluorophore was located on the 5’ 
end of the anti-sense strand (Dharmacon). 
 
Table 7.9. siRNA sequences for EGFP gene silencing. ‘Negative’ refers to scrambled siRNA, with no 
homology to the target sequence.  
 
7.7.2. Lipofection with Lipofectamine™ 2000 
HeLa-EGFP and ES-EGFP cells were seeded in the appropriate growth media to 24-
well plates (ES-EGFP cells required plates gelatinised with 0.1% gelatine/PBS) at a 
density of 3 × 104 cell/well (well volume: 350 µL). 
For each well, Lipofectamine™ 2000 (1 µL) was incubated in PBS (50 µL) at 25 ºC 
for 5 min. It was then added to siRNA (20 pmol) in PBS (50 µL) and incubated at 25 
ºC for 20 min.  
After 24 hours, the old media was removed from the cells and replaced with fresh 
serum- and antibiotic-free media (250 µL) containing siRNA treated with 
Lipofectamine™ 2000 in PBS (100 µL). After 24 – 72 hours cells were washed, 
harvested by trypsination and prepared for flow cytometric analysis as described in 
the general procedures.  
 
7.7.3. Controls for Gene Silencing 
As well as lipofecting cells with siRNA delivered by Lipofectamine™ 2000, several 
other controls were established: 
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HeLa-EGFP and ES-EGFP cells were seeded in the appropriate growth media to 24-
well plates (ES-EGFP cells required plates gelatinised with 0.1% gelatine/PBS) at a 
density of 3 × 104 cell/well (well volume: 350 µL). 
After 24 hours, the old media was removed and replaced with fresh serum-free and 
antibiotic-free media containing scrambled siRNA lipofected with Lipofectamine™ 
2000 (as Section 7.7.2), siRNA (GFP-1) alone, microspheres conjugated to 
scrambled siRNA (86 µg/mL, 28 nM siRNA) and microspheres alone (86 µg/mL). 
Analysis of EGFP expression was made by flow cytometry (general procedures) and 
compared to untreated cells. 
 





In a typical reaction, Fmoc-PEG-OH (10 eq. see Table 7.10) was activated with DIC 
(10 eq. see Table 7.10) in DMF (0.5 mL) for 10 min at 25 ºC, followed by HOBt (10 
eq. see Table 7.10) for 10 min at 25 ºC. The resulting solution was added to (2.10), 
(2.72) and (2.12) suspended in DMF (0.5 mL, 4% sc). The resulting suspension was 
mixed on a rotary wheel at 25 ºC for 18 hours. After this time, the microspheres were 
washed with DMF (3 × 1 mL), methanol (3 × 1 mL), deionised water (3 × 1 mL) and 
finally DMF (3 × 1 mL). Fmoc deprotection was achieved by treating microspheres 
with 20% piperidine/DMF (1 mL, 3 × 20 min). Microspheres were washed 
sequentially with DMF, methanol and deionised water, yielding 0.2 (6.1.3), 0.5 
(6.1.2) and 2 µm (6.1.1) PEGylated microspheres. Microspheres were stored in 






Table 7.10. Quantities of Fmoc-PEG-OH, DIC and HOBt used for coupling with the 0.2, 0.5 and 2 
µm microspheres. Reagents were used in a 10 equivalent excess over microsphere loadings. 
 




In a typical reaction, succinic anhydride (10 eq. see Table 7.11) and DIPEA (10 eq. 
see Table 7.11) in DMF (0.5 mL) were added to either (6.1.1), (6.1.2) or (6.1.3) 
suspended in DMF (0.5 mL, 4% sc). The resulting suspension was mixed on a rotary 
wheel at 25 ºC for 18 hours. After this time, the microspheres were washed with 
DMF (3 × 1 mL), methanol (3 × 1 mL) and deionised water (3 × 1 mL), yielding 0.2 
(6.2.3), 0.5 (6.2.2) and 2 µm (6.2.1) succinic microspheres. Microspheres were stored 
in deionised water at 4 ºC. 
 
Table 7.11. Quantities of succinic anhydride and DIPEA used for couplings with 0.2, 0.5 and 2 µm 
microspheres. Reagents were used in a 10 equivalent excess over microsphere loadings. 
 
7.7.6. Preparation of PEG-Disulphide Microspheres, (6.4.1) – (6.4.2) 
 
 
(6.2.1) – (6.2.3) 
(6.4.1) – (6.4.2) 
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Carboxyethyldisulphide (10 eq. see Table 7.12) was activated with DIC (10 eq. see 
Table 7.12) in DMF (0.5 mL) for 10 min at 25 ºC, followed by HOBt (10 eq. see 
Table 7.12) for 10 min at 25 ºC. The resulting solution was added to (6.1.2) or 
(6.1.3) suspended in DMF (0.5 mL, 4% sc). The resulting suspension was mixed on a 
rotary wheel at 25 ºC for 18 hours. After this time, the microspheres were washed 
with DMF (3 × 1 mL), methanol (3 × 1 mL) and deionised water (3 × 1 mL), 
yielding 0.2 (6.4.2) and 0.5 µm (6.4.1) disulphide microspheres. Microspheres were 
stored in deionised water at 4 ºC. 
 
Table 7.12. Quantities of carboxyethyldisulphide, DIC and HOBt used for couplings with 0.2 and 0.5 
µm microspheres. Reagents were used in a 10 equivalent excess over microsphere loadings. 
 





Succinic and disulphide microspheres (100 µL, 2% sc) (6.2.1), (6.2.2), (6.2.3), 
(6.4.1) and (6.4.2) were isolated by centrifugation and washed with MES buffer (pH 
5.5, 3 × 100 µL) before activation with EDAC.HCl (10 eq., Sigma-Aldrich) in MES 
(100 µL) for 2 hours. Microspheres were isolated by centrifugation and treated with 
RNase Zap™ solution (100 µL, Ambion) before being transferred to an RNase-free 
eppendorf and washed with RNase-free deionised water (100 µL). siRNA (GFP-1, 1 
nmol) was added to microspheres in RNase-free PBS (100 µl) and shaken at 25 ºC 
for 24 hours. After this time siRNA-microspheres were isolated by centrifugation, 
yielding 0.5 (6.3.2), 0.2 µm (6.3.3) succinic siRNA microspheres and 0.5 (6.6.1), 0.2 
(6.3.2) – (6.3.3) 
(6.6.1) – (6.6.2)
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µm (6.6.2) disulphide-siRNA microspheres, stored in RNase-free deionised water at 
4 ºC. 
 
7.7.8. Analysis of siRNA Loading on Microspheres 
0.2 (6.1.3) and 0.5 µm (6.1.2) succinic microspheres (100 µL, 3% sc) were loaded 
with TAMRA-labelled siRNA as according to Section 7.7.7, yielding 0.2 (6.3.3) and 
0.5 µm (6.3.2) siRNA microspheres. Following coupling, siRNA microspheres were 
obtained by centrifugation and washed with RNase-free deionised water (100 µL) 
and the supernatant collected and analysed by spectrofluorometry (excitation: 540 
nm, emission collected over 560 – 700 nm). 
Calibration solutions of TAMRA-labelled siRNA in RNase-free deionised water 
were prepared at concentrations of 0.25, 0.15, 0.1 and 0.05 µM and analysed by 
spectrofluorometry. 
The emission maximum was found at 580 nm and the fluorescence intensity at this 
wavelength was plotted against the solution siRNA concentration, giving a linear 
relationship. From this the concentration of siRNA present in supernatants collected 
from (6.3.2) and (6.3.3) was calculated and found to be 0.3 and 0.4 µM respectively. 
Given that 1 nmol of siRNA was originally added to microspheres, this allows the 
concentration of siRNA on the microspheres to be calculated as follows: 
The 0.2 µm bead-siRNA supernatant contained 4 × 10-11 moles of siRNA and the 0.5 
µm bead-siRNA supernatant 3 × 10-11 mol of siRNA. A total of 1 × 10-9 moles 
siRNA was added to the beads originally thus the 0.2 µm beads must have retained 
9.6 × 10-10 moles siRNA (96% of siRNA coupled to microspheres) and the 0.5 µm 
beads must have retained 9.7 × 10-10 moles siRNA (97% of siRNA coupled to 
microspheres). 
The number of beads per gram of solid can be calculated by Equation 7.7. 
 
Number of beads/g = 6 × 1012 / (π × ρ × d3) 
Equation 7.7. Number of microspheres per gram of solid, where ‘ρ’ is the density of the microspheres 





0.2 µm siRNA Microspheres 
In the case of 0.2 µm microspheres, there are 2.4 × 1014 beads/g and in a 100 µL 
aliquot (solid content of 3%, as used in the siRNA couplings) there was 3 mg of 
beads. This equates to 7.2 × 1011 beads, therefore each bead holds, on average, 1.3 × 
10-21 moles of siRNA, which equates to 783 molecules of siRNA per bead.  
In a typical culture where 86 µg/mL microspheres (or 2.1 × 1010 beads/mL) are 
added to cells, 1.3 × 10-21 moles of siRNA per bead equates to 9.4 × 10-12 moles 
siRNA per culture. Given the cell culture volume is 350 µL, this gives a 
concentration of 2.7 × 10-8 moldm-3. 
 
0.5 µm siRNA Microspheres 
In the case of 0.5 µm microspheres, there are 1.5 × 1013 beads/g and in a 100 µL 
aliquot at a solid content of 3% (as used in the siRNA couplings) this equates to 3 mg 
of beads. This equates to 4.5 × 1010 beads, therefore each bead holds, on average, 2.2 
× 10-20 moles of siRNA, which equates to 13,244 chains of siRNA per bead. 
In a typical culture where 86 µg/mL (or 1.3 × 109 beads/mL) microspheres are added 
to cells, 2.2 × 10-20 moles of siRNA per bead equates to 1.0 × 10-11 moles siRNA per 
culture. Given then cell culture volume is 350 µL, this gives a concentration of 2.8 × 
10-8 moldm-3. 
 
7.7.9. siRNA stability on Microspheres 
siRNA microspheres (6.3.2) and (6.3.3) were incubated (37 ºC/5% CO2) in complete 
growth media, serum-free media, phenol red- and serum-free media and PBS (pH 
7.4) for 30 min to 24 hours. Microspheres were collected by centrifugation and 
analysed for TAMRA fluorescence by flow cytometry in RNase-free PBS and 







7.7.10. Preparation of PEG-Fluorescein (Succinic/Disulphide) Microspheres (6.5.1), 
(6.5.2), (6.7.1), (6.7.2) 
 
          
 
 
Succinic and disulphide microspheres (1 mL, 2% sc) (6.2.2), (6.2.3), (6.4.1) and 
(6.4.2) were isolated by centrifugation and washed with DMF (3 × 1 mL) before 
being suspended in DMF (0.5 mL). To these, DIC (10 eq. see Table 7.13) and HOBt 
(10 eq. see Table 7.13) were added in DMF (0.5 mL) and the resulting suspension 
mixed on a rotary wheel for 5 hours at 25 ºC. After this time, fluoresceinamine (10 
eq. see Table 7.13) was added and the suspension mixed in the dark at 25 ºC for 18 
hours. Microspheres were washed with DMF (3 × 1 mL), methanol (3 × 1 mL) and 
deionised water (3 × 1 mL) and finally stored in deionised water at 4 ºC, yielding 0.2 
(6.5.2) and 0.5 µm (6.5.1) disulphide-FAM and 0.2 (6.7.2) and 0.5 µm (6.7.1) 
succinic-FAM microspheres. 
 
Table 7.13. Quantities of fluoresceinamine, DIC and HOBt used for couplings with 0.2 and 0.5 µm 
microspheres. Reagents were used in a 10 equivalent excess over microsphere loadings. 
 
7.7.11. Disulphide Cleavage with Glutathione and DTT 
(6.5.1) and (6.5.2) disulphide-FAM microspheres were treated with glutathione 
(Sigma-Aldrich) (10 mM) or dithiothreitol (DTT, Sigma-Aldrich) (10 mM) in PBS 
(pH 7.4) for 1, 6 and 24 hours. Cleavage was assessed via the reduction in 
fluorescence intensity of the microspheres compared to untreated control beads by 
flow cytometry (in PBS). (6.7.2) and (6.7.1) succinic-FAM microspheres were 
additionally treated with glutathione and DTT as controls. 
(6.5.1) – (6.5.2) (6.7.1) – (6.7.2) 
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7.7.12. Preparation of Lysine Microspheres, (6.8.1) 
 
 
PEGylated 0.5 µm microspheres (1 mL, 2% sc) (6.1.2) were washed with DMF (3 × 
1 mL) and re-suspended in DMF (0.5 mL) prior to addition of orthogonally protected 
Fmoc-Lysine(Dde)-OH (3.0 mg, 5.7 µmol, 10 eq.) pre-activated with DIC (0.9 µL, 
5.7 µmol, 10 eq.) (10 min, 25 ºC) and HOBt (0.8 mg, 5.7 µmol, 10 eq.) (10 min, 25 
ºC) in DMF (0.5 mL). The resulting suspension was mixed on a rotary wheel for 18 
hours at 25 ºC. Microspheres were obtained by centrifugation and subsequently 
washed with DMF (3 × 1 mL), methanol (3 × 1 mL), deionised water (3 × 1 mL) and 
finally DMF (3 × 1 mL). Fmoc deprotection was facilitated in 20% piperidine/DMF 
(1 mL, 3 × 20 min), yielding free amino residues, which were PEGylated as 
described in Section 7.7.4, yielding (6.8.1). PEG residues were not Fmoc deprotected 
at this stage. 
 
7.7.13. Preparation of Cy5 Lysine (Disulphide/Succinic) Microspheres, (6.10.1), 
(6.11.1) 
              
(6.8.1) Lysine microspheres (1 mL, sc 2%) were washed with DMF (3 × 1 mL) and 
suspended in DMF (0.5 mL) before treatment with hydroxylamine.HCl (0.4 mmol) 




this time, microspheres were washed sequentially with methanol and then returned to 
DMF (0.5 mL). Cy5 (1.8 mg, 2.9 µmol, 5 eq.) in DMF (0.5 mL) activated with 
PyBOP (1.5 mg, 2.9 µmol, 5 eq.), HOBt (0.4 mg, 2.9 µmol, 5 eq.) and DIPEA (0.5 
µL, 2.9 µmol, 5 eq.) was added to microspheres and the resulting suspension mixed 
on a rotary wheel for 18 hours at 25 ºC. Microspheres were washed sequentially with 
DMF (3 × 1 mL), methanol (3 × 1 mL), deionised water (3 × 1 mL) and DMF (3 × 1 
mL). Fmoc deprotection of the PEG residue was subsequently achieved by treatment 
of microspheres with 20% piperidine/DMF (1 mL, 3 × 20 min) followed by washing 
with DMF, methanol and deionised water as previous, yielding (6.9.1). Microspheres 
were returned to DMF (0.5 mL) and coupled with succinic anhydride (see Section 
7.7.5) yielding (6.11.1) or carboxyethyldisulphide (see Section 7.7.6) yielding 
(6.10.1). Microspheres were stored in deionised water. 
 
7.7.14. siRNA Coupling for Dual Functionalised Microspheres, (6.12.1), (6.13.1) 
              
(6.10.1) and (6.11.1) (2 × 0.5 mL, 2% sc) were washed with MES buffer (pH 5.5, 3 × 
0.5 mL) and re-suspended in MES (250 µL). Microspheres were activated with 
EDAC.HCl (1.1 mg, 5.7 µmol, 10 eq.) in MES (250 µL) for 2 hours prior to the 
addition of siRNA (GFP-1, 1 nmol) as according to Section 7.7.7, yielding 
disulphide (6.12.1) and succinic (6.13.1) Cy5-co-siRNA microspheres. 
 
7.7.15. Disulphide Cleavage in HeLa Cells 
Cells were seeded to a 24-well plate at a density of 3 × 104 cell/well and beadfected 
as described in the general procedures with  (6.5.1) and (6.5.2) disulphide-FAM 
(6.12.1) (6.13.1) 
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microspheres (86 µg/mL). Cells were imaged by microscopy as according to the 
general procedures after 6, 12 and 24 hours on a Zeiss Axiovert 200M pseudo-
confocal microscope in 2% FBS/PBS. 
 
7.7.16. Microscopy of Gene Silencing and Cell Staining 
Assessment of GFP silencing by microscopy was made in 2% FBS/PBS as according 
to the general procedures after 24, 48 and 72 hours. Staining of cells with Hoechst 
33342 and AlexaFluor®-568 phalloidin was achieved as according to the general 
procedures. 
 
7.7.17. Toxicity of (6.3.2), (6.3.3), (6.6.1) and (6.6.2) by MTT Assays 
Toxicity assays with MTT were carried out as according to Section 7.2.18 using 43 
and 86 µg/mL of microspheres and analysis was performed after 72 hours. 
 
7.7.18. Beadfection of Cells for Gene Silencing 
Beadfections with siRNA microspheres were carried out as according to the general 
procedures. However, siRNA microspheres were added to cells in serum-free media, 
which was exchanged for complete growth media after 24 hours. Analysis of EGFP 
expression was made after 24, 48 and 72 hours by flow cytometry and by microscopy 
(general procedures). 
 
7.7.19. Beadfection of Cells with Cy5-co-siRNA Microspheres for Gene Silencing  
Beadfections were carried out as according to the general procedure.  
Analysis of EGFP expression was made after 24, 48 and 72 hours by flow cytometry 
selecting only those cells that were positive for Cy5 (i.e. beadfected cells). Analysis 
was additionally made by confocal microscopy using a Leica confocal microscope, 
exciting EGFP with a 488 nm argon laser and collecting emission at 500 nm – 560 
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